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ABSTRACT 
Phenotypic heterogeneity in the yeast Saccharomyces cerevisiae has input from both genetic 
and epigenetic determinants. In addition to changes in DNA sequence induced by mutagens and 
error-prone mechanisms, there are a variety of ‘non-mutagenic’ chemicals that can trigger 
inherited changes in phenotype. One such agent, guanidine hydrochloride (GdnHCl), can both 
generate mitochondrial petite mutants and also induce the loss of various prions from this yeast 
species. Prions are novel protein-based epigenetic determinants that undergo self-perpetuating, 
heritable changes in their structure, resulting in the aggregation of an alternative conformational 
form of a protein. To date, prions have been almost exclusively studied in laboratory-bred strains 
of S. cerevisiae, and the work in this thesis broadens the study to wild strains i.e. non-laboratory 
strains of S. cerevisiae and three related Saccharomyces species: S. bayanus, S. mikatae and 
S. kudriavzevii. The studies outlined here sought to answer two questions; whether the
mechanism of petite induction by GdnHCl is the same as leads to prion loss i.e. by inhibition of 
the molecular chaperone Hsp104; and whether we can identify prion-associated traits in other 
Saccharomyces species by GdnHCl-mediated curing. To answer the first question, the use of S. 
cerevisiae mutants lacking either Hsp104 or the related mitochondrial chaperone Hsp78 ruled out 
inhibition of both of these proteins as the mechanism of petite induction by GdnHCl, as both 
mutants maintained mitochondrial function. Furthermore, GdnHCl also generates respiratory-
deficient petite mutants in the three Saccharomyces species under test, and a detailed 
comparative analysis of the impact of GdnHCl on the ultrastructure and respiratory functions of 
mitochondria in these species is reported. The search for prion-related phenotypes in these 
Saccharomyces species uncovered the possible existence of one or more endogenous prion 
which may control phenotypic traits that impact on a cell’s chance of survival in fluctuating 
environments. Finally, the ability of these genetically-related species to facilitate and perpetuate 
the formation of other amyloid-forming proteins; Alzheimer’s disease associated protein Aβ42 
and Huntingtin (Htt)-associated polyglutamine (polyQ) was analysed. The results obtained 
indicate that each of these species can propagate the amyloid forms of Aβ42 and polyQ, but 
these amyloid states are differentially impacted upon by the endogenous prion state of the host 
yeast species. The expansion of studies into alternate species of Saccharomyces has uncovered 
the possible existence of prions and prion-related phenotypes in these species; and provides 
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STREs Stress-response elements 
TE Tris/HCl/EDTA 
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YEPD Yeast extract peptone dextrose 
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YEPG Yeast extract peptone glycerol 
YFP Yellow fluorescent protein 
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1. Chapter 1: Introduction
1.1. Prion proteins and their mechanisms of inheritance 
Proteinaceous infectious particles, commonly known as prions, are misfolded structures of 
proteins that were initially described by Stanley Prusiner in 1982. Such proteins were found to 
consistently co-purify with scrapie infectivity, a rare degenerative disorder initially thought to be 
caused by slow viruses (Prusiner, 1982). The discovery of protease-resistant proteins in scrapie-
infected brain tissue helped confirm the presence of a novel causative agent in a range of 
transmissible spongiform encephalopathies. Subsequently, prion proteins have been identified in 
mammals, fungi, and more recently bacteria and viruses (Tetz & Tetz, 2018),  with the ability to 
undergo self-propagating, heritable conformational changes which alter homologous protein 
function thus leading to the evolution of diverse traits and in some cases, disease. The term ‘prion’ 
describes a protein that exists in multiple physically distinct states, for example a) a [prion-] state 
displayed by an array of secondary structures with a soluble conformation associated with normal 
cellular activity, and b) a [PRION+] state displayed by a stable conformational change that is 
enriched in β-structure and prone to aggregate into insoluble amyloid-like structures, associated 
with altered protein function. 
The mechanism of prion inheritance is linked to the conformational change of the prion protein 
from a [prion-] to a [PRION+] state, and is described as the ‘protein-only hypothesis’ of prion 
formation and replication (Baskakov et al., 2002; Prusiner, 1982). This sporadic misfolding takes 
place when the [PRION+] protein induces the same conformational change in other homologous 
prion protein molecules currently in the [prion-] state, thus highlighting the infectious nature of the 
[PRION+] protein (Figure 1.1). 
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Prions transmit phenotypes via self-propagating structures that are both active and dominant, 
while maintaining a common pathway of conversion, aggregation, and replication. The initial step 
is the formation of the first prion protein; a process which remains largely unclear but involves at 
least partial unfolding and misfolding of the protein into small oligomers (Tuite & Koloteva-Levin, 
2004). This process is followed by the aggregation or elongation event, in which the oligomers 
act as ‘seeds’ or ‘propagons’ to recruit native proteins into the growing aggregate. Breaking of 
the aggregating fibrils is then required to generate new seeds, resulting in an exponential rise in 
amyloid formation (Figure 1.1).  
In mammalian cells, prions are transmitted in a process termed ‘seed spreading’, whereby seeds 
exit the cell via exocytosis and bind to native prion molecules or receptor proteins found on the 
cell membrane in the brain. Following such binding, seeds are internalised via endocytosis of a 
Figure 1.1: The mechanism of prion inheritance. The mechanism of prion inheritance is linked 
to the conformational change of the prion protein from a [prion-] to a [PRION+] state. This sporadic 
misfolding takes place when the [PRION+] protein (labelled PrPSc) induces the same 
conformational change in other homologous prion protein molecules in the [prion-] state (labelled 
endogenous PrPC). This initial conformation change is followed by the aggregation event, in which 
the oligomers act as ‘seeds’ to recruit native proteins into the growing aggregate. Breaking of the 
aggregating fibrils is then required to generate new seeds, resulting in an exponential rise in 
amyloid formation. 
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new cell, and travel along the axon to reach neighbouring cells via axon dendrite connections and 
nanotubes (Brundin et al., 2010). The exact mechanism of prion protein entry into the mammalian 
cytoplasm is yet to be defined. In unicellular organisms such as yeasts, a protein in the [PRION+] 
state is transmitted from mother to daughter cell during mitosis and meiosis by the division of 
‘infected’ cytoplasm between cells or spores. Newly synthesised prion proteins are then 
susceptible to [PRION+] conversion by existing [PRION+] molecules, thus maintaining the pool of 
[PRION+] proteins that would otherwise be filtered out by replication.  
1.2. Defining a prion protein 
Defining a prion protein requires accurate identification, detection, isolation, and monitoring in 
vivo; allowing the many subtleties in their form to be distinguished. Recent research focuses on 
the generation of prion candidates using bioinformatics and genetic screening, but further 
evaluation involving molecular dynamics, biophysical modelling and composition-based prion 
propensity is required for the discovery of new prions. The activity of novel prions also requires 
an understanding of the key impacting factors such as localisation and interaction with other 
proteins. The following sections introduce well-established criteria required for a protein to be 
defined as a prion, with a primary focus on yeast prions. 
1.3. Wickner’s genetic criteria for a prion 
Yeast prions have been described as “proteins acting as genes”, with the ability to transmit 
phenotype both vertically to daughter cells and horizontally by cytoplasmic mixing to neighbouring 
cells (Wickner et al., 2013). In 1994, Wickner developed the main criteria that allow prions to be 
distinguished from nucleic acid-based determinants of phenotype in yeasts (Wickner, 1994) 
(Figure 1.2): 
1. Expression of the gene encoding the prion protein must be essential to the establishment
and maintenance of the [PRION+] state.
2. The [PRION+] phenotype is the same or similar to the phenotype of a mutant of that gene,
and such mutants fail to propagate the prion. The relation of phenotype to mutant is true if
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the prion produces effects as a result of protein inactivity, but not if it produces a novel or 
toxic effect, as seen for [PIN+] (described in Section 1.6.2) and toxic variants of [PSI+] and 
[URE3] (Wickner et al., 2013). 
3. Mutagenic agents can reversibly eliminate the [PRION+] state, and the same prion could
rarely arise in this ‘prion-cured’ strain. The prion may still arise de novo at a very low
frequency, as the corresponding prion protein is still being produced in the cell. The
consequential [prion-] cells can be returned to the [PRION+] state by cytoplasmic transfer from
a [PRION+] strain. It is the reversibility, not the curing itself, which highlights the prion nature
of the protein.
4. Over-expression of the prion protein in a [prion-] cell can greatly increase the frequency with
which the [PRION+] state arises de novo. The more there is of the protein that is capable of
changing to the [PRION+] state, the more frequently the phenomenon will occur in a cell.
Figure 1.2: The genetic criteria required for a yeast or fungal prion. Both [URE3] and [PSI+] 
follow all criteria outlined by Wickner; displaying prion-mediated phenotypes as a result of 
deficiency in the normal function of the corresponding protein (Taken from Wickner, 1994).  
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Some proteins have been described as prions without necessarily following all of Wickner’s 
criteria because their phenotypes are due to a gain of function; examples include [Het-s] in 
Podospora anserina and [PIN+] in Saccharomyces cerevisiae (Coustou et al., 1997; Derkatch et 
al., 2001) (see Sections 1.7.2 and 1.6.2 below). More recently, novel examples of protein-based 
inheritance have been described which show properties distinct to ‘classical’ prions; namely 
prion-like proteins and mnemons (Caudron & Barral, 2013) which also fail to meet all of Wickner’s 
criteria. Such novel examples of protein-based inheritance cause a heritable phenotypic change 
in the cell following elevated protein levels and have no association with amyloid formation (see 
Section 1.9.2).  
1.4. The prion-forming domain 
The prion-forming capacity of a protein is reliant on the presence of a modular domain, typically 
longer than 60 amino acids in length and referred to as the prion-forming domain (PFD) (Ter‐
Avanesyan et al., 1993). In most prions discovered to date, the PFD is essential for the de novo 
manifestation and maintenance of the protein in the [PRION+] state. Fusion of the PFD to an 
unrelated protein can confer the prion-forming capability to that non prion-forming protein. This 
property is illustrated by the fusion of Sup35 PFD with the unrelated rat glucocorticoid receptor, 
which results in both aggregation and inheritance of the fusion protein (Li & Lindquist, 2000). This 
newly created prion maintained the epigenetic nature of the original [PSI+] prion and was subject 
to both induction and curing. However, the prion-mediated phenotype changed drastically with 
the phenotype of the [PSI+] prion transformed from one affecting protein synthesis to one affecting 
the transcription of the rat glucocorticoid-regulated promoter. These findings confirm the protein-
only nature of yeast prion inheritance, as the function domain of the protein attached to the PFD 
is solely responsible for determining the change in phenotype (Li & Lindquist, 2000). 
1.4.1. Prion forming domains are amyloidogenic 
Once converted into a [PRION+] state, prion proteins have a highly infectious nature, with 
structural rearrangements that increase the abundance of β-strands; stretched out regions of 
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polypeptides, within the PFD; common in most yeast prions. When hydrogen bonds form between 
the main chain carbonyl group C=O of one β-strand and the -NH group of another, a major form 
of secondary structure known as the β-pleated sheet is formed. Typically, β-strands aligned in 
opposite or ‘anti-parallel’ directions are more stable, and stack upon one another to form 
unbranching polymers or fibrils, collectively named amyloid (Figure 1.3). 
For example, following an initial lag period that is inversely correlated with protein concentration, 
the Sup35 PFD polymerises spontaneously, forming amyloid. The resulting fibrils of Sup35 
display characteristics indicative of amyloid, including protease and heat resistance, β-rich 
structure, and binding to the dye Congo red (Glover et al., 1997; King et al., 1997). Further in vitro 
studies of the Sup35 PFD support the protein-only hypothesis of prion inheritance, as the 
introduction of sub-stoichiometric quantities of Sup35 into the cytoplasm of living yeast using a 
liposome transformation protocol greatly increases the rate of [PSI+] appearance in yeast, as a 
result of self-propagating aggregates of cellular Sup35 (Sparrer et al., 2000). 
The mechanism by which a PFD in the β-rich [PRION+] form templates the conversion of other 
homologous PFDs to the same [PRION+] conformation, thereby propagating the amyloid state, is 
yet to be determined. Segregation and structural analysis at the single-fibril level is required to 
Figure 1.3: The formation of amyloid fibrils. Once converted into a [PRION+] form, structural 
rearrangements increase the abundance of β-strands, seen in green. Typically, β-strands aligned in 
opposite or ‘anti-parallel’ directions are more stable, and stack upon one another to form 
unbranching polymers or fibrils, collectively named amyloid. 
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distinguish not only the possible link between amyloid structure and propagation, but also the link 
between amyloid structure and function. Single-fibril structural analysis would also help allow 
quantification of amyloid polymorphisms in heterogeneous populations, which may uncover 
differing biological activities between cells infected with the same amyloid sample. Structural 
characteristics have been shown to determine the replication rates of prion fibrils and 
consequently the phenotypic characteristics of Creutzfeldt-Jakob disease (Safar et al., 2015). 
This behaviour has also been implicated with numerous ‘strains’ of the Tau protein causing 
different pathologies in different regions of the brain (Kaufman et al., 2016), and is further 
implicated in Alzheimer’s related Aβ peptides (Cohen et al., 2016) (see Section 1.8.2.4 below). 
1.4.2. Many prion-forming domains are glutamine and asparagine rich 
Initial bioinformatic screening to identify novel prion proteins relied on the use of common features 
of Sup35 and Ure2 as query sequences. Common features include the PFD; highly enriched for 
glutamine (Q) and asparagine (N) and lacking in hydrophobic and charged residues. Such 
bioinformatic approaches identified RNQ1 as a possible prion encoding gene (Sondheimer & 
Lindquist, 2000) (Section 1.6.2). Mutagenesis studies of Sup35 revealed that mutations involving 
the replacement of Q/N residues with alternate charged residues blocks the addition of monomers 
to [PSI+] aggregates in nearly all cases, and short, highly Q/N-rich segments within the Sup35 
PFD were important for prion aggregate growth (Maclea & Ross, 2011).  
Both Q and N are intrinsically linked through their structural similarity, possessing carboxamide 
as the side chain functional group (Figure 1.4). Carboxamide makes PFDs a rich source of 
hydrogen bonds, thought to contribute to interfacial electrostatic interactions between charged 
amino acids, thus promoting the formation of larger amyloid oligomers (Yun et al., 2007). As 
previously mentioned in Section 1.4.1, hydrogen bonds form between the main chain C=O of one 
β-strand and the N-H group of another, forming the β-pleated sheet. Carboxamide groups have 
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been labelled as ‘polar zippers’, which further increase the abundance of hydrogen bonds, which 
are then further stabilised by the binding of water molecules (Yun et al., 2007).  
The crucial role that both glutamine and asparagine residues play in the aggregation driven by a 
PFD was shown using Sup35 mutants that are either poorly recruited into, or cause curing of, 
wildtype amyloids in vivo. Such mutations were mapped exclusively within a short 
glutamine/asparagine-rich region of Sup35, and all but one occur at polar residues (DePace et 
al., 1998). Furthermore, substituting these residues for charged residues resolubilises the 
associated protein and reverses the prion phenotype (Alberti et al., 2009). 
Most prions identified to date share Q/N-richness as a common prion-associated characteristic. 
A notable exception is the PFD of HET-s, a protein of the fungus Podospora anserina further 
discussed in Section 1.7.2. Het-s has been shown to propagate as a prion in S. cerevisiae, and 
such yeast-derived propagons are infectious when introduced into Podospora (Taneja et al., 
2007). These findings suggest that the observed Q/N-richness characteristic of most fungal 
prions is not a specific requirement of S. cerevisiae, and non-Q/N-rich prion proteins may exist in 
S. cerevisiae e.g. Mod5 and other yeast species. Moreover, the presence of the [PIN+] prion
enhances HET-s ring-like aggregate formation in S. cerevisiae, highlighting an interaction 
between Q/N-rich and non-Q/N-rich prions (Taneja et al., 2007). 
Figure 1.4: The chemical structure of asparagine and glutamine. 
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1.4.3. Prion forming domains and the species barrier 
The PFD confers a high degree of specificity to prion aggregation as demonstrated by a ‘species 
barrier’ during Sup35 prion replication. This ‘barrier’, which prevents cross-seeding between 
PFDs from different yeast species, was first observed when the PFD of Sup35 from Candida 
albicans was fused to the functional C domain of S. cerevisiae Sup35 and formed a prion, yet the 
presence of the S. cerevisiae Sup35 prion gene was notably required for continued propagation 
of the heterologous prion (Santoso et al., 2000). Such species specificity appears to be 
controlled by a 19-amino acid Q/N rich region at the N-terminus of ScSup35p. Substituting this 
region in the CaSup35p-PFD with amino acids 8-26 from ScSup35p was sufficient to confer 
species specificity to Sup35p polymerisation, now acting as wild type ScSup35p (Santoso et 
al., 2000). Similarly, Chernoff et al. (2000) found that the [PSI+] state of the endogenous S. 
cerevisiae Sup35 could not be transmitted by expression of the heterologous Sup35p from 
Pichia methanolica, in the absence of the S. cerevisiae protein. However, Chernoff et al. 
(2000) later reported that over-expressing full length PmSup35p induced the prion form of 
ScSup35 at low levels, suggesting a bypass of species barrier with high-level overexpression of 
the heterologous PFD.   
The PFD-associated species barrier of Sup35 was further studied in members of the 
Saccharomyces species, namely Saccharomyces paradoxus and Saccharomyces 
bayanus. All three Sup35 proteins formed prions in S. cerevisiae, although prions formed 
by such heterologous proteins were less stable than endogenous ScSup35p (Chen et al., 
2007). Interestingly, all Sup35 proteins co-aggregated in S. cerevisiae cells, but cross-
species prion transmission was asymmetric; ScSup35 could not co-aggregate in S. 
bayanus or S. paradoxus in almost all heterologous combinations. Such a decreased level of 
prion conversion provides evidence of a species barrier which occurs at the level of 
conformational transition, rather than with co-aggregation (Chen et al., 2007).  
Chen et al. (2010) later noted that the ability of a heterologous PFD to either reproduce or 
switch the variant-specific prion pattern in species of Saccharomyces depends on both 
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sequence divergence, and the prion variant. In contrast with previous work, the PFD of 
S. paradoxus was shown to be sufficient for a strong transmission barrier for weak [PSI+], yet 
only caused a slight decrease in transmission of strong [PSI+] (Chen et al., 2010). Furthermore, 
Chen et al. (2010) concluded that individual amino acid substitutions within short amyloidogenic 
stretches of S. bayanus Sup35 PFD can drastically affect prion conversion. In S. bayanus, PFD 
length also appears to contribute to the species barrier, as length is significant in amyloid core 
formation, as well as correct alignment of interacting sequences in different amyloid units (Chen 
et al., 2010). The importance on furthering our understanding of the prion species barrier within 
Saccharomyces species will be further discussed in Section 1.10.  
1.5. The [PRION+] state depends on interactions with chaperones 
In yeast, the infectious nature of the prion protein relies on the exploitation of molecular 
chaperones; commonly responsible for the refolding and stabilisation of proteins following 
exposure to stress. Such molecular interactions rely on substrate specificity, and/or a specific 
localisation within the cell, to function. The discovery that continued propagation of [PSI+]; the 
prion form of the translation termination factor Sup35 (Section 1.6.1) is reliant on Hsp104 for its 
maintenance a) provided support for the prion hypothesis, and b) highlighted that [PSI+] is a result 
of a Sup35 misfolding event (Chernoff et al., 1995). The critical role of Hsp104 in prion 
propagation is necessary for all amyloid-based yeast prions, with the exception of few yeast 
prions, namely [ISP+] and [GAR+] (Brown & Lindquist, 2009; Rogoza et al., 2010). In the case of 
[ISP+], a lack of Hsp104 dependency may be due to the difference in [ISP+] localisation, with 
formation of foci in the nucleus as opposed to cytoplasmic foci formed by most yeast prions 
(Rogoza et al., 2010). 
Hsp104 plays a key role in prion propagation by passing the chain of aggregated protein through 
a central pore formed by the hexameric Hsp104, thus denaturing the protein and allowing it to 
renature (Lum et al., 2004). Millimolar concentrations of guanidine hydrochloride (GdnHCl) cure 
[PSI+] by reversibly inhibiting the prion propagation and disaggregase activity of Hsp104, through 
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a direct target of amino acid residue 184 (Jung et al., 2002; Ness et al., 2002). This suggests that 
Hsp104 actively fragments Sup35 prion fibrils, creating new seeds or propagons thus increasing 
the availability of ‘recruiting’ ends (Chernoff et al., 1995; Glover et al., 1997). The severance of 
the prion amyloid is therefore blocked by GdnHCl-associated inhibition of Hsp104, preventing the 
generation of new seeds that can be passed on to daughter cells, thus filtering out prions by 
replication (Byrne et al., 2007; Eaglestone et al., 2000; Ness et al., 2002; Satpute-Krishnan et al., 
2007). In support of this, a dominant ATPase-negative mutant of Hsp104 is unable to maintain 
[PSI+] (Chernoff et al., 1995). Remarkably, the Candida albicans orthologue of Hsp104 can 
replace all functions of ScHsp104 in an S. cerevisiae null mutant, but CaHsp104 function is 
resistant to GdnHCl (Zenthon et al., 2006). 
Overexpression of Hsp104 also inhibits formation of the [PSI+] prion, and was originally thought 
to over-fragment Sup35 fibrils (Chernoff et al., 1995). In more recent years, Hung and Masison 
(2006) showed that mutations within, or total deletion of the N-terminal domain of Hsp104 does 
not affect prion propagation or heat shock tolerance, but eliminates the ability of Hsp104 
overexpression to cure [PSI+] (Hung & Masison, 2006). Interestingly, Ness et al. (2017) showed 
that Hsp104 overexpression creates [psi-] cells by malpartition of [PSI+] propagons between 
mother and daughter cells during cell division. Furthermore, in conditions of overexpression, 
Hsp104 does not interfere with the incorporation of newly synthesised Sup35 into fibrils, nor with 
the multiplication of propagons as numbers decline while growing in the presence of GdnHCl 
(Ness et al., 2017). 
Prion propagation and overproduction curing of [PSI+] by Hsp104 also requires contributions from 
other molecular chaperones, namely members of the Hsp70 family and their co-chaperones; the 
Hsp40 family (Lazarev et al., 2017; Newnam et al., 1999). Co-chaperone Sti1 which interacts with 
Hsp90, Hsp70 and Hsp104 is also required for overproduction curing (Moosavi et al., 2017), and 
radicicol-mediated curing of Hsp90 blocks Hsp104 curing (Reidy & Masison, 2010). The 
requirement of co-chaperones was also shown by Reidy, Miot and Masison (2012), who 
suggested that ClpB, the Escherichia coli homolog of Hsp104, can only propagate the yeast 
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prions [PSI+], [PIN+] or [URE3] when replaced with Hsp104 and E.coli Hsp70 (DnaK), but not 
when replaced with Hsp104 alone (Reidy et al., 2012). 
1.6. Prion proteins of Saccharomyces cerevisiae 
Although prions do not cause disease in yeast, they manifest themselves as heritable cytoplasmic 
elements with a mechanism of inheritance that operates at the level of protein conformation rather 
than nucleotide sequence. Yeast prions therefore provide a model system for studying 
mechanisms of amyloid formation and propagation that are applicable to mammalian diseases.  
1.6.1. Translation termination: Sup35p and the [PSI+] prion 
[PSI+] is the most extensively studied yeast prion and has formed the basis of much of prion 
biology research. Initially discovered by Brian Cox; [PSI+] was found to be a non-Mendelian 
genetic element of S. cerevisiae with a clear enhancement of nonsense codon suppression (Cox, 
1965). In a yeast cell-free translation system, addition of 20% [psi-] lysate to a [PSI+] lysate was 
sufficient to prevent detectable nonsense suppressor activity (Tuite et al., 1983). The [psi-] ‘factor’ 
inhibiting suppression activity was found to be ribosome-associated and was thought to be 
involved in translation termination and inactivated in a [PSI+] cell (Tuite et al., 1987).  
[PSI+] was subsequently identified as the prion form of the yeast Sup35 protein that was found to 
be necessary for the propagation of the [PSI+] prion (Wickner, 1994; Cox et al 1994; Ter-
Avanesyan et al., 2014). Conformational conversion of Sup35 to its proposed prion form was 
shown to reduce the functional pool of Sup35 available for translation termination, resulting in the 
nonsense suppressor phenotype associated with the [PSI+] prion (Cox et al., 1994). The initial 
connection between Sup35 and [PSI+] was made following Sup35 over-expression studies, 
which caused significant growth defects in a [PRION+] but not in a [prion-] state, and induced 
the de novo appearance of [PSI+] in a [psi-] cell (Chernoff et al, 1992; Ter‐Avanesyan et al., 
1993).  
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Sup35/eRF3 is an essential protein (Stansfield et al., 1995) composed of 3 regions; an N-
terminal domain (the modular prion-forming domain), the highly charged middle (M)-domain, 
and the C-terminal region containing a GTPase domain. Sup35 is an essential component of the 
translation termination complex in eukaryotic cells; mediating the termination of translation upon 
arrival of a stop codon (UAA, UAG or UGA) in the ribosomal A-site with another 
essential protein Sup45/eRF1 (Stansfield et al., 1995; Zhouravleva et al., 1995). In the 
presence of a stop codon, Sup45 associates with the ribosome, and Sup35 is thought to bind to 
Sup45 to promote a better positioning within the ribosome (Stansfield et al., 1995). The Sup35 
C-terminal GTPase domain is then responsible for release of the polypeptide from the peptidyl-
tRNA at the ribosomal P site (Zhouravleva et al., 1995). The efficiency of stop-codon recognition 
by the Sup35/Sup45 complex is sensitive to both nucleotide sequence surrounding the 
stop codon, and the relative abundancies of both proteins (Zhouravleva et al., 1995). 
Deletion of the SUP35 gene results in total loss of cell viability (Ter‐Avanesyan et al., 1993). 
Interestingly, cells remain viable when Sup35 is present in its aggregated prion form, but a 
measurable defect in translation termination is apparent, thus suggesting only a partial loss of 
protein function, or a small pool of the soluble form remains and is sufficient for protein function 
(Byrne et al., 2009). 
In [PSI+] cells, the termination defect is widely used to confirm the presence of the prion. As 
previously mentioned, [PSI+] was discovered as a trait which gave rise to enhancement 
of nonsense suppression whereby suppression of nonsense mutations such as the 
ade1-14 nonsense (UGA) allele restores function to the encoded gene product. The red 
pigmented colonies formed by an ade1-14 mutant are a result of a defect in adenine 
biosynthesis, and [psi-] cells thus require adenine for growth on defined medium (Figure 1.5). 
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1.6.2. [PSI+] inducibility: Rnq1p and the [PIN+] prion 
Initial studies into the role of Sup35 demonstrated that curing of the [PSI+]-associated phenotype 
using guanidine hydrochloride resulted in two distinct populations of prion-free cells; a) cells in 
which Sup35 overexpression would re-induce a [PSI+] state, and b) cells where Sup35 
overexpression was not sufficient for the re-induction of [PSI+] (Derkatch et al., 1997). The 
remarkable difference between these two populations was [PSI+] inducibility, and a strain was 
found to be either [PSI+]-inducibility positive ([PIN+]), or negative ([pin-]). The ability of this [PIN+]-
associated trait to appear in strains lacking the Sup35 PFD led to the suggestion that [PIN+] was 
a novel yeast prion, which interacts with, but is not a variant of [PSI+] (Derkatch et al., 1997). 
Much like [PSI+], [PIN+] showed non-Mendelian inheritance and is dependent on the molecular 
chaperone Hsp104, but unlike most yeast prions, the [PIN+]-associated phenotype produces a 
gain-of-function for the prion protein; providing a necessary template for the de novo formation of 
Figure 1.5: The [PSI+] prion causes a defect in translation termination in S. cerevisiae. Panel 
A: Translation termination in ade1-14 prion-free cells is mediated by the interaction between Sup35 
and Sup45 (eFR1), giving rise to red colonies. Panel B: In [PSI+] ade1-14 cells Sup35 is mostly 
present in its [PRION+] state. Reduced translation termination results in the synthesis of functional 
ADE1 gene product, thus restoring the ‘wild-type’ colony phenotype. The balance of truncated and 
full-length protein defines the efficiency of nonsense suppression. Taken from Tuite (2013). 
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[PSI+] in cells overexpressing Sup35 (Derkatch et al., 2001). The presence of [PIN+] also 
facilitates the de novo appearance of other yeast prions, namely [URE3] (Derkatch et al., 2001) 
and the de novo aggregation of polyglutamine-expanded yeast proteins (Meriin et al., 2002) (see 
Section 1.8.2.1). Despite several theories to explain how [PIN+] may mediate de novo [PSI+] 
formation, the ‘direct seeding model’ developed by Derkatch et al., (2001) appears to be the 
most likely. This highlights [PIN+] as a ‘universal nucleating factor’; providing an origin on 
which the seeds of a yeast prion can convert soluble forms of the heterologous protein into a 
[PRION+] state, thus stabilising and promoting spontaneous conversion (Derkatch et al., 2001).  
Recent findings by Villali et al., (2020) suggest an unrelated role for [PIN+] after seed formation; 
promoting the amplification of Sup35 amyloid rather than its clearance, by directly competing 
with Hsp104 thus limiting its disassembly activity of Sup35 amyloid (Villali et al., 2020). 
Mathematical models and in vivo experiments also linked the persistence of Sup35 
amyloid to the conformationally-defined size of the Sup35 seed (Villali et al., 2020).
In a gene candidate analysis, deletion of the non-essential cellular RNQ1 gene cured cells of the 
[PIN+] phenotype thereby identifying Rnq1p as the protein determinant of [PIN+] (Derkatch et al., 
2001). Further analysis of Rnq1p highlighted a C-terminal domain highly enriched for glutamine 
(Q) and asparagine (N) residues, identifying the protein as a ‘prion-forming protein’ with a prion-
like domain required for the switch to a transmissible prion form (Sondheimer & Lindquist, 2000). 
The Rnq1 protein was also shown to be aggregated in a [PIN+] strain, but not in a [prion-] strain 
(Derkatch et al., 2001). Fundamental research by Patel and Liebman (2007) further highlighted 
Rnq1 as the determinant of [PIN+], as fibrils formed from the PFD of Rnq1 were able to induce 
the [PIN+] phenotype when transformed into a [pin-] yeast strain (Patel & Liebman, 2007). 
The sequence of Rnq1p and its PFD became an intriguing area of study due to its highly 
polymorphic nature. Various strains of S. cerevisiae possess RNQ1 alleles with numerous 
polymorphisms clustered to three regions within the PFD, with distinct deletions or insertions 
which alter the abundance of glutamine residues within Rnq1 (Kelly et al., 2012; Resende et al., 
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2003). An increase in the number of glutamine residues increases the likelihood of aggregation, 
and particularly the neurodegenerative nature of polyglutamine diseases (Meriin et al., 2002) (see 
Section 1.8.2.1).  
Interestingly, genetic screening revealed at least eleven other proteins that can give rise to the 
[PIN+] phenotype when overexpressed, including Cyc8 and Swi1 both of which can form prions 
in their own right (see Section 1.6.4) (Derkatch et al., 2001). Lsm4; responsible for mRNA 
processing and turnover, and Nup116; responsible for nuclear transport were also highlighted as 
likely prion candidates in this genetic screen (Alberti et al., 2009). More recently, overexpression 
of Lsm4 has been shown to eliminate [PSI+], [URE3] and [RNQ+] prions by forming amyloid in 
vivo, and the Q/N-rich region of this protein was revealed as being responsible for such prion loss 
(Oishi et al., 2013).  
1.6.3. Nitrogen catabolism: Ure2p and the [URE3] prion 
When grown on a rich source of nitrogen such as ammonia, yeast cells repress the transcription 
of genes needed for using poor nitrogen sources. Ure2p mediates such nitrogen catabolite 
repression by blocking the positive transcription regulator, Gln3p. Dal5p, a transporter for the 
poor, but useable, nitrogen source allantoate is also regulated by Ure2p. Ureidosuccinate (USA) 
is an intermediate in uracil biosynthesis with similar structure to allantoate, making it a suitable 
substrate for uptake by Dal5p. Therefore, ure2 mutants can take up ureidosuccinate (labelled the 
“USA1 phenotype”) on ammonia containing media, whereas wild type cells cannot (named the 
“USA2 phenotype”) (Wickner, 1994). [URE3] was first identified as a genetic element which 
causes the defective control of nitrogen catabolism  (and the USA1 phenotype), and was later 
discovered to be the prion form of Ure2p (Wickner, 1994). Edskes, Gray and Wickner (1999) 
found that as a GFP fusion, Ure2p is aggregated in cells carrying the [URE3] prion, but evenly 
distributed in [ure3-] cells cured by guanidine hydrochloride, thus highlighting the self-propagating 
aggregation of Ure2 (Edskes et al., 1999). The properties of [URE3] show great similarities to 
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[PSI+], which also relies on the aggregation of a previously misfolded protein and does not 
segregate in accordance with Mendel’s 1st and 2nd laws of inheritance. 
Maintenance of [URE3] also relies on the molecular chaperone Hsp104; indicated by elimination 
when grown on GdnHCl (Moriyama et al., 2000). [URE3] was found to be transmissible via 
cytoduction but was no longer transferred in this way when in the absence of Hsp104. 
Interestingly, unlike the [PSI+] prion, [URE3] was not eliminated by Hsp104 overproduction 
(Moriyama et al., 2000). However, overproduction of nucleotide exchange factor Sse1p cures 
strains of [URE3] (Kryndushkin & Wickner, 2007). Sse1p promotes the release of ADP from 
molecular chaperone Hsp70 (Ssa1), in turn allowing ATP to bind, impacting the balance of 
binding, release and refolding activities of Hsp70. On complete loss of Sse1, Ssa1 was found in 
a continuous ADP-bound state, thus blocking the addition of new monomers to the [URE3] fibril 
and further highlighting the requirement of Hsp70 in [URE3] propagation (Kryndushkin & Wickner, 
2007).  
1.6.4. Chromatin remodelling: Swi1p and the [SWI+] prion 
The accessibility of genes, their regulatory sequences and control of gene expression is altered 
by reversible modifications of DNA structure, such as the packaging of DNA into chromatin by 
association with histones. The basic repeating structural and functional unit of chromatin is the 
nucleosome, and disruption of the nucleosome is caused by protein complexes such as the 
SWI/SNF complex in eukaryotes (the BAF complex in mammals) (Saha et al., 2006). Cells use 
the SWI/SNF complex to remodel chromatin so that relevant regions of the DNA can be made 
accessible for control of gene expression, and this process requires the energy of ATP hydrolysis, 
in one of three ways; a) nucleosome remodelling which alters the interactions of histones within 
the nucleosome to expose required regions of DNA; b) nucleosome sliding to a different position 
on the DNA exposing required regions of DNA; and c) nucleosome displacement which 
dissociates the nucleosome from one DNA molecule to another (Saha et al., 2006). 
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In S. cerevisiae, the SWI/SNF complex is composed of at least 11 subunits, and one of these 
subunits; Swi1p, regulates the transcriptional activity of ~6% of total genes (Saha et al., 2006). 
Null mutants of SWI/SNF are viable, but display phenotypes of slow growth, reduced mating-
type switching and an inability to use non-fermentable carbon sources. In mammals, mutations 
in the Snf5 homolog, Ini1, are associated with reduced levels of tumour suppression (Saha et 
al., 2006). 
In S. cerevisiae, Swi1p has been shown to convert to the [SWI+] prion without 
Swi1p overexpression, indicating the probability of this event occurring naturally in the cell. Such 
prion conversion displays a partial loss-of-function phenotype of the SWI/SNF complex. 
Further resemblance to other yeast prions is the dependency of [SWI+] propagation on Hsp104, 
indicated by a loss of [SWI+] on HSP104 deletion or GdnHCl-mediated Hsp104 inhibition. 
Moreover, [SWI+] is dominantly and cytoplasmically transmitted, forms aggregates in the cell, 
and components of the SWI/SNF complex have high glutamine and asparagine content (Du 
et al., 2008). Such observations led to the discovery of [SWI+] as an endogenous prion and 
epigenetic regulator of protein conformation in S. cerevisiae (Goncharoff, Du and Li, 2018). 
1.6.5. Transcription regulation: Sfp1p and the [ISP+] prion 
The Sfp1p protein is a transcription factor containing at least two functional zinc-finger domains 
and is the global regulator of the expression of ~10% of yeast genes, including those that encode 
ribosomal proteins and other components of translational machinery (Marion et al., 2004). The 
function and nuclear targeting of Sfp1p is regulated by TORC1 phosphorylation, as part of the 
rapamycin (TOR) signalling pathway (Marion et al., 2004). Sfp1p belongs to a group of 
asparagine-enriched proteins and was initially detected in its prion form as a non-chromosomal 
anti-suppressor in strains containing specific sup35 nonsense suppressor mutations. It was noted 
that strains containing [ISP+] expressed the dominant non-suppressor phenotype, whereas the 
[isp-] derivative displayed the suppressor (i.e. stop-codon read-through) phenotype (Rogoza et 
al., 2010). A sfp1Δ deletion strain shows the irreversible loss of [ISP+], and although the prion 
form is associated with a non-suppressor phenotype, the sfp1Δ does not display this same 
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phenotype. A lack of [ISP+] phenotype observed in the sfp1Δ strain may be because a) cytosolic 
[isp-] does not interact with the nonsense suppressor, or b) the [ISP+] prion accumulates in the 
nucleus and may sequester the nucleocytoplasmic protein with nonsense-suppressor activity 
(Rogoza et al., 2010).   
The observed behaviours of the [ISP+] prion appear to differ from other well-established yeast 
prions, with a higher spontaneous prion conversion rate at around 1.0 x 10-4 per cell per 
generation, compared to 1.0 x 10-6 per cell per generation for [PSI+]. Moreover, an Sfp1-GFP 
fusion in an [ISP+] strain formed nuclear localised foci (Rogoza et al., 2010). Interestingly, neither 
deletion nor overproduction of Hsp104p influenced the propagation of [ISP+], suggesting the 
absence of dependence on Hsp104 as a molecular chaperone (Rogoza et al., 2010). 
1.6.6. Overriding glucose repression: Pma1p, Std1p and the [GAR+] prion 
When grown on medium containing 2% glycerol and 0.05% glucosamine (GGM), certain mutant 
yeast cells arise that do not follow Mendelian patterns of inheritance and the underlying genetic 
determinant of this trait was later recognised as the [GAR+] prion (Brown & Lindquist, 2009). 
[GAR+] leads to an override of the preference of carbon source and provides yeast with a gain-
of-function resistance to the monosaccharide glucosamine, in contrast with wild type [gar-] cells 
which specialise in glucose metabolism. Glucosamine is structurally similar to glucose, and 
therefore gives a strong signal that glucose is present in the culture, triggering glucose repression. 
Cells that acquire [GAR+] can circumvent this repression and grow well on GGM (Jarosz, 
Lancaster, et al., 2014).  
Much like other yeast prions, [GAR+] produces ‘strong’ and ‘weak’ phenotypes, displaying either 
robust or moderate growth on GGM respectively. Both laboratory yeast strains and strains derived 
from unique ecological niches display such phenotypes, which are stably inherited from one 
generation to the next (Brown & Lindquist, 2009). On the other hand, several characteristics of 
the [GAR+] trait distinguish it from other well-established yeast prions including the lack of amyloid 
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fibril formation, and the association of two protein components with the [GAR+] trait. One of these 
proteins, the nuclear transcription factor Std1p, when overexpressed in yeast causes a new 
heritable state of carbon utilisation. Such protein overexpression indicated that Std1p is the 
determinant of the [GAR+] prion and is not simply a dynamic regulator of glucose repression 
(Brown & Lindquist, 2009). Strikingly, the prion phenotype of [GAR+] cells did not mimic a loss-
of-function phenotype of Std1p, and Δstd1 cells continued to grow on GGM, suggesting Std1p is 
not the sole determinant of the [GAR+] prion. Furthermore, [GAR+] propagation continued in Δstd1 
cells, highlighting that this transient inducing agent is not required for [GAR+] maintenance. 
Moreover, gene expression profiling studies identified a 40-fold downregulation of the Std1p-
regulated hexose transporter Hxt3p as the only transcriptional difference between [GAR+] and 
[gar-] cells. Despite Hxt3p downregulation found in a [GAR+] state, glucose uptake was not 
decreased, and Δhxt3 cells did not lose the glucose-repression phenotype of [GAR+] (Brown & 
Lindquist, 2009).  
Leading on from this, membrane-bound protein pump Pma1p was labelled as a propagating 
agent which physically interacts with Std1p in [GAR+] formation, and attenuation of Pma1p 
activity is a contributing factor to the [GAR+] state (Brown & Lindquist, 2009). Substitution of the 
essential S. cerevisiae PMA1 with the S. bayanus or S. paradoxus orthologue blocked [GAR+] 
propagation (Brown & Lindquist, 2009). Transient overexpression of either PMA1 or STD1 was 
shown to be sufficient in establishing a heritable conversion to the [GAR+] state, and once 
established, either protein was sufficient for propagation. Δstd1 cells carrying a deletion in the 
N-terminus of PMA1 are unable to propagate [GAR+] suggesting the formation of a Pma1p/
Std1p complex in [GAR+] cells which is no longer detectable in [gar-] cells (Brown & Lindquist, 
2009).  
The [GAR+] trait can also be differentiated from other well-established yeast prions by its 
reliance on alternative molecular chaperone Hsp70, as opposed to Hsp104 (Brown & Lindquist, 
2009). Propagation of [GAR+] continued in Δhsp104 cells, following HSP104 overexpression, 
and in cells cured by GdnHCl indicating that Hsp104p is not required for the inheritance of 
[GAR+].  
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In contrast, cells lacking Hsp70 proteins Ssa1 and Ssa2 lost the ability to grow on GGM, and a 
transient change in chaperone proteins was sufficient to reversibly cure cells of [GAR+] (Brown 
& Lindquist, 2009). [GAR+] variants of wild S. cerevisiae strains also lose their ability to grow 
on GGM following inhibition of Hsp70, further highlighting both the role of Hsp70 in 
[GAR+] propagation and the potential impact of originating in diverse ecological niches on the 
de novo acquisition of [GAR+] (Jarosz, Lancaster, et al., 2014). 
In [gar-] cells, glucose is utilised as the sole carbon source and is metabolised and fermented 
into high levels of ethanol, which is known to inhibit the growth of bacteria. In contrast, the 
[GAR+] state creates a bacteria-friendly environment by reducing the ethanol output by >50%, 
and this state is initially triggered by a chemical messenger secreted by bacteria in close 
proximity to the yeast, indicated by green dots in Figure 1.6 (Jarosz, Brown, et al., 2014). This 
bacteria-friendly environment was initially displayed in arrested wine fermentations with a 
particularly strong capacity for [GAR+] induction, suggesting both the low ethanol and high 
residual sugar content of the environment.  
Figure 1.6: Cross-kingdom communication rewires yeast metabolism. In [gar] cells, glucose 
is the primary carbon source and is fermented to high levels of ethanol, inhibitory to bacterial 
growth. However, some bacterial species can secrete a chemical messenger (green dots) that 
induces the [GAR+] state, resulting in an override in the preference of carbon source.
Consequently, yeast cells become metabolic generalists with the ability to use alternative carbon 
sources in the presence of carbon source, leading to a reduction in ethanol levels which favours 
bacterial growth.  
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A bacterially-secreted chemical messenger was determined by growth of hundreds of 
generations on YEPG without direct selective pressures from either glucosamine or bacteria, 
following initial contamination of Staphylococcus hominis. In such conditions, yeast retained their 
ability to circumvent glucose repression, indicating that the chemical messenger secreted by S. 
hominis had induced a stable [GAR+] trait, and did not simply influence the metabolism of nearby 
yeast cells (Jarosz, Brown, et al., 2014). This cross-kingdom chemical interaction was not 
exclusive to S. hominis, as 30% of evolutionarily and ecologically diverse bacteria tested had the 
capacity to secrete a diffusible factor which allowed yeast to grow on GGM (Jarosz, Brown, et al., 
2014). 
More recently, the bacterially secreted chemical messenger was identified as lactic acid by 
activity guided fractionation and reversed-phase high performance liquid chromatography (HPLC) 
of  S. gallinarum and L. innocua extracts, which caused yeast cells to heritably bypass glucose 
repression on exposure (Garcia et al., 2016). Given that environmental conditions can greatly 
affect the amount of lactic acid produced by bacteria, various concentrations were tested to 
determine the optimum for [GAR+] induction. Robust reversal of glucose repression was observed 
in yeast grown on GGM with concentrations of L- or D-lactic acid ranging from 0.025% up to 
0.625%, albeit in a concentration-dependent manner. Interestingly, 1% lactic acid caused strong 
induction of [GAR+] yeast, such that nearly all cells in the population grew into large colonies on 
GGM. Addition of 0.05% lactic acid did not increase growth on YEPD alone, eliminating the 
possibility that the yeast simply metabolise lactic acid.  
Lactic acid also induces [GAR+]-associated phenotypes in Dekkera bruxellensis; a fungus with 
~200 million years of evolutionary distance from S. cerevisiae. D. bruxellensis strains exposed to 
concentrations of lactic acid within the physiological range produced by bacteria (0.02%) grow 
robustly on GGM. Colonies selected from such conditions were propagated for ~75 generations 
on YEPD and streaked onto GGM, indicating the heritable trait of circumventing glucose 
repression in each case (Garcia et al., 2016).  
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The ability of D. bruxellensis cells to circumvent glucose repression was significantly reduced 
following growth on GGM supplemented with the Hsp70 inhibitor myricetin, at concentrations that 
do not significantly affect growth on YEPG alone (Garcia et al., 2016). This suggests that the 
[GAR+]-like traits that arise spontaneously or are induced by bacteria in this species depend 
strongly on the activity of Hsp70 chaperones (Garcia et al., 2016). In conclusion, bacterial 
production of lactic acid can heritably convert neighbouring fungi from metabolic specialists to 
generalists, even across a vast evolutionary distance.  
1.7. Prions found in other species 
1.7.1. Mammalian PrPSc 
In 1982, Stanley Prusiner proposed that a protease-resistant protein, PrP, was responsible for 
scrapie; a well-established neurodegenerative disease of sheep that was both clinically and 
pathologically similar to several neurodegenerative disorders in humans (Prusiner, 1982). 
Prusiner suggested that it was in fact an isoform of PrP that was infectious, and went on to 
highlight the importance of identifying the replication mechanisms involved with this protein. He 
also stated that the emergence of prions may be in response to evolutionary pressure and as 
protection against degradation by the immune system (Prusiner, 1982).   
The analysis of infected brain homogenate led to the identification of a 27-30 kDa portion of 
normal, cellular PrP (labelled PrPC) which could undergo a conformational change from an α-
helical to a β-sheet structure, and this modified isoform of PrPC was labelled PrPSc (Pan et al., 
1993) (Figure 1.7). The  PrP sequence contains five variant octapeptide coding repeats in the N-
terminus that are well conserved across mammals (Goldfarb et al., 1991) and these 
mediate the ability to bind copper and zinc at physiologically relevant concentrations (Pan et al., 
2001). The ability of these repeats to bind metal ions may be significant as a 50% reduction in 
copper and elevated zinc and manganese levels has since been detected in the brains of 
patients with Creutzfelt-Jakob disease (CJD) (Pan et al., 2001). 
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Both isoforms of PrP are tethered to the surface membrane of a glycophosphatidylinositol (GPI) 
anchor and are found in lipid rafts which are membrane domains rich in both sphingolipid and 
cholesterol. The presence of PrP in such domains implicates a role in signal transduction, 
cholesterol transport and the regulation of receptor trafficking (Madore, 1999). A GPI-anchored 
version of Sup35 (see Section 1.6.2) was expressed in neuronal cells which were later exposed 
to pre-formed Sup35 fibrils. Remarkably, the Sup35p-GPI fusion was found to self-propagate and 
form protease-resistant aggregates, implicating a key role of the GPI-anchor in PrP infectivity. 
PrP is the only known protein involved in a misfolding disease that possesses a GPI anchor 
(Speare et al., 2010). In more recent years, evidence has emerged that PrP is not sufficient for 
infectivity alone as a phospholipid component which affects the specificity of infectivity is also 
required (Deleault et al., 2012; Kim et al., 2010). 
Figure 1.7: The PrP polypeptide is 254 residues long and is processed as shown, resulting 
in a 209 residue PrP molecule. Proteolysis of PrPSc generates a 142 residue fragment (PrP 27-
30).  
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PrP also appears to be involved in developmental processes of the central nervous system (Hu, 
2008), and has been recognised as a high affinity cell surface receptor for soluble amyloid-β 
peptide (Aβ) (Lauré  n et al., 2009) (see Section 1.8.2.4). An absence of PrPC or the use of PrPC 
antibodies block Aβ binding, inhibits Aβ-specific obstruction of potentiation and rescues synaptic 
plasticity (Lauré  n et al., 2009). Thus, PrPC was identified as a mediator of Aβ-induced synaptic 
dysfunction, and PrPC-specific chemical inhibitors may have therapeutic potential for 
Alzheimer’s disease (Laurén   et al., 2009). 
Collectively, the transmissible spongiform encephalopathies (TSEs) of scrapie, bovine 
spongiform encephalopathy (BSE), kuru and Creutzfelt-Jakob disease (CJD) are labelled as 
‘prion diseases’ which can either a) occur sporadically, b) be inherited following mutations in the 
PrP gene, or c) can be transmitted through ‘infected’ material. Symptoms of inherited CJD include 
dementia and deterioration of coordinated movement, and analysis of CJD-infected brain tissue 
shows PrPSc in the form of amyloid plaques, spongiosis and neuronal loss. As with many yeast 
prions, various prion ‘strains’ of PrPSc occur with differing structural versions of the PrPSc 
isoforms, leading to a diverse range of disease symptoms and PrPSc deposit patterns in the 
brain. 
1.7.2. The [HET-s] prion in the fungus Podospora anserina 
Podospora anserina is a filamentous fungus that grows as a multicellular network of hyphae, 
which fuse to other cells for communication and homeostasis in a process called anastomosis. 
Such hyphal fusion can also occur between different individuals to form heterokaryons, which 
describes the mixing of genetically different nuclei within the cytoplasm of a hyphal fusion cell 
(Glass et al., 2000). The viability of heterokaryons depends on the genetic composition at 
heterokaryon (het) loci, and rejection of the heterokaryon is known as vegetative incompatibility 
(Rizet, 1952). All of the 9 het genes are represented by one of at least 2 polymorphic alleles 
(Rizet, 1952). In particular, the het-s locus encodes a prion-forming protein, and it is the prion 
state of the encoded HET-s protein that determines the outcome of the heterokaryon reaction 
between the het-s and a het-S strain, assuming there are complementarities at all other het-loci 
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(Coustou et al., 1997). In the prion form [Het-s], vegetative incompatibility occurs, whereas the 
hyphal fusion survives if the HET-s protein is in the non-prion state [Het-s*] (Coustou et al., 1997). 
1.7.3. Plant Arabidopsis [LD+] 
With regards to biological memory, plant flowering has been an intriguing focus due to its unique 
regulation; a process involving memorising and integrating environmental conditions previously 
experienced. Using the highly developed computational programme Prion-Like Amino Acid 
Composition (PLAAC), prion domains were identified in nearly 500 plant proteins (Chakrabortee, 
Kayatekin, et al., 2016). More specifically, the prion-forming capacity of three Arabidopsis prion 
candidates involved in flowering was investigated using yeast as a model, as the function of such 
prion-forming domains (PFDs) can be confirmed using complementation of a known yeast PFD. 
All three proteins aggregated and formed SDS-resistant assemblies, although only the PFD of 
Luminidependens; a protein of the autonomous flowering pathway, could stably and heritably 
adopt both a soluble and insoluble prion conformation (Chakrabortee, Kayatekin, et al., 2016). 
Remarkably, LDPrD fully functionally replaced the prion-domain functions of Sup35 
(Chakrabortee, Kayatekin, et al., 2016)  In contrast with well-established yeast prions, [LD+] was 
not removed by GdnHCl-mediated inhibition of Hsp104, and did not form high-molecular weight 
amyloids, as visualised using GFP fusions. Instead, [LD+] formed low-molecular weight oligomers 
and was shown to rely on both Hsp90 and Hsp70 for propagation; similar to the behaviour of the 
non-amyloid forming [GAR+] prion (Chakrabortee, Kayatekin, et al., 2016). These results indicate 
the evolutionarily conservation of prion-like conformational switches, and the significance of such 
switches in a variety of common biological processes.  
1.7.4. Amoeba Dictyostelium discoideum Q/N-rich proteome 
The use of bioinformatics has revealed that Dictyostelium discoideum, a soil-dwelling amoeba, is 
an organism with the highest content of putative prion-like proteins so far investigated. Despite a 
seemingly high aggregation-prone proteome, prion-like proteins Htt-Q103 and Sup35 remained 
soluble and innocuous to D. discoideum (Malinovska et al., 2015). However, impairment of 
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molecular chaperones such as Hsp100 by heat stress or specific inhibitors leads to the formation 
of cytosolic, cytotoxic aggregates of these prion-like proteins. This suggests a distinct role of 
cytosolic molecular chaperones in protein aggregation. Interestingly, prion-like proteins can 
accumulate in the nucleus to be degraded by the ubiquitin-proteasome network, highlighting the 
evolutionary adaptation of D. discoidseum to allow efficient regulation of the high number of 
aggregation-prone proteins in its proteome (Malinovska et al., 2015). 
1.7.5. Bacterial Clostridium botulinum (Cb-Rho) 
Using the probability-based Markov algorithm to model randomly changing systems, ~60,000 
bacterial genomes were screened for proteins containing candidate prion-forming domains 
(cPrDs). The Clostridium botulinum transcription termination factor Rho, a highly conserved 
hexameric helicase which terminates transcription by RNA polymerase, was identified as a 
candidate containing a cPrD (Hochschild & Yuan, 2017). Rho was also found to assemble into 
amyloid aggregates using an E. coli-based secretion assay used to detect extracellular amyloid, 
and formed amyloid-like material when fused to yellow fluorescent protein (mYFP) (Hochschild & 
Yuan, 2017). The significance of the cPrD was further highlighted by a lack of amyloid-associated 
mYFP in variants lacking the cPrD and by the fully functional substitution of the Sup35 PrD with 
Cb-Rho cPrD. Yeast cells containing the Cb-Rho cPrD fused to Sup35 displayed a [PSI+] 
phenotype with propagation dependant on the chaperone Hsp104, indicating the infectious 
properties of Cb-Rho aggregates introduced into yeast once produced in bacteria (Hochschild & 
Yuan, 2017). The identification of Cb-Rho as a bacterial prion-forming protein establishes protein-
based inheritance in the bacterial domain, and specifically highlights the significance of cPrDs in 
Rho proteins of bacteria that represent at least six phyla. Typically, the switch to the prion state 
leads to a reduced or loss of function phenotype, but it must be noted that such mutations often 
facilitate the survival of bacteria in fluctuating environments, and bacterial prions therefore give 
rise to increased epigenetic diversity.  
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1.7.6. Viral AcMNPV LEF-10 
It had previously been reported that LEF-10; a protein essential for viral DNA replication and gene 
expression in the double-stranded DNA virus Autographa californica multiple 
nucleopolyhedrovirus (AcMNPV), can form SDS-resistant, high-molecular weight aggregates 
(Nan et al., 2019). More recently, it was suggested that the nuclei of LEF-10-EGFP induced the 
soluble protein to adopt the insoluble, aggregated form resulting in repression of late gene 
expression, indicating the prion-like behaviours of LEF-10. Much like the described findings of 
Chakrabortee, Kayatekin et al. (2016) and Hochschild and Yuan (2017), the PFD of yeast Sup35 
was replaced with LEF-10, with the fusion protein exhibiting a [PSI+] phenotype. The resulting 
‘prion’ was labelled [LEF+]. Furthermore, the reliance of [LEF+] propagation on Hsp104 in yeast 
was confirmed using both GdnHCl-mediated curing and HSP104 gene deletion, resulting in [lef-] 
cells, further highlighting the similarities of [PSI+] and [LEF+] requirements for maintenance (Nan 
et al., 2019). 
Confirmation of the first virus-derived prion extends current knowledge of prion proteins into non-
cellular life forms, thus providing evidence for their widespread occurrence in nature. Following 
on from the early suggestion that a combination of both herpes simplex virus type 1 (HSV1) and 
carriage of apolipoprotein E ε4 (APOE -ε4) allele is a strong risk factor for Alzheimer’s disease 
(Itzhaki et al., 1997), further studies should focus on the idea that novel virus-derived prions can 
trigger the biogenesis of prion-related diseases in mammals following viral infection. 
1.7.7. A recent hunt for ancient prions 
More recently, novel amyloid-forming proteins have been identified in two of the oldest 
evolutionary lineages; Archaea and Cyanobacteria. Bioinformatic screens of NCBI’s protein 
database predicted prion-like proteins by PLAAC (Chakrabortee, Kayatekin, et al., 2016) and 
identified prion candidates across all three domains of life (Zajkowski et al., 2019). This may 
suggest the presence of prion-like proteins in our last universal common ancestor. Further studies 
are required to characterise the amyloid properties of the 11 confirmed archaeal and 3 confirmed 
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cyanobacterial prion candidates, as well as uncovering the ability of such proteins to seed to 
amyloid form and transmit phenotypic traits (Zajkowski et al., 2019).  
1.8. The biological significance of prions 
1.8.1. Prion-mediated phenotypic heterogeneity 
The initial identification of prions being associated with certain mammalian neurodegenerative 
disorders characterised these proteins as causative agents of disease, yet the subsequent 
identification of prions in yeast implied that the correlation between prions and disease was not 
the full story. In particular, naturally-occurring prions in yeast have been found to promote 
heritable changes in protein conformation and function that can lead to the evolution of diverse 
new traits and survival in fluctuating environments i.e. are potentially beneficial rather than 
detrimental. For example, the [PSI+] prion in yeast can lead to a growth advantage of cells under 
stressful conditions, allowing greater rates of stress adaptation (True & Lindquist, 2000). 
In recent years, it has become more apparent that yeast prions represent a level of epigenetic 
control of certain cellular processes, but questions remain as to whether such control is 
coordinated with genotype, especially given the role that many yeast prions play in transcriptional 
processes. It also raises the question of whether a network of prion-specific interactions occur 
within the cell. Beneficial phenotypes associated with [PSI+] are not seen in all [PSI+] strains 
tested (True & Lindquist, 2000), indicating that the host cell genotype plays a significant role in 
phenotype, without overriding the underlying translation termination defect (Tuite, 2013). The 
presence of inactivating stop codon mutations (ISCMs) present in both lab and wild strains of S. 
cerevisiae could explain how different genotypes can modulate [PSI+]-dependant phenotypes, 
thus highlighting the interplay between epigenetic and genetic makeup within a strain (Fitzpatrick 
et al., 2011). Such interplay can give rise to a range of prion-mediated phenotypes (Tuite, 2013). 
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1.8.2. Prion-associated toxicity 
1.8.2.1. [PIN+] as a toxic amyloid model 
Studies of glutamine expansion diseases have revealed the toxic aggregation and impact of 
polyglutamine-rich proteins on cellular physiology, also highlighting glutamine as an aggregation-
prone amino acid. Models focussing on chains of glutamine residues i.e. polyglutamine – polyQ 
– tracts, suggest that glutamines possess random coiled coil conformations in the presence of
highly soluble carriers, which destabilise on expansion, thus promoting aggregation and the 
formation of β-sheets (Masino et al., 2002).  
Huntingtin molecules with expanded polyQ are more prone to aggregate into intracellular 
inclusion bodies, and overexpression of the yeast prion protein Rnq1 (Section 1.6.2) has also 
been shown to promote inclusion body formation (Meriin et al., 2002). Moreover, Rnq1 in its [PIN+] 
prion state is essential for polyQ aggregation (Meriin et al., 2002). Interestingly, Hsp104 can also 
affect polyQ toxicity either via a) the direct modulation of polyQ aggregates or b) the indirect 
modulation of prions that interact with polyQ aggregation. Similar to most yeast prion proteins, 
defects in Hsp104 function can lead to the inhibition of seeding of polyQ aggregates (Meriin et 
al., 2002).  
Moreover, mutant Htt-GFP (see Section 1.8.2.2) expressed in a yeast cell co-localises with 
Hsp104 and is continuously and directly removed from the inclusion body formed (Aktar et al., 
2019). In yeast cells expressing Htt-72Q and lacking either HSP104 or RNQ1; no inclusion 
bodies, GFP aggregates or liquid assemblies form, further highlighting the role of these proteins 
in Htt-polyQ associated toxicity (Aktar et al., 2019). In contrast, deletion of the proline-rich region 
in the amino-terminal region of Htt by-passes the requirement of Hsp104 for aggregate formation, 
and overexpression of Hsp104 or Hsp70 rescues growth defects in cells without resolving 
inclusions (Dehay & Bertolotti, 2006). Interestingly, aggregates formed by toxic proteins and 
cured by chaperones are physically distinct from aggregates formed by toxic proteins (Dehay & 
Bertolotti, 2006).  
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1.8.2.2. Polyglutamine-associated toxicity: Huntington’s disease 
In all known polyglutamine-associated diseases, a loss of neuronal cells in the brain results in 
progressive deterioration of muscle coordination (Harjes & Wanker, 2003). Despite the similarity 
of disease-symptoms, the only sequence similarity in the polyQ expanded proteins is within the 
polyQ tract, which plays a role in polyQ-associated toxicity. 
Huntington’s disease was first described as an autosomal dominant disease by George 
Huntington in 1872, and is a progressive neurodegenerative disorder caused by the expansion 
of the polyglutamine tract in the HTT gene (also referred to as the IT-15 gene). Expansion of the 
number of repeated trinucleotides (CAG; codon for Gln) within exon-1 of Htt leads to a loss of 
neuronal cells and results in uncoordinated body movements, neuropsychiatric abnormalities and 
dementia. The critical threshold for glutamine expansion before pathological changes occur is 
35-40 glutamines, and a repeat of 60 or more CAG units leads to a diagnosis of juvenile
Huntington’s. Interestingly, the longer the polyQ expansion, the more severe the disease 
symptoms and the earlier the onset (Norremolle et al., 1994). The Htt protein lacks sequence 
homology with any other known protein in eukaryotes and is expressed in nearly all tissues. Htt 
proteins are found in the nucleus and cytoplasm of neurons in the CNS, but also associate with 
mitochondria, Golgi apparatus and the endoplasmic reticulum (Harjes & Wanker, 2003). 
Disease onset occurring at a 35-40 glutamine expansion implies a molecular or functional barrier 
controlled by polyglutamine tract length, regardless of protein identity or flanking sequence. 
However, differences between polyglutamine diseases highlight that the toxic nature and length 
of the polyglutamine tract is not the only factor influencing disease pathology. Analysis of the 
affected protein’s identity, cellular localisation and flanking sequences may help to uncover 
possible mechanisms for disease progression and reveal cellular components with potential as 
therapeutic targets. 
Differences in amino acids flanking the polyQ regions influence the specific toxic nature of each 
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polyQ expansion protein in a yeast cell. The commonly used FLAG-epitope (DYKDDDK) at the 
terminus of Htt- exon 1 causes non-toxic polyQ proteins to increase in toxicity, whereas the 
endogenous carboxyl-terminal polyproline region of Htt-exon 1 convert toxic polyQ proteins into 
non-toxic ones (Duennwald et al., 2006). Furthermore, different flanking sequences can direct 
polyQ misfolding to at least two morphologically distinct types of polyQ aggregate; “tight and 
benign” or “amorphous and toxic” (Duennwald et al., 2006). Interestingly, Peskett et al (2018) 
showed that aggregates of Htt- exon1 exist in both distinct liquid-like and solid-like forms, and 
lengthening of the polyQ tract is sufficient to drive such assembly formation. In a yeast model, 
time-lapse movies of aggregation events show the presence of liquid-like assemblies driven by 
the polyQ and proline-rich regions of Htt-exon1. Such assembly formation is thought to require 
Rnq1 as cells lacking the RNQ1 gene display weak fluorescent polyQ assemblies (Peskett et 
al., 2018). Furthermore, observations of mutant Htt-GFP expressed in a yeast cell suggest that 
such assemblies move randomly and grow through the collision and coalescence of small 
aggregative particles (Aktar et al., 2019).  
1.8.2.3. Genetic modifiers of polyQ-mediated toxicity 
Upf proteins 1, 2 and 3 are involved in the nonsense-mediated mRNA decay (NMD) pathway; 
responsible for degradation of aberrant mRNA transcripts that carry premature termination 
codons, preventing synthesis of harmful C-terminally truncated proteins (Wang et al., 2001). 
In Upf-deficient mutants, mRNA transcripts containing premature termination codons are 
stabilised. More specifically, the Upf1 protein is an ATP-dependant RNA helicase located in the 
cytoplasm, forming a complex with both Upf2 (also localised in the cytoplasm and rich in acidic 
amino acid residues) and Upf3 which localises to the nucleus and is rich in basic amino acid 
residues (Mendell & Dietz, 2008). Both eRF1 (Sup45) and eRF3 (Sup35) interact with Upf 
proteins in yeast, and UPF gene deletions promote nonsense suppression (Wang et al., 2001). 
Findings reported in this thesis imply a role of Upf proteins in disease-associated amyloid 
aggregation. 
Like the Upf proteins, further genetic modifiers have been found to play a role in disease-
associated amyloid aggregation. Deletion of BNA4 in the tryptophan degradation pathway, and 
SCP160 involved in translation elongation efficiency prevent polyQ-mediated cytotoxicity in a 
[PIN+] background (Cheng et al., 2018; Giorgini et al., 2005). Additionally, genome-wide analyses 
in yeast have identified fourteen genes, that, when deleted, result in elevated polyQ toxicity 
(Papsdorf et al., 2015). UGO1, ATP15 and NFU1 all encode mitochondrial proteins and damage 
to the mitochondrial network is seen in polyQ-intoxicated cells (Papsdorf et al., 2015). Moreover, 
non-fermentative growth is inhibited in yeast cells expressing polyQ proteins. This implies a 
connection between polyQ-mediated toxicity and mitochondrial functionality (Papsdorf et al., 
2015). 
1.8.2.4. Amyloid-associated toxicity: Alzheimer’s disease 
Amyloid-β peptide (Aβ) is a 40-42 amino acid proteolytic fragment of the Alzheimer’s Precursor 
Protein (APP), generated by β- and γ- secretases (Goedert & Spillantini, 2006). The most 
common Aβ fragment is Aβ40, however mutations in APP or the γ- secretase network results in 
increased Aβ42 production which is a more hydrophobic peptide. Aβ42 is the predominant 
causative agent of Alzheimer’s disease, causing β-amyloid oligomerization and the formation of 
β-amyloid deposits (Goedert & Spillantini, 2006). Such deposits; namely plaques, are found in 
the extracellular space of the brain, compared to intracellular β-amyloid found in the secretory 
pathway, the cytosol, and the mitochondria (LaFerla et al., 2007).  
Yeast models have been used extensively to evaluate the cellular consequences of both extra 
and intracellular β-amyloid, which can be stabilised in yeast by the fusion to protein tags 
(Bharadwaj et al., 2008; Von Der Haar et al., 2007). Despite a high turnover, Aβ42 fusion 
proteins are reported to be non-toxic to yeast, although Aβ42-GFP expression causes a slight 
decrease in growth rate and induces the heat shock response (Caine et al., 2007). Von Der 
Haar et al. (2007) showed that both Aβ40 and Aβ42 peptides can mediate aggregation of yeast 
prion protein Sup35 when they replace the endogenous PFD. However, such Sup35-Aβ42 
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fusions form aggregates that are qualitatively different from [PSI+] prions in their requirements for 
maintenance and propagation (Von Der Haar et al., 2007).  
Further studies by D’Angelo et al., (2013) also expressed Aβ42-GFP expression proteins in S. 
cerevisiae, and established a system in which Aβ enters the secretory pathway, moves to the 
plasma membrane and thus becomes cytotoxic. Aβ also crosses membranes and targets the 
mitochondria in the cell (D’Angelo et al., 2013). However, the level of toxicity depends on the form 
of Aβ expressed, with an arctic mutant (AβARC) being more toxic than the wild type Aβ42 (D’Angelo 
et al., 2013). Furthermore, the level of Aβ-induced cytotoxicity also depends on the presence of 
proteins involved in protein trafficking pathways, namely PICALM; encoding phosphatidylinositol-
binding clathrin assembly protein in mammals (D’Angelo et al., 2013). The PICALM yeast 
homologues; AP180 proteins (Wendland & Emr, 1998) increase Aβ toxicity in S. cerevisiae 
(D’Angelo et al., 2013).  
Interestingly, treatment of cells with the Hsp104 inhibitor, GdnHCl stimulates Aβ42-GFP 
oligomerisation, however deletion of the HSP104 gene inhibits oligomerisation of this fusion 
protein. This suggests an interaction of Hsp104 with Aβ42-GFP, which may protect the protein 
from disaggregation and degradation (Bagriantsev & Liebman, 2006). 
Studies must therefore address how yeast cells are able to tolerate, detoxify and maintain Aβ42; 
and whether the presence of a prion protein or specific molecular chaperone facilitates 
aggregation, and impacts Aβ42 polymer size and structure. In addition, the Sup35-Aβ42 fusion 
model may be used to identify novel compounds that can modify Aβ42-associated aggregation. 
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1.9. Alternative mechanisms of protein inheritance in Saccharomyces cerevisiae 
The ongoing study of yeast prions has led to a general acceptance of the existence and biological 
impact of protein-based inheritance and the field is continuing to widen. A fairly novel example of 
protein-based inheritance is the concept of ‘prion-like’ proteins; proteins which show no diagnostic 
sequence or biochemical feature of known S. cerevisiae prions, but which have similar non-
Mendelian laws of segregation (Chakrabortee, Byers, et al., 2016). In a screening of ~5300 
proteins of S. cerevisiae, 46 were found to cause a heritable phenotypic change following 
elevated protein levels, and such phenotypes were retained once expression returned to normal. 
Many of the observed phenotypes had no associated amyloid-forming protein. Further prion-like 
behaviours were investigated through reliance on the molecular chaperones Hsp104, Hsp70 and 
Hsp90 and proteins that did not require such chaperone activity, yet caused the emergence of a 
beneficial new trait were labelled as prion-like (Chakrabortee, Byers, et al., 2016). Although such 
studies resulted in the discovery of several novel prion-like proteins, stress levels which induced 
such prion-associated phenotypes were engineered. Such stress was caused by protein 
overexpression, specifically causing aggregation and protein insolubility. The question which 
needs to be addressed is whether a natural signal can trigger such an epigenetic trait.  
1.9.1. Stress granules 
Although the molecular mechanisms underlying the form and function of such granules remain 
unclear, it is thought that stress granules cause a range of morphological changes (Hou et al., 
2011). Such morphological changes take place in response to cellular stimuli such as stress or 
viral infection, and an example is an altered structure of the nucleolus (Courchaine et al., 2016). 
In such adverse conditions, the stress granules are able to assemble and disassemble in the cell. 
It is thought that stress granules contain RNA-binding proteins, as well as factors which stall 
translation (Courchaine et al., 2016). Many of the RNA-binding proteins in such stress granules 
contain prion-like domains (PrLD) consisting of intrinsically disordered regions thought to be 
recruited to stress granules to elicit formation via liquid-liquid phase separation (Baer & Ross, 
2020). Prion-like domains that are recruited to such stress-induced assemblies require specific 
amino acid composition as shown by the efficient stress granule formation following synthetic 
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prion-like domain (Baer & Ross, 2020). Similarly, serine-arginine (SR) protein kinase Sky1; 
responsible for mRNA splicing regulation and RNA transport, has been established as a novel 
regulator of stress granule dynamics in S. cerevisiae (Shattuck et al., 2019). As previously 
discussed, the PrLD of Sky1 plays a definitive role in such stress granule formation, although the 
exact interaction of the PrLD within the stress granule remains to be defined.  
1.9.2. Mnemons 
Several studies have demonstrated that S. cerevisiae has an intrinsic ability to maintain ‘biological 
memories’ as exemplified by the Whi3 mnemon. Haploid yeast exist in two mating types; a cells 
which secrete the pheromone a factor and α cells which secrete α factor. Using pheromone 
receptors, cells of the opposite mating types sense each other’s presence, which in turn leads to 
a series of activation pathways to promote successful mating. Caudron and Barral (2013) showed 
that yeast exposed to mating pheromones for an extended period without experiencing 
successful mating become refractory to this signal, and continue to divide in both the presence 
and absence of such a signal. Cells were found to ‘memorise’ such unproductive mating attempts, 
and so the refractory state is maintained throughout the life span of the cell (Caudron & Barral, 
2013). It was suggested that this refractory state of the cells is caused by the super assembly 
and inactivation of the mRNA binding protein Whi3, which in turn allows the expression of the 
normally inhibited Cln3; a G1 cyclin involved in cell cycle progression. Much like prion proteins, 
such conformational change is counteracted by the molecular chaperone Hsp70, but interestingly 
this trait is only stable in mother cells over many divisions, and is not inherited by daughter cells 
(Caudron & Barral, 2013). Thus, Whi3 was labelled as a ‘mnemon’, a protein establishing memory 
through conformational change. This therefore leads to the question of whether other proteins 
exist in the form of mnemons in both unicellular and multicellular organisms. This existence could 
uncover alternative forms of memory, and encode the cell state used in previous environmental 
conditions (Caudron & Barral, 2013).  
More recently it was reported that (Whi3mnem) is strongly associated with the endoplasmic 
reticulum (ER) membranes, and only confined in the mother cell by the presence of membrane 
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diffusion barriers at the bud neck (Caudron et al., 2020). Interestingly, defects in this diffusion 
barrier facilitates (Whi3mnem) propagation in a mitotically stable manner, similar to prions. 
However, neither induction or curing of the [PSI+] prion is affected by whether diffusion barriers 
are present or not. Thus, (Whi3mnem) is a self-templating state, whose anchorage to the ER 
membranes maintains its confinement in the mother cell, preventing prion-like infectious 
propagation (Caudron et al., 2020). Furthermore, yeast cells can acquire a mitotically stable 
refractory state to pheromone, recently termed constitutive escapers (CE). Such a phenotypic 
state has been shown to mimic a loss of function of Whi3 and requires the prion-like domain of 
Whi3 (Caudron et al., 2020). This further highlights Whi3 as a dominant, inactive, self-templating 
prion form in CE variants, and indicates a promising case for the identification of novel prions in 
yeast.  
1.10. Saccharomyces species
As described in Section 1.4.3, prions are poorly transmitted between species due to the presence 
of a “species barrier”. This phenomenon was first recognised in scrapie prion transmission 
between sheep and goats, which adopted an extended incubation period when compared to intra-
species transmission (Cuille and Chelle, 1939). The notion of a species barrier to prion 
transmission has been studied in members of the evolutionarily-related species of 
Saccharomyces. 
Saccharomyces species are a complex of at least seven species ranging from key industrial 
and laboratory species, to those that remain in geographically limited environmental ranges 
(Borneman & Pretorius, 2014). Near complete genome sequences and a collection of 
genetically marked haploid strains of S. bayanus, S.kudriavzevii and S. mikatae have allowed 
comparison to the genomes of S. cerevisiae and S. paradoxus (Figure 1.8). Such comparison 
has given us insight into species-specific gains and losses, and provides a valuable toolset for 
comparative studies of gene function, metabolism, prions, and key evolution events (Scannell et 
al., 2011).  
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The species barrier for prion transmission has been studied in Saccharomyces species, 
highlighting a decreased level of prion conversion between species (Chen et al., 2007). It is 
clear that sequence divergence at a single nucleotide level, the physical interaction of 
heterologous proteins between different species and prion variants all contribute to the cross-
species species barrier. Whether a link exists between % amino acid sequence divergence 
of the heterologous PFD and the effectiveness of such a barrier remains to be established 
(Bruce & Chernoff, 2011).   
Moreover, it remains unclear whether well-established prion proteins of S. cerevisiae, namely 
Sup35 and Ure2, can transform into their stable prion conformations in the native cellular 
context of non-cerevisiae species (Afanasieva et al., 2011; Edskes et al., 2009). Also, among 
Saccharomyces species, the Rnq1 sequence is significantly more divergent across the 
whole molecule, yet a transmission barrier for the Rnq1 prion between members of 
Saccharomyces has yet to be investigated experimentally (Harrison et al., 2007). In a study 
of 21 different yeast species only 9 appeared to encode a Rnq1 orthologue, 
Figure 1.8: The phylogenetic tree of Saccharomyces species. The phylogenetic
relationships among members of the Saccharomyces genus. Red boxes denote the 
Saccharomyces species used throughout this study. 
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suggesting that the RNQ1 gene is missing from some fungal genomes (Harrison et al., 2007). 
This leaves a distinct gap in the knowledge of whether a) the RNQ1 gene exists in the 
evolutionarily-related species of S. cerevisiae, b) if present, whether Rnq1 can convert into its 
prion derivative in other Saccharomyces species, and c) whether Htt-polyQ expansion proteins 
can become cytotoxic in these species. 
A requirement for further investigation also lies in the presence of other prion-like proteins in this 
group of yeasts and specifically those prions considered as molecular memory devices. 
One example is the search for Lsb2; a stress-inducible cytoskeleton-associated protein, which 
forms a metastable prion in response to high temperature, and possession of an 
amino acid substitution required for Lsb2 prion formation coincides with acquisition 
of increased thermotolerance in Saccharomyces species evolution (Chernova et al., 
2017). Remarkably, only S. paradoxus and S. cerevisiae, characterised by increased optimal 
growth temperature, contain the N residue at position 213 required for Lsb2 prion 
formation, compared to the more distantly related S. mikatae and S. bayanus. 
Therefore Lsb2 prion formation in response to heat stress coincides with yeast 
adaptation to grow at higher temperatures, connecting prion formation in Saccharomyces 
to the cellular response to environmental stresses (Chernova et al., 2017).  
1.11. The Saccharomyces cerevisiae clade 
The reduced levels of prion discovery in non-domesticated strains of S. cerevisiae have been 
used to support the argument that prions have a detrimental impact on the host, and a strong 
selective pressure against their retention in a natural environment (Nakayashiki et al., 2005). 
More specifically, it has been suggested that more than half of [PSI+] variants observed are lethal 
or highly pathogenic, in contrast with the ‘mild’ variants usually studied (McGlinchey et al., 2011). 
Thus, the idea that certain prions cause ‘disease-like’ states in yeast may provide us with an 
answer as to why there are lower levels of ‘naturally-occurring’ prions in a natural environment. 
Leading on from this, many of the fungal prions discovered so far have been in laboratory-bred 
strains and have been labelled as potential ‘laboratory artifacts’ that arise through cultivation of 
fungal cells under conditions far removed from the environment in which they would have evolved 
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in (Tuite, 2013). ‘Unnatural’ lab environments include short-term storage at 4oC or long-term 
storage at -80oC, each creating possible selective pressures on the cell population (Tuite, 2013). 
The de novo formation of many yeast prions in the lab could have been induced by chemical 
pressures or unnatural protein overexpression which otherwise may not occur in a natural 
environment and therefore certain yeast prions would not have existed in a natural yeast 
population. It is therefore important to use non-domesticated strains of the S. cerevisiae clade to 
establish whether fungal prions are present in these strains, and whether any naturally-occurring 
prions can be transferred between closely or distantly related species.  
In contrast, many of the studies already focussing on the use of wild strains of S. cerevisiae have 
suggested that prions are not artefacts of culturing under laboratory conditions. Great care is 
taken to maintain the wild character of such strains and comparative growth of archived strains 
and their well-studied derivatives shows no difference (Halfmann et al., 2012). Studies show that 
prions can be advantageous in the strain’s natural ecological niche as exemplified in the strain 
Sc. #5672 where presence of the [PSI+] prion in this strain caused a clear growth advantage on 
synthetic grape must, a medium that mimics conditions of early wine fermentation (Halfmann et 
al., 2012).  
Phenotypic analysis in undefined wild strains of the same species also allows us to acknowledge 
the presence of the pan-genome; the concept of ‘accessory’ non-conserved genes across strains 
of the same species which contribute to intra-specific variability (McCarthy & Fitzpatrick, 2019). 
The core S. cerevisiae genome contains 4900 gene models, conserved across 100 strains 
tested, accounting for 85% of the total species pan-genome (Figure 1.9). The remaining genes 
are either duplicates of core gene models conserved across one or more strain, accessory genes 
missing a syntenic orthologue in only one other strain, or singletons; a gene carried by a unique 
chromosome in the sample. Overall, accessory genes which differ between strains make up 
14.9% of the pan-genome in S. cerevisiae (McCarthy & Fitzpatrick, 2019) (Figure 1.9).  
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Using the Pangenome Ortholog Clustering Tool (PanOCT), the intraspecific variability of each 
gene has been investigated (McCarthy & Fitzpatrick, 2019). Focusing on such variability on a 
gene-to-gene level rather than studying the pan-genome based on families of related gene 
models meant that both the conservation and distribution of a biological function can be observed. 
Not only do such analyses account for loss of micosynteny between fungal strain genomes, the 
extent of core genome content duplication occurring within fungal accessory genomes can also 
be established (McCarthy & Fitzpatrick, 2019). Functionally, core genomes are enriched for 
housekeeping processes, whereas accessory gene models are found within clusters in the 
terminal and subterminal regions of genomes and are enriched for processes that may be 
implicated in antimicrobial resistance (McCarthy & Fitzpatrick, 2019).  
Further studies using BLASTP searches of the systematic mutation set available on 
Saccharomyces Genome Database (SGD) showed that less than 20% of the genes in the S. 
Figure 1.9: The pan-genome of Saccharomyces cerevisiae. The ring  represents the total 
number of gene models in the pan-genome, expressed as a proportion of total pan-genome size. 
Coloured sections denote the core genes, accessory genes, and duplicated core gene models in 
the accessory genome. Labelled % add up to >100%, as duplicated core gene models have been 
accounted for both in the accessory genome, and as duplicates.  
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cerevisiae S288C genome are essential for growth while 962 of the 1031 predicted gene models 
with an inviable knockout phenotype are within the core S. cerevisiae genome. On the other hand, 
a significant proportion of gene models within the Sc. S288C accessory genome are associated 
with a viable knockout phenotype, which may reinforce the more variable nature of accessory 
genomes, relative to core genomes (McCarthy & Fitzpatrick, 2019).  
The variable nature of accessory genomes between different strains of the same species 
highlights the importance of studying strains of the S. cerevisiae clade on both a genotypic and 
phenotypic level. Such differences infer that many prions and prion variants may remain to be 
discovered in these strains, each with different impacts on host growth and behaviour in a wide 
range of habitats. 
1.12. Aims of the project 
The aims of this research project initially focused on exploring extrachromosomal regulators of 
phenotypic heterogeneity in both Saccharomyces species and members of the S. cerevisiae 
clade using GdnHCl to generate potentially prion-free strains of these yeasts. As well as the loss 
of prions from S. cerevisiae, GdnHCl causes the generation of mitochondrial petite mutants. 
Therefore the answers to two related questions were sought: (1) is the mechanism of petite 
induction by GdnHCl the same as leads to prion loss i.e. by inhibition of the molecular 
chaperone Hsp104?; and (2) can we identify prion-associated traits in other Saccharomyces 
species by GdnHCl-mediated curing? Analyses of well-established yeast prion proteins Sup35 
and Rnq1 were also undertaken in Saccharomyces species, with the aim of investigating the 
potential impact of minor differences in amino acid sequences within the PFD on cross-species 
prion transmission. Finally, the ability of these genetically related species to facilitate and 
perpetuate the formation of other amyloid-forming proteins has also been examined, with a focus 
on the Alzheimer’s disease associated protein Aβ42 and Huntingtin (Htt)-associated polyglutamine 
(polyQ). The behaviour of these amyloidogenic proteins was investigated, focussing on the impact 
of the prion state of the microbial host. 
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2. Chapter 2: Materials and Methods
Safety Information: 
Risk assessments including COSHH were carried out for all required procedures, involving the 
use of hazardous chemicals or equipment. All work involving genetically modified organisms and 
pathogens were performed in an ACDP category two laboratory. 
2.1. Media used for the culture of Saccharomyces cerevisiae, Saccharomyces 
bayanus, Saccharomyces mikatae, Saccharomyces kudriavzevii and Escherichia 
coli  
Unless otherwise stated, all media and sterile solutions were sterilised by autoclaving at 121 
oC, 15 lb/sq.in for 11 mins in a Prestige Medical benchtop autoclave. 
2.1.1. Water used in study 
Pure deionised water (dH2O) was produced by Thermo Scientific Barnstead NanoPure Diamond 
water system.  
2.1.2. Yeast extract, peptone, dextrose (YEPD) medium 
Table 2.1: Ingredients required for YEPD (Complete) media. 
Ingredients Amount per litre 
Glucose 20 g 
Yeast Extract (Difco) 10 g 
Bactopeptone (Difco) 20 g 
dH2O Up to 1 L final volume 
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For solid medium, Granulated Agar (Difco) was added to a final concentration of 2 % w/v prior 
to autoclaving.  
2.1.3. Prion curing with guanidinium salts 
For prion curing and the continued inhibition of Hsp104p, guanidine hydrochloride (Sigma) was 
added to YEPD medium after autoclaving to a final concentration of 5 mM from a 6 M stock 
solution in dH2O. 
2.1.4. Inhibition of Hsp90 with radicicol 
For Hsp90 inhibition, radicicol (Sigma) was added to the appropriate medium after autoclaving to 
a final concentration of 10 µg/ml, from a 5 mg/ml stock solution in dH2O.  
2.1.5. Generating petite mutants with ethidium bromide and guanidinium salts 
For the generation of respiratory-deficient petite mutants, ethidium bromide (Sigma) was added 
to the appropriate medium after the medium had been autoclaved, to a final concentration of 10 
μg/ml, from a stock solution of 10 mg/ml in dH2O. Guanidine hydrochloride and guanidine 
thiocyanate were also used for the generation of petite mutants, added to the appropriate 
medium after autoclaving to a final concentration of 5 mM, from a stock solution of 6 M in 
dH2O. Petite mutants were confirmed by a lack of growth on YEPG (See Section 2.1.6).  
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2.1.6. Yeast extract, peptone, 3 % glycerol (YEPG) medium
Table 2.2: Ingredients required for YEPG medium
Ingredients Amount per litre 
Glycerol (100 %) 30 ml 
Yeast Extract (Difco) 10 g 
Bactopeptone (Difco) 20 g 
dH2O Up to 1 L final volume 
Glycerol (100 %) is added to the medium after autoclaving. For solid medium, Granulated 
Agar (Difco) was added to a final concentration of 2 % w/v prior to autoclaving.  
2.1.7. Synthetic dextrose (Minimal) medium 
Table 2.3: Basic requirements for synthetic dextrose (minimal) media. 
Ingredients Amount per litre 
Glucose 20 g 
Yeast Nitrogen Base (without amino acids, 
with ammonium sulphate – Difco) 
6.7 g 
dH2O Up to 1 L final volume 
For solid medium, Granulated Agar (Difco) was added to a final concentration of 2 % w/v prior to 
autoclaving. To select for yeast cells carrying plasmid DNA the relevant nutritional marker was 
selected for by adding Yeast Synthetic Complete Drop-Out Media Supplement (Formedium) 
prior to autoclaving, lacking the appropriate amino acid. For uracil drop-out media, 1.9 g per litre 
was added.  
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2.1.8. Galactose induction (YEPGal) medium 
Table 2.4: Ingredients required for galactose induction media. 
Ingredients Amount per litre 
Galactose 20 g 
Yeast Nitrogen Base (without amino acids, with 
ammonium sulphate – Difco) 
6.7 g 
dH2O Up to 1 L final volume 
For solid medium, Granulated Agar (Difco) was added to a final concentration of 2 % w/v prior to 
autoclaving. To select for yeast cells carrying plasmid DNA the relevant nutritional marker was 
selected for by adding Yeast Synthetic Complete Drop-Out Media Supplement (Formedium) 
prior to autoclaving, lacking the appropriate amino acid. For uracil drop-out media, 1.9 g per litre 
was added. 
2.1.9. Complete medium with variable carbon source 
Table 2.5: Ingredients required for complete media with variable carbon source. 
Ingredients Amount per litre 
Carbon source (dextrose, galactose, sucrose, 
fructose, maltose) 
20 g 
Yeast Nitrogen Base (without amino acids, with 
ammonium sulphate – Difco) 
6.7 g 
dH2O Up to 1 L final volume 
For solid medium, Granulated Agar (Difco) was added to a final concentration of 2 % prior 
to autoclaving.  
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2.1.10. Glycerol glucosamine medium (GGM) 
Table 2.6: Basic requirements of glycerol glucosamine media, prior to autoclaving. 
Ingredients Amount per litre 
Glycerol (100 %) 20 ml 
Yeast Extract (Difco) 10 g 
Bactopeptone (Difco) 20 g 
dH2O Up to 1 L final volume 
After autoclaving, 0.05 % D-[+]-glucosamine hydrochloride (Sigma) was added from a 1 % stock 
filter sterilised in dH2O. For solid medium, Granulated Agar (Difco) was added to a final 
concentration of 2 % w/v prior to autoclaving. For control GGM, glycerol (100 %) was replaced 
with glucose 20 g per litre.  
For the induction of the [GAR+] prion, sodium D-lactate (sigma) was added to the medium prior 
to autoclaving to give final concentrations of 0.025 %, 0.625 % and 1.25 %. 
2.2. Luria Bertani (LB) media for the culture of Escherichia coli 
Table 2.7: Ingredients required for Luria Bertani (LB) media. 
Ingredients Amount per litre 
Bactotryptone (Difco) 10 g 
Yeast Extract (Difco) 5 g 
Sodium Chloride 10 g 
dH2O Up to 1 L final volume 
For solid medium, Granulated Agar (Difco) was added to a final concentration of 2 % w/v prior to 
autoclaving. To select for ampicillin resistant transformants of E. coli, ampicillin was added to a 
62 
final concentration of 100 μg/mL after the medium had been autoclaved, from a 100 mg/mL 
stock solution in dH2O, filter sterilised.  
2.3. Incubation conditions for the culture of Saccharomyces cerevisiae, 
Saccharomyces bayanus, Saccharomyces mikatae, Saccharomyes kudriavzevii 
All strains of Saccharomyces cerevisiae, Saccharomyces bayanus and Saccharomyces mikatae 
were grown at 30 oC unless otherwise indicated, with constant shaking at 200 rpm for 
liquid cultures. All strains of Saccharomyces kudriavzevii were grown at room temperature 
(~24 oC), with constant shaking on a rolling mixer for liquid cultures.  
2.4. Incubation conditions for the culture of Escherichia coli 
All strains of Escherichia coli were incubated at 37 oC, with constant shaking at 200 rpm for 
liquid cultures.  
2.5. Growth and viability analysis of Saccharomyces strains 
2.5.1. Automated growth rate analysis 
A single colony of yeast was inoculated into 5 ml of the relevant medium for overnight growth. 
Cell density was determined by absorbance at OD 600, and the appropriate volume of 
overnight culture was used to inoculate 1ml of fresh media in a sterile 24-well plate (Greiner) 
to a final OD 600 ~0.1 units. A BMG Labtech FLUOstar OPTIMA plate reader was used to 
measure growth rate of the culture with the following settings: 
 double orbital shaking mode
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 3 mM diameter shaking width
 1837 second cycle time
 600 nm excitation
 400 nm shaking frequency
 30 secs additional shaking time before each cycle
 0.5 sec positioning delay
The strain doubling time was determined using the following calculation: time in minutes was 
plotted against OD600 values using Microsoft Excel, and then an exponential trend-line was 
applied to the graph along with the trend-line equation. The natural logarithm of 2 was divided by 
the equation x value to give the doubling time in minutes.  
2.5.2. Growth analysis on different carbon sources 
Strains were grown overnight in 5 ml YEPD complete media (see Section 2.1.2). Cells from a 500 
μl aliquot were pelleted by centrifugation at 13,000 rpm for 30 secs at room temperature, washed 
in 500 μl sterile dH2O, pelleted and resuspended again. An aliquot of the washed cells was used 
to establish a 5x fold dilution series in water, before a 96 well replica-plater was used for 
spotting onto complete agar medium containing various carbon sources (see Section 2.1.9). 
Plates were incubated at 30 oC for 2-3 days or until growth was present (~24 oC for S. 
kudriavzevii). 
2.5.3. Methylene blue staining of yeast cells 
Strains were grown overnight in 5 ml YEPD complete media (see Section 2.1.2). Cells from 
a 200 µl aliquot were then centrifuged at 13,000 rpm for 30 secs at room temperature and 
mixed with 200 µl 0.1% (w/v) methylene blue solution. Stained cells were immediately 
visualised by loading in a haemocytometer, and images were captured on a Huawei P20 Pro 
using the Lictin Cell Phone Microscope Adapter. 
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2.6. Saccharomyces cerevisiae strains used in this study 
Table 2.8: Saccharomyces cerevisiae strains used in this study. 
Strain Genotype Source 
BY4741 MATα his3Δ1 leu2Δ0 
met15Δ0 ura3Δ0 
(Brachmann et al., 1998) 
74D-694 MATa ade1-14, trp1- 
289, his3Δ-200, ura3-52, leu2-
3, 112 
(Patino et al., 1996) 




(Brachmann et al., 1998) 
DBVPG6044 (3983) Mat α, ho::HygMX, 
ura3::KanMX-Barcode
(Cubillos et al., 2009) 
YPS128 (3903) 
Y12 (3913) 
UWOPS 03.461.4 (3923) 
DBVPG6765 (3883) 
SX1 Genetically undefined* (Wang et al., 2012) 
SX2 Genetically undefined* (Wang et al., 2012) 
SX6 Genetically undefined* (Wang et al., 2012) 
BJ6 Genetically undefined* (Wang et al., 2012) 
BJ20 Genetically undefined* (Wang et al., 2012) 
BJ14 Genetically undefined* (Wang et al., 2012) 
Mat α, ho::HygMX, 
ura3::KanMX-Barcode
Mat α, ho::HygMX, 
ura3::KanMX-Barcode
Mat α, ho::HygMX, 
ura3::KanMX-Barcode
Mat α, ho::HygMX, 
ura3::KanMX-Barcode
(Cubillos et al., 2009) 
(Cubillos et al., 2009) 
(Cubillos et al., 2009) 
(Cubillos et al., 2009) 
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HN11 Genetically undefined* (Wang et al., 2012) 
HN14 Genetically undefined* (Wang et al., 2012) 
HN15 Genetically undefined* (Wang et al., 2012) 
HN16 Genetically undefined* (Wang et al., 2012) 
FJ7 Genetically undefined* (Wang et al., 2012) 
HN2 Genetically undefined* (Wang et al., 2012) 
*Preliminary studies were carried out with genetically undefined wild strains of S. cerevisiae,
discovered in remote parts of the planet ranging from rotten tree bark in primeval forests to fruit 
in secondary forests in Northern and Southern China.  
2.7. Saccharomyces cerevisiae strains from the Yeast Knock-Out Collection 
(http://www.openbiosystems.com/GeneExpression/Yeast/YKO/) used in this 
study 
BY4741 (Mat a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) derivatives with the kanMX4 gene inserted in 
the place of indicated gene:  
Table 2.9: Saccharomyces cerevisiae strains from the knockout collection used in this 
study. 
Hsp104Δ hsp78Δ hsp82Δ upf1Δ upf2Δ upf3Δ 
2.8. Saccharomyces strains used in this study 
Table 2.10: Strains of Saccharomyces used in this study. 
Strain Genotype Source 
S.bayanus JRY9194* MATa hoD::loxP his3 lys2 ura3 C.T.Hittinger (Scannell et
al., 2011) 
S.bayanus JRY9195* MATα hoD::loxP his3 lys2 ura3 C.T.Hittinger (Scannell et
al., 2011) 








S.kudriavzevii JRY9185 MATa hoD::natMX ura3D0 C.T.Hittinger (Scannell et
al., 2011) 




For long term storage, 500 µl of each strain was mixed with 500 µl 80 % glycerol and stored at 
-80 oC until required. Strains streaked on solid media were stored at 4 oC until required.
* Within the species Saccharomyces bayanus, a natural subgroup; Saccharomyces uvarum was
identified, with unique characteristics making it clearly distinguishable from other species of
Saccharomyces (Rainieri et al., 1999). This species is often referred to as S. bayanus var
uvarum. In 1999, it was reported that strain CBS 7001 is a standard S. uvarum strain, with a
fully sequenced genome and auxotrophic mutants being derived from it (Rainieri et al., 1999). In
this study, S. bayanus JRY9194 and S. bayanus 9195 are used; derived from this CBS 7001
type strain. In line with the description by Scannell et al. (2011) from which these strains were
obtained, both S. bayanus JRY9194 and JRY9195 will be referred to as S. bayanus, despite
being derived from strain CBS 7001 earlier labelled as S. uvarum.
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2.9. Escherichia coli strains used in this study 
Table 2.11: E. coli strains used in this study. 
Strain Genotype 
DH5α F-deoR endA1 recA1 relA1 gyrA96 hsdT17(rk- 
mk+) phoAsupE44 thi-1 Δ(lacZYA-argF)U169 
Ф80δlacZΔM15 
For long term storage, 500 µl of each strain was mixed with 500 µl 80 % glycerol and stored 
at -80 oC until required. Strains streaked on solid media were stored at 4 oC until required. 
2.10. Plasmids used in the study 
Table 2.12: DNA plasmids used in this study. 





2 μ, URA3 Campbell Gourlay 




GFP tag under 
the 
control of the 
CUP1 promoter 
2 μ, PCUP1, URA3 T. Serio Lab 
pAG426-RNQ1-GFP RNQ1 ORF, C- 2 μ, PGAL1 URA3 Gemma Staniforth 







GFP tag under 
the control of 
the GAL-
promoter  





GFP tag under 
the control of 
the GAL-
promoter  
2 µ, PGAL1 URA3 Y Chernoff (Meriin et al., 
2002) 
GAL72Q+ProGFPp416 HTT region with 
C-terminal GFP
tag 
PGAL1 URA3 Addgene plasmid # 15582 ; 
http://n2t.net/addgene:15582 
; RRID:Addgene_15582 
GAL46Q+ProGFPp416 HTT region with 
C-terminal GFP
tag 





2 μ, PGAL1 URA3 Nadejda Koloteva-Levine 
(University of Kent) 
pBEVY-GU-
mNeonGreen 
2 μ, PGAL1 URA3 Nadejda Koloteva-Levine 
(University of Kent) 
a selectable markers for transformation used: 
URA3: uracil biosynthesis gene from Saccharomyces cerevisiae 
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2.11. Oligonucleotide primers 
Table 2.13: Oligonucleotide primers used in this study.























All oligonucleotide primers were synthesised by Eurofins MWG Operon. The primers were 
stored as 100 pmol/μL stock solutions in sterile MilliQ water at -20 oC until required. 
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2.12. Introduction of DNA into host cells 
2.12.1. Transformation of Saccharomyces species using the lithium acetate
method 
Using a sterile inoculating loop, a fresh colony of yeast was picked and inoculated into 5ml of 
appropriate medium and incubated overnight at 30 oC with shaking (~24 oC for S.kudriavzevii). 1 
ml of the fresh overnight culture was harvested by benchtop centrifugation at 13,000 rpm for 20 
sec at room temperature. The supernatant was decanted and the pellet was resuspended in the 
following reagents added sequentially: 240 μl of polyethylene glycol (PEG)-4000 (50 % w/v), 36 
μl of 1 M LiOAc, 10 μl of freshly denatured single-stranded carrier DNA (salmon sperm DNA, 10 
mg/ml), 5 μl of plasmid DNA (up to 1 ug), and 34 μl of sterile dH2O. The transformation mix was 
vortexed at full speed for 1 min before incubating at 30 OC for 30 min (~24 oC for S. 
kudriavzevii), followed by incubation at 42 oC for 30 min. Cells were harvested by benchtop 
centrifugation at 3,000 rpm for 2 min at room temperature. Following centrifugation, the 
supernatant was decanted and the pellet resuspended in 1 mL YEPD medium and left at room 
temperature overnight. This media was decanted, and cells were resuspended in 300 μl of sterile 
dH2O prior to plating 50-200 μl on the appropriate synthetic complete drop-out selection 
medium. Plates were incubated at 30 OC for 3-4 days, and the transformants subsequently re-
streaked onto fresh synthetic complete drop-out selection medium, as appropriate. 
2.12.2. Optimised transformation of Saccharomyces species using the
lithium acetate method 
Cells from an overnight culture were resuspended in 50 ml YEPD and grown to a density of 
0.7-1.0 OD600. Cells were harvested by centrifugation at 4000 rpm for 5 mins and 
resuspended in 10 ml sterile water (purchased from Sigma: W4502-1L and autoclaved). Cells 
were harvested again, resuspended in 1 ml sterile water and transferred to a 1.5 ml Eppendorf 
tube. The cells were harvested again by centrifugation at 5000 rpm for 1 minute and 
resuspended in 1.5 ml freshly prepared sterile TE/LiOAc prepared from 10 x 
concentrated stocks (giving a final dilution v/v of 1TE: 1LiOAc: 8dH2O).  
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Components of TE/LiOAc: 10x LiOAc = 1 M LiOAc (adjusted to pH 7.5 with dilute acetic acid), 
10 x TE (0.1 M Tris/HCL, 0.01M EDTA [pH 7.5]
A 50 µl aliquot of cells were harvested again, resuspended in 200 ul TE/LiOAc and mixed with 5 
µl plasmid DNA and 5 µl of ssDNA. 300 µl of freshly prepared sterile 40% PEG 4000 prepared 
from stock solutions (giving a final dilution vol/vol of 1TE: 1LiOAc: 8PEG) was added. The cells 
were then incubated for 30 mins at 30 oC with constant agitation. 
Components of 40 % PEG solution:
50 % PEG 4000 (filter sterilised), 10 x TE, 10 x LiOAc
84 ul undiluted DMSO was added to each sample, and cells were incubated at 42 oC for 15 mins. 
Following the addition of 800 μl sterile H2O, cells were collected by centrifugation at 13000 rpm 
for 10 secs, and resuspended in 1ml YEPD for 2-3 hrs at 30 oC (~24 oC for S. kudriavzevii). The 
media was decanted, and cells were resuspended in 300 μl of sterile dH2O prior to plating 50-200 
μl on the appropriate synthetic complete drop-out selection medium. Plates were incubated at 30 
OC for 3-4 days, and the transformants subsequently re-streaked onto fresh synthetic complete 
drop-out selection medium, as appropriate. 
2.12.3. Transformation of Saccharomyces species using electroporation
A single colony of yeast was used to inoculate 100 ml of YEPD complete medium and incubated 
overnight at 30 oC with shaking (~24 oC for S. kudriavzevii). 100 ml of culture was harvested 
by centrifugation at 5000 rpm for 2 mins, resuspended in TELiDTT (using fresh DTT) (filter-
sterilised), and incubated at room temperature for 1 hr. 
Components required for TELiDTT: 10 ml 10 x TE, 10 ml 1 M LiOAc, 1 ml 1 M DTT, dH2O up to 
100 ml final volume.
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The cell suspension was centrifuged at 5000 rpm at 4 oC for 5 mins, sequentially washed in 25 
ml ice-cold water and then 10 ml 1 M sorbitol. Samples were harvested again at 5000 rpm at 4 
oC for 5 mins, resuspended in 100 µl ice cold 1 M sorbitol and kept on ice. For electroporation, 
40 µl of cell suspension was placed in a pre-chilled 1.5 ml Eppendorf tube along with ~5 ng 
plasmid DNA. The mixture was incubated on ice for 5 mins, transferred to an electroporation 
cuvette, placed in an electroporation chamber and pulsed at 1.5 kV, 25 µFD and 200 ohms. 
1 ml 1 M sorbitol was immediately added to the sample and was mixed by inversion. 100 
µl of each sample was plated on the appropriate selective medium with the addition of 1 M 
sorbitol, and incubated at 30 oC for 2-5 days until growth was observed.
2.12.4. Transformation of Escherichia coli with plasmid DNA 
The appropriate purchased competent bacterial strain (see Section 2.9) was removed from -80 
oC storage and thawed on ice. The cells were mixed gently by flicking the tube and 50-100 µL of 
cells were transferred to a pre-chilled 1.5 ml Eppendorf tube. Up to 5 μl of plasmid DNA (≤1 μg) 
was added to the cell suspension per 50 μl of competent cells, and the tube was gently swirled 
to mix. The transformation mix was incubated on ice for 30 mins before 45 secs heat-shock at 
45 oC and returned to ice for a further 2 mins. The transformation reaction was diluted with 
900-950 μl of LB medium (Table 2.7) and incubated at 37 oC for 1 hr, with shaking at 200 rpm.
Between 50-200 μl of the mixture was plated on LB agar plates containing 100 µl ampicillin 
(Table 2.7), and the plates were incubated at 37 oC overnight. 
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2.13. DNA Methods 
2.13.1. Extraction and small-scale purification of plasmid DNA from Escherichia 
coli 
5 ml LB medium with 100 µg/ml ampicillin (see Section 2.2) was inoculated with a single colony 
of E.coli bearing the plasmid of interest and grown overnight at 37 oC with shaking. Cells were 
harvested by centrifugation at 13,000 rpm for 10 min at room temperature and the supernatant 
decanted. The resulting pellet was used to isolate the required plasmid DNA using a Qiagen 
QIAprep Spin Miniprep Kit according to manufacturer’s instructions. The DNA was eluted with 
50 μl of the EB buffer provided with the Qiagen QIAprep Spin Miniprep Kit.
2.13.2. Separation of DNA by agarose gel electrophoresis 
DNA fragments were separated by electrophoresis on 1 % (w/v) agarose gel when the 
fragments were expected to be greater than ~1 kb in length. For samples containing fragments 
of a smaller size (<1 kb) a 1.5 % (w/v) agarose gel was used. The analytical gels were made 
with Molecular Biology Grade agarose (Sigma) and were melted in 1x TAE buffer in 
a microwave oven for 2 mins at full power. 
Components of 1 x TAE buffer: 4.84 g Tris Base per 1 L, 1.14 mL Glacial Acetic Acid per 1 L, 
2 mL 0.5 M EDTA (pH 8.0), milli-Q water up to 1 L.
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The molten liquid agarose was cooled to ~50 oC before 5 μL of Sybr-Safe DNA stain (ThermoFisher) 
per 50 ml of gel was added. The gel solution was poured into a gel forming cassette and placed in 
an electrophoresis tank once solidified. 1x TAE buffer was added in sufficient quantity to cover 
the gel surface by 2-3 mm. DNA samples were prepared by adding 1/5 of a volume of 6x blue 
loading dye (Promega) to the samples and loaded into the wells of the gel. For plasmid DNA 
preparations and PCR products, 5 μl of samples were loaded. Electrophoresis was carried out 
at 100 V until the bands had migrated the desired distance ~1 cm from the end of the gel. The 
DNA fragments were visualised by short wavelength (312 nm) UV transillumination wearing 
appropriate PPE. 
2.13.3. Extraction and purification of genomic DNA from Saccharomyces species
A single yeast colony was used to inoculate 300 μl of Yeast Cell Lysis Solution supplied in the 
Yeast Genomic DNA Purification Kit (MasterPure), before incubation at 65 oC for 15 min. 
Samples were placed on ice for 5 min, and 150 μl of MPC Protein Precipitation Reagent 
(MasterPure) was added. Samples were mixed by gentle vortexing, and cellular debris was pelleted 
by centrifugation in a microcentrifuge at room temperature for 10 min at ≥ 10,000 rpm. The 
supernatant was mixed with 500 μl isopropanol in a clean 1.5 ml Ependoorf tube, and DNA was 
pelleted at room temperature by centrifugation for 10 min at ≥ 10,000 rpm. The supernatant was 
removed, and the pellet containing the DNA was washed with 70 % (v/v) ethanol. The remaining 
DNA was suspended in 35 μl TE Buffer. 
Components required for TE Buffer: 10 mM Tris-HCl, 1 mM EDTA (pH 8.0)
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2.13.4. Polymerase Chain Reaction (PCR) amplification of specific DNA 
PCR was performed using the Roche “High Fidelity PCR System‟ and a Techne TC-3000 
thermal cycler. Either 1.5 μl of mini-prep plasmid DNA (see Section 2.10) or 1 μl of yeast 
genomic DNA (see Section 2.13.3) was used as the source of the DNA template. The following 
reagents were mixed on ice in a thin-walled 0.2 ml thin-walled Eppendorf PCR tube (Table 2.14) 
Table 2.14: Reagents required for PCR amplification of DNA.
Reagent Volume Added Final Concentration 
High Fidelity Buffer (10x) with 
15 ml MgCl2
5 μl (1.5 ml MgCl2) 
dNTP mix, 10 mM each dNTP 1 μl 200 μM each dNTP 
Forward Primer 100 pmol/μl 1 – 5 μl 300 nM 
Reverse Primer 100 pmol/μl 1 – 5 μl 300 nM 
Template DNA 1 – 5 μl 0.1 – 250 ng 
High Fidelity Enzyme Mix 1 μl 3.4 U/reaction 
Sterile Milli-Q water Up to 50 μl 
The contents of the tube were mixed thoroughly by vortexing and placed in the thermal cycler. 
The cycling programme used was specifically tailored to the size of the DNA being amplified 
and to the primers being used (Table 2.13).  A 5 μl aliquot of the PCR product was run on an 
agarose gel (see Section 2.13.2) and the remainder stored at -20 oC until required.  
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2.14. Protein Methods 
2.14.1. Separation of proteins by SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed with precast gels using 
NuPAGE 10 % Bis-Tris gels with NuPAGE MOPS SDS running buffer, according to 
manufacturer’s instructions. An Invitrogen X-Cell SureLock gel tank was used, and the gel was 
typically run at 200 V for 50 mins. 
2.14.2. Preparation of cell-free lysates for western blot analysis 
A single colony of the desired strain was used to inoculate 10 ml of appropriate liquid medium. 
The culture was grown overnight at 30 oC (~24 oC for S. kudriavzevii) with constant shaking. 
This starter culture was then used to inoculate a further 10 ml of appropriate medium to an 
OD600 of 0.1. Depending on the strain being studied, a wash step was carried out prior to sub-
culturing. This wash step included harvesting cells by centrifugation at 3,000 rpm for 5 min at 
room temperature, decanting the supernatant and resuspending the pellet in sterile water. Two 
further wash steps were carried out, and the sub-culture was then incubated at 30 oC until an 
OD600 of 0.4-0.6 was reached. Certain strains were resuspended in a 2 % galactose induction 
medium (Table 2.4) and incubated for a minimum of 3 hrs. The OD600 of each culture was 
measured and a volume equivalent to 4.0 OD600 units was removed and placed into a separate 
tube. The cells were harvested for 5 min at 3,000 rpm and the cell pellet was resuspended in 
200 μl of lysis buffer.
Components of Western Blotting Lysis Buffer:
100 mM NaOH, 0.05 M EDTA, 2 % SDS, 2 % β-mercaptoethanol 
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The cell suspension was incubated at 90 oC for 10 mins, before 5 μl of 4 M acetic acid was 
added and the suspension was vortexed for 30 secs. The cell suspension was incubated at 90 
oC for a further 10 mins. For cultures intended for western blot analysis, 50 μl loading buffer was 
added. 
Components required for western blotting loading buffer: 0.25 M Tris- HCl (pH 6.8), 50% 
glycerol, 0.05 % bromophenol blue.
Protein concentration for each sample was determined using an Eppendorf Biophotometer at 280 
nm, and 50 μl of a 1 μg/μl preparation was made by diluting an adequate volume of sample in 
the sample buffer. 15 μl of the preparation was loaded onto an SDS-PAGE gel (see Section 
2.14). 
2.14.3. Preparation of cell-free lysates for sedimentation analysis 
A single colony of the desired strain was used to inoculate 10 ml of appropriate liquid 
medium. The culture was grown overnight at 30 oC (~24 oC for S. kudriavzevii) with 
constant shaking. This starter culture was then used to inoculate a further 10 ml of appropriate 
medium to an OD600 of 0.1. Depending on the strain being studied, a wash step was carried 
out prior to subculturing. This wash step included harvesting cells by centrifugation at 3,000 rpm 
for 5 min at room temperature, decanting the supernatant and resuspending the pellet in 200 µl 
sterile water. Two further wash steps were carried out, and the sub-culture was incubated at 30 
oC until an OD600 of 0.4-0.6 was reached. Certain strains were resuspended in a YEPGal 
medium (see Section 2.1.8) and incubated for a minimum of 3 hrs. The OD600 of each culture 
was measured and a volume equivalent to 4.0 OD600 units was removed and placed into a 
separate tube. The cell suspension was transferred to a 1.5 ml microcentrifuge tube to which 50 
μl lysis buffer and an equal volume of glass beads (diameter 425-600 μm) was added. Cells 
were lysed by vortexing 4 times for 30 secs, with 30 secs on ice in each interval. 100 μl of lysis 
buffer was then added and the resuspension briefly vortexed. 
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Components of sedimentation analysis lysis buffer: 1 x PBS, 100 mM NaCl, 2 mM PMSF, 
Protease Inhibitor Tablet (Sigma).
The tubes were immediately placed on ice and centrifuged for 3 min at 8,000 rpm in a pre-
cooled centrifuge at 4 oC. 80 μl of supernatant was carefully pipetted to a clean pre-chilled tube, 
and 40 μl of this was transferred to a 1ml Beckman thick-walled polycarbonate tube. This tube 
was then placed into a pre-chilled TLA.100 rotor and centrifuged at 50,000 rpm for 15 mins at 4 
oC in a Beckman Optimax ultracentrifuge machine. The remaining 40 μl represented the total (T) 
lysate fraction. The 40 μl of supernatant collected from the polycarbonate tube following 
ultracentrifugation represented the soluble (S) lysate fraction and this was transferred to a pre-
chilled 500 µl micro-centrifuge tube. A 40 μl aliquot of lysis buffer was used to resuspend the 
pellet in the polycarbonate tube and this suspension represented the pellet (P) lysate fraction, 
which was also transferred to a pre-chilled tube. To each fraction, 20 μl of sample buffer was 
added and the samples boiled for 5 mins at 100 oC before loading 15 μl of each onto an SDS-
PAGE gel (see Section 2.14).  
2.14.4. Staining of SDS-PAGE gels 
After electrophoresis, proteins within a gel were visualised following a 1hr incubation with 
Coomassie stain, followed by a 1hr incubation with de-stain, and then an overnight de-staining 
step in fresh de-stain solution at room temperature.  
Components required for Coomassie stain: 40 % (v/v) Methanol, 20 % (v/v) Glacial Acetic 
Acid, 0.1% (w/v) Coomassie Brilliant Blue R250.
Components required for de-stain: 10 % (v/v) Methanol and 10 % (v/v) Acetic Acid.
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2.14.5. Western blot analysis of SDS-PAGE gels 
Proteins were separated on the basis of molecular mass by SDS-PAGE (see Section 2.14). The 
wells and bottom edge of the gels were removed using a gel knife and the gel was then 
incubated in transfer buffer. Six pieces of Whatmann 3 mm paper (Thermo Fisher) were cut 
to approximately the same size as the gel (~30 mm x 30 mm) and soaked briefly in transfer 
buffer immediately prior to blotting. One piece of PVDF Polyvinylidene fluoride (PVDF) 
membrane (Thermo Fisher) was activated in 100 % methanol for 1 minute with agitation. 
Components required for western blotting transfer buffer: 0.29 % (w/v) Glycine, 0.58 % (w/
v) Tris-HCl, 0.037 % (w/v) SDS, 20 % Methanol.
Two pieces of blotting paper were placed on the anode plate of a Trans-Blot Semi-Dry Transfer 
cell (BioRad), followed by the PVDF membrane, the polyacrylamide gel, and the final two pieces 
of blotting paper. To ensure that there were no significant air bubbles present between layers, a 
roller was used to remove any excess air. The cathode plate was place on top and the 
apparatus was connected to a power supply. A voltage of 10V was applied for 1 hr. Upon 
completion of the semi-dry transfer the PVDF membrane was removed for use in the 
immunoblotting procedure (see Section 2.14.6).
2.14.6. Immunoblotting procedure 
Following on from the semi-dry transfer protocol, the PVDF membrane was placed in 6 
ml of blocking solution in a clean polyethylene terephthalate box and incubated with 
shaking for 1 hr at room temperature. The membrane was briefly washed twice with TBS/T, 
placed in 15-20 ml of blocking solution containing the appropriate concentration of primary 
antibody (Table 2.16), and incubated at 4 oC overnight with shaking.  
Components of western blotting blocking solution:
5 % (w/v) Dried Skimmed Milk (Oxoid), TBS/T (Tris Buffered Saline and 0.2 % Tween 20 
[Sigma])
80 
Following overnight incubation, the PVDF membrane was carefully removed and washed 3 
times with TBS/T for 5 mins. After completion of the wash phases, the PVDF membrane was 
placed in fresh blocking solution containing an appropriate concentration of secondary 
antibody (Table 2.16) and incubated at room temperature with shaking. The PVDF membrane 
was then washed with TBS/T as previously undertaken after the primary antibody straining.    
2.14.7. ECL detection (Enhanced Chemiluminescence) 
The PVDF membrane was placed in a clean polyethylene terephthalate box and the ECL 
solutions (Table 2.15) were mixed in a 1:1 ratio. The TBS used to incubate the PVDF membrane 
was discarded and the ECL solution was added and the PVDF membrane incubated for 1 min 
with constant agitation. The ECL solution was then discarded and the membrane removed and 
placed in a Saran wrap. The membrane was placed into the SYNGENE G:BOX gel doc system 
and blots were visualised. The GeneSys Software (Version 1.6.5.0) was used to visualise blots 
and a Synoptics 6MP camera was used to capture images. 
Table 2.15: Components required for ECL solutions 1 and 2.
Solution Components Amount up to 5ml 
ECL Solution 1 250 mM luminol 
3-aminophthalhydrazide
(Fluka No. 09253) 
50 µl 
90 mM p-coomaric acid 
(Sigma No C9008) 
22 μl 
1 M Tris.HCl (pH 8.5) 500 μl 
dH2O Up to 5 ml final volume 
ECL Solution 2 30 % hydrogen peroxide 3.2 μl 
1 M Tris.HCl (pH 8.5) 500 μl 
dH2O Up to 5 ml final volume 
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2.14.8. Semi-Denaturating Detergent Agarose Gel Electrophoresis (SDD-AGE analysis)
The yeast cultures were grown in appropriate medium until OD600 ~4 prior to lysis, which was 
then performed using the glass bead method (see Section 2.14.3) in PEB buffer.  
Components of SDD-AGE PEB Buffer: 25 mM Tris-HCl (pH 7.5), 50 mM KCl, 10 mM 
MgCl2*6H2O, 1 mM EDTA-Na, Complete Protease Inhibitor Tablet (Sigma).
Once the crude lysate was obtained, cell debris was removed using a 3 min spin at 8000xg 
(4oC). Lysate obtained in this way is turbid with a total protein concentration of 3-10 mg/ml, 
measured using a Biophotometer. 1.5 % w/v agarose was melted in 1xTAE, and 10 % w/v SDS 
was added drop by drop to the molten agarose to avoid solidification, giving a final concentration 
of 0.1 % SDS. The gel was cast in a 6 x 8 x 0.6cm electrophoresis casting chamber. Before 
loading the gel, samples containing ~80 μg of lysate protein were incubated in sample buffer at 
42 oC for 5 mins. Samples were then run in a horizontal gel chamber in 1 x TAE + 0.1 % SDS at 
a constant voltage of 125 V.  
Components required for SDD-AGE sample buffer: 60 mM Tris-HCL (pH 6.8), 5 % glycerol, 2 
% SDS, 0.05 % bromophenol blue. 
Once the gel had run to ~1cm from the end of the gel, the wells and bottom edge were removed 
using a gel knife. Nine pieces of Whatmann 3 mm paper (Thermo Fisher) were cut 
to approximately the same size as the gel and soaked in transfer buffer T immediately prior 
to blotting. One piece of PVDF membrane (Thermo Fisher) was activated in 100 % methanol for 
1 minute with agitation. 
Components required for SDD-AGE Transfer Buffer T: 20 mM Tris-base, 200 mM glycine, 
0.1% SDS, 15 % Methanol.
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The proteins were transferred from the agarose gel onto PVDF membrane using semi-dry 
transfer (see Section 2.14.5) and a voltage of 10 V was applied for 1 hr. Upon completion of the 
semi-dry transfer the PVDF membrane was removed for use in the immunoblotting procedure 
(see Section 2.14.6)  
2.14.9. Antibodies used in study 
Table 2.16: Antibodies used in study.
Antibody Host Dilution 
Anti-Sup35p (MT50) Rabbit 1:5000 
Anti-Hsp104p 34A Rabbit 1:5000 
Anti-Rnq1p Rabbit 1:5000 




2.15. Mitochondrial dysfunction assays 
2.15.1. 2,3,5-triphenyl tetrazolium chloride (TTC) overlay assay 
2,3,5-triphenyl tetrazolium chloride (TTC) is reduced from a colourless pigment to an insoluble 
red pigment by the activity of the mitochondrial respiratory chain (Ogur et al., 1957) and can 
therefore be used as an indicator of respiratory proficiency. A single colony of the yeast strain to 
be tested was used to inoculate the appropriate medium and grown as an overnight culture. 
These cultures were then diluted 1:50,000 in sterile dH2O and 200 μl plated onto the appropriate 
medium. Plates were incubated for 2-3 days at 30 oC (~24 oC for S. kudriavzevii) until colonies 
were well formed. TTC at 0.2 % w/v was dissolved in 0.067 M Sodium Phosphate buffer (pH 
7.0) containing 1.5 % granulated agar (Difco), and ~10 ml of the solution per plate was overlaid 
on the yeast colonies. Following a 1-2 hr incubation at room temperature, colony colour was 
noted and plates were scanned for record. 
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2.15.2. High resolution respirometry 
The Oroboros O2K Oxygraph High Resolution Respirometer was used to determine the 
consumption of O2 from mitochondria, and Datlab 4 software was used for the analysis of the 
data generated. Calibration of the instrument was carried out by loading 2 ml PBS into both 2 ml 
capacity chambers, maintained overnight at 30 oC. Cells from an overnight liquid culture 
were counted using a Neubauer haemocytometer and diluted to a cell density of 106 cells/ml into 
3 ml of an appropriate medium lacking glucose. 2 ml of each diluted culture was inserted into 
one of the two chambers to ensure each chamber was full. The chamber stoppers were 
inserted into position and any residual liquid culture was aspirated away. The exact cell 
concentration was then entered into the Datlab4 software for an accurate oxygen flux/unit 
sample (cell) reading. For the analysis of mitochondria, a series of drugs that target the 
electron transport chain were introduced into the chamber using clean syringes. The 
sequence of drug addition is outlined below, with a 5 minute interval left between each. 
Respirometry drugs: 
The following compounds were used to evaluate respiration in yeast cells: 
 Triethiltyn bromide (TET) (Sigma-Aldrich) (0.2 mM final concentration from a 50 mM
stock solution in DMSO)
 Carbonylcyanidep-trifluoromethoxyphenylhydrazone (FCCP) (Fluka) (0.012 mM final
concentration from a 12 mM stock solution in ethanol)
 Antimycin A (AntA) (Sigma-Aldrich) (0.002 mM final concentration from a 2 mM
stock solution in ethanol)
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2.16. Microscopy 
2.16.1. Sample preparation 
Strains from an overnight yeast culture were sub-cultured into a fresh appropriate selective 
medium and induced for plasmid expression where necessary (2.1.8). Analysis was performed 
on both stationary-phase and log-phase cells. A suitable aliquot of culture was pelleted by a 30 
second centrifugation at 13,000 rpm, washed once with 1ml 1xPBS, harvested again and 
resuspended in an appropriate volume of 1xPBS (20-200 μl). For visualisation, a 5 μl aliquot 
was spotted onto a microscope slide. 
2.16.2. Cell counting using a haemocytometer 
A 10 μl cell suspension was pipetted under the coverslip of the Neubauer haemocytometer and 
cells within a 25 square region (equivalent to 1 mm2) were counted and multiplied by 104 to 
determine the cell number per ml of the sample. Any dilution of the sample prior to counting was 
factored into the final cell number/ml. For greater accuracy, a minimum number of 5 chambers 
were counted and the average cell count was used to determine final cell number. 
2.16.3. 4′,6-diamidino-2-phenylindole (DAPI) staining of yeast cells 
A suitable aliquot (0.2 – 1 ml) of log-phase cells were pelleted by a 30 second centrifugation at 
13,000 rpm. Cells were resuspended in 0.5 ml 1xPBS buffer, and 1.5 μl of DAPI (6x 
concentration). Cells were incubated in the dye for ~30 mins, with occasional gentle agitation. 
Cells were then harvested as before, and the cell pellet resuspended in an appropriate volume of 
PBS (20 – 200 μl). A 5 μl aliquot was spotted onto a microscope slide for visualisation. 
2.16.4. Hoechst staining of yeast cells 
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Cells from an overnight culture were pelleted by centrifugation at 13,000 rpm for 30 secs and 
fixed in 70 % (v/v) ethanol. Cells were washed with PBS and stained with 0.1-1 µg/ml of 
Hoechst 33342 (Sigma-Aldrich) (using a 10mg/ml stock solution in dH2O) for 20 mins. Cells 
were washed again in PBS, and a 5 µl aliquot was mounted onto a microscope slide for 
visualisation. 
2.16.5. Light and Fluorescent Microscopy 
All yeast cell samples were visualised using an Olympus MT20 fluorescence microscope 
connected to a PC running CellR software (Manufacturer: Soft Imaging System). For the 
visualisation of fluorescent yeast cells, an Olympus 1x81 inverted microscope was used. The light 
source was provided by a Cool LED pE4000 illumination system. All images were captured using 
an Andor’s Zyla 4.2 PLUS sCMOS camera. The acquisition software used for visualisation was 
Micro Manager version 1.4.22 (Manufacturer: µManager).  A single drop of Olympus Immoil-
F30CC immersion oil was applied to the surface of the cover slip and an Olympus 60 x objective 
lens (NA = 1.35) was used to locate cells within a sample. An Olympus 100 x objective lens (NA 
= 1.4) was used to visualize individual cells. Cells with GFP-tagged proteins were analysed using 
the GFP channel with excitation/emission wavelengths of 488/512 nm. Differential Interference 
Contrast (DIC) images were taken using a halogen light source with identical settings to GFP 
imaging. To ensure images were representative of the whole population each microscopy 
experiment was repeated in triplicate and ~20 pictures were taken per sample. The counting of 
cells was conducted by eye from images generated.  
2.16.6. ImageJ processing of microscope images 
The images to be merged were opened in ImageJ FIJI software (Manufacturer: National Institute 
of Health). The images were first converted to 32-bit type and then saved in .jpeg or .png format. 
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2.17.1. DNA Sequence analysis 
Sequence alignment of gene sequences (nucleotide and amino acid sequences) was carried out 
in BLAST (Basic Local Alignment Sequence Tool, NCBI). Further analysis for percentage of 
amino acid sequence similarity between species was carried out using MUSCLE (Multiple 
Sequence Comparison by Log-Expectation, EMBL-EBI). Intrinsic disordered protein regions of 
the RNQ1 gene were predicted in all species using IUPred2 (Walsh et al., 2015). IUPred2 predicts 
global structural disorder that encompasses at least 30 consecutive residues of the protein. 
2.18. Statistical Analysis
The Analysis ToolPak was added into Microsoft Excel as a statistical add-in. Using this data 
analysis pack, the statistical significance of evidence was quantified by calculation of the p-value, 
and error bars on all graphs denote standard deviation. By using the ‘t-Test: Paired Two Sample 
for Means’ tool, statistics were performed on both the biological replicates and technical 
replicates of each experiment. When the p-value was less than the significance level of 0.05 
labelled as *, or 0.01 labelled as **, the null hypothesis was rejected and the difference between 
the two means was deemed significant. 
2.17. Bioinformatics 
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3. Chapter 3: Analysing [PSI+] and [RNQ+] prions in Saccharomyces species
3.1. Introduction 
In recent years, research on the well-established yeast prions [PSI+] and [RNQ+] has been 
predominantly focussed on laboratory strains of Saccharomyces cerevisiae, with very little known 
about the existence of endogenous [PSI+] and [RNQ+] prions in non-domesticated strains of S. 
cerevisiae, or in other closely-related species of Saccharomyces. The failure to find certain 
prions in non-domesticated strains of S. cerevisiae has contributed to the argument that prions 
have a detrimental impact on the host, and further highlights a strong selective pressure against 
their retention in cells growing in a natural environment (Nakayashiki et al., 2005).  
In contrast, the prion-forming ability of Sup35 in other species of yeast may imply an evolutionary 
value of [PSI+] formation in organisms such as Candida albicans, Candida maltose, Debaromyces 
hansenii and Kluyveromyces lactis (Edskes et al., 2014). However, prion formation in these 
species was at a much lower frequency than observed in S. cerevisiae, and [PSI+] formation could 
not take place in a number of other fungal species. This highlights that the prion-forming ability 
of Sup35 may not be a conserved trait, and is instead a side effect of a protein domain conserved 
for an alternative role (Edskes et al., 2014). Su and Harrison (2019) examined the conservation 
of sequence and of prion-like composition for collections of prion-forming proteins and prion-like 
proteins from S. cerevisiae. They showed that the prion-like status of a protein is conserved for 
around half the set of prion-formers at the level of Saccharomycetes, but the sequences of PFDs 
seem to evolve more quickly than other domains of prion-like proteins. An increase in mutation 
rate may be linked to the acquisition of functional roles of PFDs (Su & Harrison, 2019).  
Distinct amino acid sequence changes produce barriers to the transmission of [PSI+] within S. 
cerevisiae and between other species of yeast (Chen et al., 2007; Edskes et al., 2009). Most 
species transmission barriers occur as a result of amino acid substitutions in the PFD, however 
deletions in the C. albicans Sup35 M-domain; a region with non-prion function, leads to an 
89 
intraspecies transmission barrier (Edskes et al., 2014). Such sequence alterations may have 
been selected to increase prion resistance in scenarios where [PSI+] and other prions are 
severely toxic to a cell (McGlinchey et al., 2011).  Moreover, despite a high level of sequence 
divergence across the Rnq1 protein in Saccharomyces species, the possibility of a species 
barrier for [PIN+] prion formation is yet to be determined (Harrison et al., 2007).  
Near complete genome sequences of Saccharomyces will therefore allow comparisons to the S. 
cerevisiae genome, and give insight into species-specific gains, losses, and key evolution 
events (Scannell et al., 2011). This chapter provides an analysis of the sequences of the SUP35 
and RNQ1 genes in different Saccharomyces species and highlights the potential impact of 
minor differences in amino acid sequences within prion-forming domains on cross-species 
prion transmission. Western blot analysis is then used to detect the presence or otherwise of 
Sup35 and Rnq1 prion proteins in several different Saccharomyces species and the 
propensity of these species to promote the aggregation of the S. cerevisiae cross-species 
barriers examined by expression of ScSup35-GFP and ScRnq1-GFP fusion proteins in four 
different Saccharomyces species. 
3.2. A bioinformatic overview of SUP35 and RNQ1 genes in all species of 
Saccharomyces 
3.2.1. Sequence alignment of SUP35 and RNQ1 in Saccharomyces species
Amino acid sequence homology of the proteins encoded by the SUP35 and RNQ1 genes was 
inferred using a combination of sequence similarity scores and sequence identity scores. 
Sequence similarity was predicted in BLAST using a scoring matrix BLOSUM62, to find high-
scoring hits that may not match exactly but are similar. BLAST does not take into account gaps 
in this process, meaning there is potential to miss significant similarities present in the database 
(Koski & Golding, 2001). Sequence identity also fails to take gaps into account, and scores all 
amino acids present as one continuous sentence. Therefore, scores of both similarity and 
identity were considered to predict sequence homology. All sequences were manually 
aligned and analysed using MUSCLE (Multiple Sequence Comparison by Log-Expectation, 
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EMBL-EBI) as similarity spread out over an entire domain is likely to be more biologically 
significant than short, nearly exact matches. Thus, only sequences with >60% homology were 
inferred as similar, as sequences which share significant similarity are homologous, but many 
homologous sequences do not share significant similarity. 
Sequence comparison of SUP35 in the species examined revealed a significant degree of amino 
acid conservation (Figure 3.1). Both S. bayanus and S. mikatae had high percentages of 
SUP35 sequence homology to S. cerevisiae, but slightly lower similarity when compared to 
each other. The scores of S. kudriavzevii could not be considered, as SUP35 was only 
accessible as an incomplete shotgun sequence. In shotgun sequencing, segments of 
amino acids that are available are often grouped together using a chain termination 
method to create reads (Harrison & Zimmerman, 1984). Multiple overlapping reads for the 
target DNA are obtained by several rounds of fragmentation and overlapping, producing 
inaccurate results and possible false positives of sequence similarity.  
A) 
B) 
Figure 3.1: Sequence comparison of SUP35. Panel A: The number of amino acids in 
SUP35, along with the predicted molecular weight for each Saccharomyces species. Panel B: 
Alignment of each species of S accharomyces shows a high percentage of SUP35 
sequence homology. The sequence  of S. kudriavzevii was only available as an 
incomplete shotgun sequence and therefore could not be estimated. 
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Analysis of the RNQ1 sequence between species of Saccharomyces demonstrated that 
conservation of amino acid composition of the protein is maintained (Figure 3.2). High 
percentages of sequence homology are seen between S. cerevisiae, S. mikatae and S. 
kudriavzevii. A lower, but still significantly high sequence homology is seen between S. 
cerevisiae and S. bayanus, but this lower percentage may simply be down to the more distant 
relationship between the two species. These results suggest that the composition of Rnq1 in 
S. cerevisiae i.e. rich in both glutamine and asparagine residues, is significant for Rnq1
function as it is conserved in the other Saccharomyces species, and that these conserved 
residues have evolved from a common ancestor.  
Figure 3.2: Sequence comparison of RNQ1. Panel A) The number of amino acids 
in RNQ1, along with the predicted molecular weight for each Saccharomyces 
species. Panel B) Alignment of each species of Saccharomyces shows a high 




3.2.2. Analysing the similarity of the Prion-Forming Domain of Sup35 in all 
Saccharomyces species  
The N-terminal domain of Sup35 is essential for the de novo manifestation and maintenance of 
the [PSI+] prion (Li & Lindquist, 2000) and has been labelled the prion-forming domain (PFD), 
outlined in Chapter 1, Section 4.1. The exact function of the middle M-domain of Sup35 remains 
unclear, although the substitution for this domain for the charged regions from two other proteins 
created variants that acquired prion states, albeit with different properties (Liu et al., 2002). One 
M-domain variant was soluble in both the [PRION+] and [prion-] states, curable by GdnHCl, but
not curable by genetic modifications of HSP104. An alternate variant could only maintain the 
[PRION+] state in the presence of the wild-type protein, highlighting the impact of the M-domain 
on [PSI+] formation regardless of the same N-terminal prion-determining region (Liu et al., 2002). 
On the other hand, the C-terminal domain is essential for the translation termination activity of 
the protein (Ter‐Avanesyan et al., 1993) (Figure 3.3). 
In S. cerevisiae, the N-terminal prion-forming domain resides between residues 1 and 97, which 
consists of two distinct regions: a Q/N rich region (QNR, residues 1-40) and a series of 
Figure 3.3: The Sup35 protein of Saccharomyces cerevisiae consists of three distinct 
regions: an N-terminal prion-forming domain containing a Q/N-rich tract (QNR) and a 
consensus oligopeptide repeat sequence (OPR); a middle (M) domain; and the functional C-
terminal domain (C), taken from Josse et al., (2012).  
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oligopeptide repeats (OPR, residues 41-97) (Jossé   et al., 2012) (Figure 3.3). The QNR region 
forms the core of amyloid Sup35, whereas the OPR is essential for continued propagation of the 
[PRION+] state (DePace et al., 1998; Krishnan & Lindquist, 2005). Unlike the Q/N-rich region of 
the PFD, the presence of oligopeptide repeats is not recognised as a diagnostic feature of a yeast 
prion. The impact of primary sequence on prion-like properties in a protein therefore remains to 
be fully understood (Jossé  e et al., 2012). 
Although conservation of the prion properties of Sup35 exists between species of 
Saccharomyces there is an inability of these yeasts to transmit the infectious prion state 
(Chen et al., 2007). This ‘species barrier’ reflects the inability of Sup35 molecules from the 
different Saccharomyces species to co-aggregate with the S. cerevisiae Sup35, which is 
essential for transmission of the [PSI+] prion state (Kushnirov et al., 2000). Kushnirov et al. 
(2000) also suggest that the Sup35 N-terminal domain plays a key role in the observed 
species barrier, thus the sequence of the PFD was compared between each species. 
Interestingly, it is thought that the asparagine-rich nature of the PFD arose in early 
Saccharomycetes evolution, with Saccharomycetes displaying a distinctive trend for 
population sizes of prion-like proteins (An et al., 2016). Throughout the evolution of 
Saccharomycetes, the likelihood of increasing numbers of N residues and a tendency to form 
more poly-N tracts led to the expansion of the prion phenomenon. This stands in comparison 
with other fungi such as Eurotiales, which have much fewer Q/N-rich proteins highlighting a 
greater intolerance for amyloid-forming proteins (An et al., 2016).  
The percentage similarities of the PFDs of Sup35 of S. bayanus, S. mikatae and S. kudriavzevii 
compared to S. cerevisiae are 78%, 89% and 86% respectively. The Sup35 PFD of S. mikatae 
aligns with S. cerevisiae with no gaps, whereas S. kudriavzevii Sup35 PFD has one gap (Figure 
3.4). As expected the species with the highest difference in PFD similarity is the most distantly 
related S. bayanus, which lacks one oligopeptide repeat and has two single-residue insertions 
(Figure 3.4). The transmission of prions between species may therefore be inhibited due to a 
high sensitivity to small differences in PFD amino acid sequence.  
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The minimum region essential for propagation of [PSI+] in S. cerevisiae is assumed to be the first 
57 residues of Sup35; encompassing all Q/N-rich regions and the first two OPRs (Osherovich et 
al., 2004). Substitutions Q33K and A34K within a previously uncharacterised oligopeptide repeat 
of Sup35; namely the sup35-M0  allele, destabilised the fibril structure and eliminated the 
formation of [PSI+] with high efficiency (Danilov et al., 2019), further highlighting this region as 
important for [PSI+] maintenance (DePace et al., 1998). These findings stand in agreement with 
previous work by Paul et al. (2015), who suggested that both low levels of natural selection and 
small-scale mutations within the Sup35 PFD will result in aggregation-prone proteins, as a small 
number of mutations are sufficient in causing aggregation (Paul et al., 2015). Two to seven 
rationally designed point mutations introduced into four yeast Q/N-rich domains with no 
detectable aggregation activity promoted such activity in two of the domains, and prion activity 
in the remaining domains. This highlights the possibility of these non-aggregating domains 
being a few mutations away from becoming aggregating-domains (Paul et al., 2015). 
Specifically, Figure 3.4 highlights a substitution from G to A in a key oligonucleotide repeat in 
the S. mikatae PFD. Further work is thus required in order to confirm whether S. mikatae Sup35 









Figure 3.4: Sequence alignment of Sup35 PFDs of each species of Saccharomyces. 
Letters shown depict differences in amino acid residues compared to the sequence 
of Sup35 PFD in S. cerevisiae. Gaps are shown as yellow highlighted dashes, 
and boxes highlight the oligonucleotide repeats in S. cerevisiae.  
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3.2.3. Predicting the Intrinsic Disordered Protein Regions of Rnq1 in all species of 
Saccharomyces 
The PFD of Rnq1 in S. cerevisiae has four distinct QN-rich regions (Figure 3.5) and one of these 
regions is usually sufficient to maintain a heritable aggregated state in vivo, as well as 
transmission of the [PIN+] prion state to daughter cells (Kadnar et al., 2010). Specifically, amino 
acids 132-405 are thought to define the prion-forming domain (Sondheimer & Lindquist, 2000). 
Sondheimer and Lindquist (2000) also show that Rnq1153-405 can form a stable prion when 
fused to Sup35 lacking the [PSI+] PFD. This indicates that  the fusion of prion-determining 
regions with different functional proteins can produce a new prion, whose functions can be 
switched on or off in a heritable manner (Sondheimer & Lindquist, 2000). 
An increase in glutamine abundance in a protein is associated with an increased tendency to 
aggregate and is also linked to neurodegenerative pathology in polyglutamine diseases (Meriin 
et al., 2002). Therefore, differences in the QN-rich regions of Rnq1 between different species of 
Saccharomyces would be predicted to alter a) the frequency with which [PIN+] can arise, b) the 
induction of other prion proteins to undergo conformational changes into their prion state, and c) 
A) 
B) 
Figure 3.5: The PFD of Rnq1 in S. cerevisiae. Panel A) The sequence of S. cerevisiae 
Rnq1 indicating the location of the prion-forming domain, defined by Sondheimer and Lindquist 
(2000), and the location of the polymorphic regions A, B and C, adapted from Resende et al., 
(2003). Panel B) Each of the Q/N-rich regions QN1, QN2, QN3 and QN4 are seen in red,
yellow, green and orange respectively, and can all transmit the prion state (taken from Kadnar 
et al., 2010).
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the induction of heterologous polyglutamine protein aggregation. As the function of Rnq1 
remains unclear, it is possible that both aggregation and interaction with alternative aggregation-
prone proteins is key to its function (Kadnar et al., 2010). More recently, Villali et al., (2020) 
offered an unrelated role for [PIN+] after seed formation; promoting amplification rather than 
clearance of Sup35 amyloid by directly competing for Hsp104 binding, thus titrating its activity 
(Villali et al., 2020). It is now thought that the size of the Sup35 nucleation seed links to amyloid 
persistence; interactions with [PIN+], and successful transition between prion states.  
As described in Chapter 1, Section 4.1, PFDs are biased towards residues that balance disorder 
propensity and prion propensity, such as Q and N (Pierce et al., 2005). Such residues are strongly 
associated with intrinsic disorder, and are highly overrepresented in the Sup35, Rnq1 and Ure2 
PFDs (Toombs et al., 2010). Thus, it is well-established that intrinsically disordered protein 
regions (IDRs) play a critical role in the formation of many yeast prions, but further analysis is 
required to distinguish the level of IDR conservation in proteins of Saccharomyces. 
IUPred2 (Walsh et al., 2015) was used to identify IDRs which lack a stable monomeric structure 
within the Rnq1 protein of each species of Saccharomyces. Dupace et al., (1998) showed that 
prion protein Sup35 contains intrinsically disordered Q/N rich segments, but such regions 
are yet to be published in Rnq1. Establishing IDRs in the Rnq1 protein of each species may 
act as a diagnostic feature for prion propensity. Each residue in each Rnq1 sequence was 
scored between 0 and 1, corresponding to the probability of the given residue being part of a 
disordered region. An IDR is predicted as a structural disorder encompassing at least 30 
consecutive residues of the target protein (Walsh et al., 2015). The PFD of Rnq1 in S. 
cerevisiae is depicted in Figure 3.6 with consistent high scores close to 1, highlighting this 
region as one that is intrinsically disordered. The predictions for IDRs in all other 
Saccharomyces Rnq1 proteins are highly consistent with the PFD of Rnq1 in S. cerevisiae, 
suggesting region homology between species, and the predicted propensity of these 


























Figure 3.6: IUPred2 predictions of Intrinsic Disordered Regions of Rnq1 across all 
species. Each graph is based on assigning a score between 0 and 1 to each residue, 
corresponding to the probability of the given residue being part of a disordered region. 
The Rnq1 PFD in S. cerevisiae is between aa 132-405, and the predicted IDRs of Rnq1 
are predicted and labelled at the same point in each species. The Four Q/N-rich regions 



























3.3. Detecting endogenous prion proteins Sup35 and Rnq1 in all Saccharomyces 
species  
3.3.1. Western blot analysis of Sup35 and Rnq1 in Saccharomyces species 
Endogenous prion proteins Sup35 and Rnq1 were detected in all species of Saccharomyces by 
western blot analysis using a polyclonal antibody raised against the Sup35 protein from S. 
cerevisiae, as described in Materials and Methods (Section 2.14.9). Both Rnq1 and 
Sup35 were detected at sizes larger than predicted despite being are in line with the S. 
cerevisiae control (Figure 3.8). S. mikatae Sup35 appeared at a molecular weight much 
higher than expected, with the bioinformatic sequence analysis suggesting its size 
as 60kDa. However, the similarity in molecular weight of each protein in each species 
further supports the protein homology between each species (Section 3.2). The presence of a 
lower molecular weight band observed in lanes of S. cerevisiae and S. mikatae must also 
be noted. Two bands may indicate a specific protein cleavage product, highlighting a 
specific sequence recognised by endonucleases that is not presenting in S. bayanus 
or S. kudriazvevii. Successful probing with the target antibody may therefore uncover 
subtle differences in the Sup35 protein between species of Saccharomyces. The levels of 3-
PhosphoGlycerate Kinase (Pgk1p), an essential protein of known molecular weight, were also 
detected in each yeast strain as a control (Figure 3.7). 
Pgk1 
Sc: 44.7388 kDa 
Sb: 44.84 kDa 
Sm: 44.8 kDa 






Figure 3.7: Western blot analysis of Pgk1 in all species shows the protein at the 
expected molecular weight. This experiment was repeated three times and a 








Sc: 42.57 kDa 
Sb: 41.2 kDa 
Sm: 41.7 kDa 
Sk: 42.38 kDa
Figure 3.8: Western blot analysis of Sup35 and Rnq1 in all species. Panel A) Western blot 
analysis of Sup35 in all species shows the protein at molecular weight slightly higher than expected. 
Panel B) Western blot analysis of Rnq1 in all species shows the protein at a molecular weight higher 
than expected. All bands are seen in line with the S. cerevisiae control. This experiment was 
repeated three times and a representative data set is shown. 
Sup35 
Sc: 76.55 kDa 







3.3.2. Western blot analysis of Sup35 and Rnq1 in the Saccharomyces cerevisiae 
clade 
Endogenous prion proteins Sup35 and Rnq1 were also detected in all species of the 
Saccharomyces cerevisiae clade by western blot analysis. Both proteins were detected at 
molecular weights slightly higher than expected, although the bands remained in line with the S. 
cerevisiae laboratory control. There was no significant difference in the observed molecular 






Sc. 3883: 76.39 kDa 
Sc. 3893: 75.43 kDa 
Sc. 3923: 76.28 kDa 
Sc. 3913: 75.29 kDa 






Sc. 3883: 43.28 kDa 
Sc. 3893: 40.92 kDa 
Sc. 3923: 43.53 kDa 
Sc. 3913: 41.83 kDa 
Sc. 3903: 42.53 kDa
Figure 3.9: Western blot analysis of Sup35 and Rnq1 in all S. cerevisiae strains. Panel A) 
Western blot analysis of Sup35 in all species shows the protein at the a molecular weight slightly 
higher than expected. Panel B) Western blot analysis of Rnq1 in all species shows the protein 
at a molecular weight higher than expected. All bands are seen in line with the S. cerevisiae 





Further analysis of potential aggregated forms of Sup35 and Rnq1 was carried out using 
sedimentation analysis, a method used to quantify the proportion of either Sup35 or Rnq1 in 
soluble and higher molecular weight aggregated [PRION+] states by ultracentrifugation (Ness et 
al., 2002). Preliminary work included the preparation of [PRION+] and [prion-] cell extracts to 
provide total (T), soluble (S) and pellet (P) fractions according to both Sup35 and Rnq1 
sedimentation protocols in all species of Saccharomyces, although it is an incomplete analysis 
and further repeats are required (data not shown). In contrast, semi denaturing agarose gel 
electrophoresis (SDD-AGE) analysis was also carried out to allow specific separation of SDS-
resistant polymers of yeast prion proteins based on molecular weight. However, this data is 
also an incomplete analysis, lacking the S. cerevisiae [psi-] control (Figure 3.10). The SDD-
age profile for non-domesticated S. cerevisiae control strain, and species of Saccharomyces 
are comparable to the wild-type [PSI+] control strain, with SDS-resistant aggregates, albeit at a 
range of aggregate sizes. None of the strains tested showed monomeric material, despite 
being expected for the S. cerevisiae [psi-] control strain, thus highlighting a requirement for 
repeats. Nevertheless, these results may indicate the ability of Saccharomyces species to 
form prion polymers, albeit with different polymer size distribution. The high molecular 
weight SDS-resistant aggregated material should also be compared to Sc. [PSI+] controls in 
strong and weak prion variants, to identify the potential impact on aggregate size. These 
methods provide a means to assess both aggregate size and proportion of aggregated versus 
soluble material in a cell population (Ness et al., 2002; Patino et al., 1996). 
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3.4. Analysing the expression of ScSup35-GFP and ScRnq1-GFP in all species of 
Saccharomyces 
The aggregation of Sup35, indicative of the [PSI+] state in S. cerevisiae, can be observed 
microscopically by fusing the protein to Green Fluorescent Protein (GFP), the resulting plasmid 
being called p6442-SUP35NM-GFP (Patino et al., 1996). Specifically, the C-domain of Sc-
Sup35 that is not required for aggregation has been replaced with GFP. The fusion 
protein was therefore expressed in all Saccharomyces species under the control of the 
CUP1 copper-inducible promoter. In a [PSI+] state, GFP would be expected to coalesce into 
multiple bright foci in cells, compared to diffuse fluorescence one would expect to see evenly 
distributed throughout a [psi-] cell.  
The expression of p6442-SUP35NM-GFP in [PSI+] S. cerevisiae produced bright foci in both log 
and stationary phase cells, as previously reported (Patino et al., 1996). Interestingly, all other 
species of Saccharomyces produced diffuse fluorescence, indicative of a [psi-] state, but this 





















Figure 3.10: SDD-AGE analysis of Sup35 in species of Saccharomyces. SDD-AGE 
analysis of Sup35 in the different species suggests an ability to form prion polymers, but 
further repeats with [psi-] controls are required.  
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demonstrated that Sup35 from S. bayanus formed  a prion in S. cerevisiae, although prions 
formed by such heterologous proteins were less stable than endogenous ScSup35p (Chen et 
al., 2007). S. bayanus Sup35 co-aggregated in S. cerevisiae cells, but cross-species prion 
transmission was asymmetric in almost all heterologous combinations. Further analyses of the 
species barrier in other members of the Saccharomyces focused on the transmission of 
[PSI+] from S. cerevisiae Sup35 to hybrid Sup35 proteins with PFDs from such species. 
All hybrid Sup35 proteins could adopt the prion formation in S. cerevisiae, but could not 
readily adopt the prion form from the [PSI+] prion of S. cerevisiae  (Afanasieva et al., 2011). 
Furthermore, S. bayanus displayed changes in both cell size and shape in response to 
expression of fluorescent proteins, while S. kudriavzevii displayed high levels of cell flocculation, 
but very low levels of fluorescence (Figure 3.11).  





















Figure 3.11: ScSup35-GFP forms fluorescent foci in [PSI+] cells of S. cerevisiae, but not in 
other Saccharomyces species. Images shown were taken by fluorescent microscopy at 100x 
magnification during both log and stationary phases of growth, following induction with copper for 
4 hours. Each strain was visualised in three independent biological experiments, and 
a data set representative of at least 200 cells per visualisation is shown. The scale bar 
represents 10 µm.   
As with Sup35, the joining of a GFP-tagged Rnq1 fragment to endogenous Rnq1-based prion 
aggregates can be visualised by the formation of fluorescent GFP foci. The plasmid pAG426-
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RNQ1-GFP that expresses a Rnq1-GFP protein under the control of the GAL1 promoter was 
introduced into each Saccharomyces species. In an endogenous [PIN+] state, ScRnq1-GFP 
forms bright fluorescent foci in S. cerevisiae (Patel & Liebman, 2007). In contrast, in a 
[pin-] state, the fluorescence is diffuse across the cell. In S. cerevisiae, foci indicative of [PIN+] 
were present as expected in this strain, but in all other species, fluorescence was again diffuse 
across all cells, indicating the possibility by a species barrier. Harrison et al., (2007) 
expressed that a species barrier for the formation of the Rnq1 prion is yet to be demonstrated 
experimentally in members of Saccharomyces, although Kelly et al., (2012) showed even in 
wild strains of S. cerevisiae, Rnq1 polymorphisms create a small transmission barrier. These 
polymorphisms include premature stop codon alleles that cannot propgate the [PIN+] prion 
from the reference allele, several small deletions, and point mutations (Kelly et al., 2012). 
A change in vacuole size was also seen across all species (Figure 3.12).  
To confirm that the fluorescent foci visualised in S. cerevisiae was indicative of both endogenous 
[PSI+] and endogenous [PIN+], all cells were treated with GdnHCl. GdnHCl causes reversible 
inhibition of the chaperone activity of Hsp104 which is necessary for endogenous prion 
propagation (Tuite et al., 1981). Exposure to millimolar concentrations of GdnHCl therefore 
generates prion-free cells. Following GdnHCl curing, fluorescent foci indicative of the [PRION+] 
Sk. 9185 Sb. 9194 Sm. 9183 Sc. BY4741 
Figure 3.12: ScRnq1-GFP forms fluorescent foci in S. cerevisiae, but not in any other 
Saccharomyces species. Images were taken by fluorescent microscopy at 100x magnification 
during both log and stationary phases of growth, following induction with galactose for 
3 hours. Each strain was visualised in three independent biological experiments, and 
a data set representative of at least 200 cells per visualisation is shown. The scale bar 
represents 10 µm. 
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state of S. cerevisiae were no longer detectable (Figure 3.13), confirming previous findings on 
the endogenous prion state of the strain.  
3.5. Discussion 
The inability of other Saccharomyces species to form fluorescent GFP foci following 
expression of either ScSup35-GFP and ScRnq1-GFP may not be indicative of an 
endogenous [prion-] state, but instead the presence of a cross-species prion transmission 
barrier (Chen et al., 2007). Impairment of cross-species prion transmission was originally 
detected in Saccharomyces using both complete Sup35 proteins and chimeric constructs 














Figure 3.13: Fluorescent foci indicative of [PSI+] and [RNQ+] are replaced with diffuse 
fluorescence following curing with 5mM GdnHCl. Images were taken by fluorescent 
microscopy at 100x magnification following induction with copper for 4 hours or galactose for 3 
hours, for expression of ScSup35-GFP and ScRnq1-GFP respectively. Each strain was 
visualised in three independent biological experiments, and at least ~200 cells per condition 
were visualised.  
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species prion transmission was asymmetric in almost all heterologous combinations (Chen et 
al., 2007). This decreased level of prion transmission may demonstrate that the prion 
species barrier can be controlled in ways other than the physical association of heterologous 
proteins, such as the level of conformational transition. Further work by Chen et al. (2007) 
revealed that naturally occurring polymorphisms in the non-QN-rich region of Sup35N 
generate prion transmission barriers, and such barriers are not directly proportional to 
sequence divergence (Chen et al., 2010). Cross-species transmission barriers of Rnq1 were 
also shown to be generated by deletions of the QN-rich regions in Rnq1, with each region 
sufficient in maintaining the transmission of the [PIN+] prion into daughter cells (Figure 
3.5) (Kadnar et al., 2010). The data discussed highlights that the identity of specific 
sequences, not the overall level of PFD homology is essential for prion transmission. 
To further explore the possibility of cross-species prion transmission barrier preventing seeding 
of the ScSup35 and ScRnq1 proteins it will be necessary to construct Sup35-GFP and Rnq1-
GFP fusion proteins with SUP35 and RNQ1 from each Saccharomyces species. Asymmetry of 
cross-species prion transmission was detected by inefficient prion transfer from S. cerevisiae to 
S. bayanus, but efficient prion transfer in the opposite direction (Chen et al., 2010) (described
in Chapter 1, Section 1.4.3). This shows that focussing predominantly on S. cerevisiae prion 
transmission neglects the possibility of efficient prion transmission between other species of 
Saccharomyces, further highlighting the requirement for future work. Cross-species 
transmission barriers can also be analysed by cytoduction experiments where cells of 
Saccharomyces strains are exposed to non-homologous [PSI+] and [RNQ+] seeds using 
cytoplasm exchange. Cytoduction was successfully used to transmit [URE3] from one strain 
to another by cytoduction, using cytoplasmic mixing without nuclear fusion (Wickner, 1994). 
As previously mentioned, analysis of the species barrier in other members of Saccharomyces 
focused on the transmission of [PSI+] from S. cerevisiae Sup35 to hybrid Sup35 proteins with 
PFDs from such species. Hybrid Sup35 genes were created from S. cerevisiae SUP35 by 
replacing the N-terminal domain (residues 1-120) with the corresponding region from 
heterologous SUP35 genes. All hybrid Sup35 proteins could adopt the prion formation in 
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S. cerevisiae, but could not readily adopt the prion form from the [PSI+] prion of S. cerevisiae
(Afanasieva et al., 2011). Expression of the hybrid Sup35 proteins in S. cerevisiae [PSI+] cells 
also resulted in the frequent loss of the native prion. Interestingly, all hybrid Sup35 proteins 
displayed different patterns of interaction with the native [PSI+] prion, at levels of 
copolymerisation, acquisition of the prion state and induced prion loss. Such patterns of 
interaction also appeared to be linked to the variant of the [PSI+] prion, and in some cases 
expression of the hybrid Sup35 proteins caused the loss of [PSI+]. For weak [PSI+], variants in 
the presence of Sup35-bay or Sup35-mik, produced [psi-] cells at frequencies up to 24%, 
compared to no detectable [PSI+] loss in the presence of the Sup35-kud hybrid (Afanasieva et 
al., 2011). Further analyses of the presence of a species barrier for the transmission of [PSI+] 
must therefore focus on the impact of the prion variant. 
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4. Chapter 4: The impact on guanidine hydrochloride on genetic and epigenetic
determinants in Saccharomyces species
4.1. Introduction 
Mitochondria are self-replicating, DNA-containing organelles which are not essential to yeast cells 
grown in the presence of a fermentable carbon source but are required when the only carbon 
source is a non-fermentable one. Structural changes to mitochondrial DNA (mtDNA) can be 
caused by a wide range of chemical agents, providing a means to study the structure, function, 
and replication of mtDNA. One well-established example of an mtDNA-based mutation is the 
petite mutation, typically causing respiratory deficiency at a spontaneous frequency of ~1% per 
generation (Goldring et al., 1970). The petite mutation is irreversible and maintained in 
succeeding generations, often carried by a cytoplasmic factor such as mtDNA. The petite 
phenotype is characterised by a small yeast colony size when grown on fermentable carbon 
sources such as glucose, and an inability to grow on non-fermentable substrates such as lactate 
or glycerol (Goldring et al., 1970). 
In addition to changes in nuclear or mitochondrial DNA sequence induced by chemical and 
physical mutagens in S. cerevisiae, there are a variety of ‘non-mutagenic’ chemicals that result 
in inherited changes in cytoplasmic determinants such as mitochondrial DNA or prions. One 
example, is guanidine hydrochloride (GdnHCl) which generates mitochondrial petite mutants in 
S. cerevisiae (Juliani et al., 1973), as well as inducing the loss of [PSI+] (Tuite et al., 1981) and 
other prions from this yeast species (Edskes et al., 1999). In S. cerevisiae the efficiency of 
GdnHCl to induce petite mutants is comparable to the efficiency of ethidium bromide, and occurs 
even when cell growth does not, indicating that even parent cells are transformed into petites by 
GdnHCl (Juliani et al., 1973).  
The observation that GdnHCl can induce petite mutants in all species of Saccharomyces 
(Section 4.2) led us to question whether the mechanism of petite induction by GdnHCl is the 
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same as leads to prion loss i.e. by inhibition of the molecular chaperone Hsp104, or 
through an Hsp104-independent mechanism. The results described in this chapter provide a 
detailed comparative analysis of the impact of GdnHCl on the ultrastructure and respiratory 
functions of mitochondria in all species, and details whether mutants of S. cerevisiae lacking 
either Hsp104 or the related mitochondrial chaperone Hsp78 (Leonhardt et al., 1993) are 
able to maintain mitochondrial function, thereby exploring the role of these proteins in the 
mechanism of petite induction by GdnHCl. 
4.2. The frequency of spontaneous and GdnHCl-induced petite mutants in 
Saccharomyces species
The initial aim was to measure the frequency of spontaneous and GdnHCl-induced petite 
mutants in all species of Saccharomyces, in order to verify that all species were susceptible 
to GdnHCl prior to exploring prion curing. Following growth on YEPD with increasing 
concentrations of GdnHCl (0-5mM), the 2,3,5-triphenyl tetrazolium chloride (TTC) assay was 
used as an indicator of respiratory proficiency (Chapter 2). TTC is reduced by the activity of 
a fully functioning mitochondrial respiratory chain from a colourless pigment to an insoluble red 
one (Ogur et al., 1957).  
In both laboratory and wild strains of S. cerevisiae, a linear increase in the percentage of petite 
mutants was observed following treatment with increasing concentrations of GdnHCl (Figure 
4.1). This observation was also made in all species of Saccharomyces. It was noted that 
fewer GdnHCl-induced petite mutants were observed in S. mikatae, but a reduced sensitivity 
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Figure 4.1: The induction of petite mutants in S. cerevisiae following treatment 
with increasing concentrations of GdnHCl. Petites were identified by the TTC overlay 
assay. TTC is reduced by the activity of a fully functioning mitochondrial respiratory chain 
from a colourless pigment to an insoluble red one. Red cells are respiratory efficient, 
compared to petite white mutants. 

















Figure 4.2:  The induction of petite mutants in Saccharomyces species following 
treatment with GdnHCl. Petites were identified using the TTC overlay assay. TTC is reduced 
by the activity of a fully functioning mitochondrial respiratory chain from a colourless pigment 
to an insoluble red one. Red cells are respiratory efficient, compared to petite white mutants. 
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A percentage increase in petite mutants was observed following exposure to GdnHCl in all 
species of Saccharomyces (Figure 4.3). Interestingly, the frequency of spontaneous petite 
mutants in S. bayanus at a given concentration of GdnHCl was much higher than in 
other species. No spontaneously occurring petite mutants were observed in ~600 untreated 
cells of S. mikatae, suggesting the evolution of a robust network of mitochondrial proteins 
within this species. The status of all petite mutants in each species was confirmed by a lack 
of growth on glycerol, by restreaking ~30 petite mutants. These data confirm that GdnHCl is 











0 mM 5 mM
GdnHCl
0 mM 5 mM
GdnHCl
0 mM 5 mM
GdnHCl
0 mM 5 mM
GdnHCl









Figure 4.3: The frequency of petite mutants in Saccharomyces species increases following 
exposure to 5 mM GdnHCl. The percentage of petite mutants was calculated by counting the number of 
respiratory deficient (white) colonies observed in a total of ~250 colonies, taken across 
three biologically independent TTC overlay assays. The dataset presents an average of these results. 
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4.3. GdnHCl causes an increase in cell flocculation in S. kudriavzevii 
Following the induction of petite mutants in S. kudriavzeveii by GdnHCl, the TTC overlay assay 
revealed colonies with uneven, scattered pigment. Not only did the degree of TTC reduction vary 
from pink to red pigment between colonies; red, pink and white spots were also observed within 
a single colony, indicating cells that are activating respiration in defined regions within a single 
colony. These observed phenotypes in S. kurdriavzevii were both stable and reproducible 
following treatment with GdnHCl.  
To further explore the nature of this unusual phenotype, a loopful of cells from each of the red, 
pink and white colonies was visualised using differential interference contrast (DIC) microscopy, 
which revealed an increased level of flocculation in cells that are respiratory-deficient (Figure 
4.4). In liquid culture, flocculation of S. kudriavzevii was readily apparent in the form of 2-3 
mm spherical pellets, but such flocculation increased following treatment with GdnHCl and was 
not reversed using sonication. Flocculence has been reported to be regulated by mating type, 
with diploids showing a lower level of flocculation than haploids in this species (Scannell et al., 
2011), although a haploid strain was used here and there was no indication of a change in 
ploidy following exposure to GdnHCl.  
Figure 4.4: Flocculation of S. kudriavzevii increases in petite mutants generated by GdnHCl. 
Images were taken using DIC microscopy at 100x magnification and visualised in three 
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In all species of Saccharomyces, flocculation is controlled by the expression of FLO1, FLO5, 
FLO8, FLO9 and FLO10 genes, and such expression can be influenced by pH, temperature, 
carbon source and ethanol concentration (Soares, 2011). Additionally, S. kudriavzevii has a 
number of genetic alterations, particularly the PDC6 gene which is replaced by a 
pseudogene; responsible for pyruvate decarboxylase and its expression is induced by sulphur 
limitation. This highlights that this species may have experienced selective pressure to alter 
alcohol metabolism, and in turn, flocculation capacity (Scannell et al., 2011).   
The link between mitochondria and flocculation remains unclear, as our data disagrees with 
literature previously published. For example, Acta et al. (1980) initially reported that defects in 
the inner mitochondrial membrane of petite mutants resulted in changes in cell adhesion. 
However, it was suggested that defective mitochondria in petite mutants caused a decrease in 
the ability of cells to flocculate, which is most likely linked to mitochondria regulating the 
permeability of the cell (Acta et al., 1980). Similarly, [rhoo]  mutants of S. cerevisiae showed 
fewer biologically active glycoproteins in the form of peripheral phosphopeptidomannans 
(PPMs), which are ligands of lectins crucial for flocculation (Iung et al., 1999). 
Alternatively, the link between mitochondria and flocculation may be via an activation in MAPK 
signalling, triggering flocculation in S. cerevisiae and in our case, S. kudriavzevii (Patrick 
Rockenfeller, University of Witten, personal communication). It remains to be established whether 
the observed increase in flocculation in S. kudriazvevii was due to an increase in petite mutants, 
or a more direct interaction between GdnHCl and the cell wall.  
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4.4. The impact of GdnHCl exposure on mitochondrial DNA and the ultrastructure of 
mitochondria in Saccharomyces species 
4.4.1. Impact on nuclear DNA 
Following the demonstration of an increase in the frequency of petite mutants in all species of 
Saccharomyces after treatment with GdnHCl, the impact of GdnHCl exposure on mtDNA and 
nuclear DNA was investigated at an ultrastructural level. In live yeast, Hoechst dye treatment 
showed bright nuclear DNA in Saccharomyces species indicating intact nuclear DNA and 
no clear differences were observed (Figure 4.5).  
4.4.2. Analysis of the morphology of mitochondria in Saccharomyces species 
The morphology of mitochondria was visualised in the Saccharomyces species using a 
plasmid encoded with mitochondrial matrix-directed green fluorescent protein (GFP). The 
plasmid expressed GFP fused in frame to a Neurospora crassa-derived leader sequence, 
taken from a mitochondrial ATPase subunit protein. This leader sequence interacts with the 
TOM and TIM complexes in both the mitochondrial outer and inner membranes (Westermann & 
Neupert, 2000), thus directing the GFP into the matrix as if it was an ATPase subunit protein 
Figure 4.5: Visualisation of DNA in species of Saccharomyces using Hoechst dye. 
Cells of each species were visualised using fluorescent microscopy at a magnification of 
100x, following Hoechst staining and three wash steps with PBS. Each strain 
was visualised in three independent biological experiments, and a dataset representative 
of at least 200 cells is shown. The scale bar represents 10 µm.  
Sb. 9194 Sm. 9183 Sk. 9185Sc. BY4741
116 
(Westermann & Neupert, 2000). Once in the matrix, the leader sequence is cleaved and the 
mitochondria are visualised as bright, fluorescent, tubular structures at the periphery of the cell.  
Although subtle differences in the morphology of mitochondria were observed between the 
Saccharomyces species, treatment with GdnHCl caused no apparent structural changes in petite 
mutants of any of the species (Figure 4.6). The mitochondria of S. cerevisiae appeared 
fragmented as opposed to long tubular structures as expected. The mitochondria of petite 
mutants of S. mikatae could not be visualised following treatment with GdnHCl, as the 
frequency of petite mutants was so low in this species, that none were available for 
transformation. 
Ethidium bromide (EtBR) can efficiently induce petite mutants at a comparable frequency to that 
seen for GdnHCl in S. cerevisiae. Petite mutants generated by treatment with 10 µg/ml ethidium 
bromide often lack mitochondrial DNA and are referred to [rhoo] mutants, in contrast to [rho-] 
mutants which contain non-functional, mutated mtDNA (Nagley & Linnane, 1970).  
Using mitochondrial matrix-directed GFP, the mitochondrial morphology of EtBr-induced petite 
mutants was also visualised in all species. The mitochondria of S. cerevisiae remained in a more 
fragmented state than the long, tubular structures expected, and the mitochondria of EtBr-treated 
S.mikatae appeared to be less bright than the wildtype control. This may indicate a reduced= 
plasmid uptake of these cells. Overall, there were no observed difference in the mitochondrial 
morphology of any of the Saccharomyces species following treatment with EtBr, and there were 
no difference in the morphology of mitochondria in GdnHCl-induced or EtBr-induced petite 
mutants (Figure 4.6). 
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4.4.3. Analysis of mitochondrial DNA 
The nature of the petite status induced by GdnHCl was confirmed with 4’,6-diamidino-2-
phenylindole (DAPI) staining, a fluorescent dye which binds strongly to adenine-thymine rich 
regions in DNA such as those found in yeast mtDNA. In all wildtype cells of S. cerevisiae, S, 
bayanus and S. mikatae, cytoplasmic DAPI staining was observed, indicative of mtDNA (Figure 
4.7). Only nuclear signal was revealed in S. kudriavzevii wildtype cells, suggesting the absence 
of detectable amounts of mtDNA and the possibility of this species being ‘petite negative’. In 
‘petite negative’ yeasts, several species form small, irregular-shaped microcolonies, 
compromising a few to several thousand cells, visible only under the microscope (Fekete et al., 




















Figure 4.6: Visua lisa tion of mitoc hondrial mor phology fol lowing GdnHCl-induced or 
Etbr-induced petite generation using a mitochondrial matrix-directed GFP. Cells of each 
species were visualised using fluorescent microscopy at a magnification of 100x. Each strain 
was visualised in three independent biological experiments, and at least ~200 cells per 
condition were studied. The scale bar represents 10 µm. The mitochondria of GdnHcl-induced 
petite mutants of S. mikat ae co uld not be visualise d, as  the frequen cy of pet ite muta nts w as 
so l ow in this species cells could not be selected for transformation. 
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2007). Confirming the absence of mtDNA in selected petite colonies using DAPI staining may 
therefore indicate nuclear petites (pet) or mitochondrial (mit)- cells (Chen & Clark-Walker, 
1999).  
Following treatment with GdnHCl, no mtDNA could be observed in most cells of S. cerevisiae, S. 
bayanus or S. kudriavzevii, confirming the [rhoo] phenotype, comparable to the indicated 
percentages of petite frequency observed in these strains. DAPI staining did reveal the presence 
of mtDNA in GdnHCl-treated S. mikatae, further highlighting the reduced sensitivity to GdnHCl 
and concomitant low frequency of petite mutants in this species (Figure 4.7). Alternatively, intact 
mtDNA in this species may demonstrate that the DNA modification that occurred as a result of 
exposure to GdnHCl behaved as if a “sensitive site” i.e. target for the action of GdnHCl had been 
removed. 
Figure 4.7: Visualisation of DAPI stained cells in Saccharomyces species following 
treatment with GdnHCl. Cells of each species were visualised using fluorescent 
microscopy at a magnification of 100x, following staining with fluorescent dye DAPI. 
Each strain was visualised in three independent biological experiments, and at least 
~200 cells per condition were studied. Percentages indicate the frequency of 
GdnHCl-induced petite mutants in each species. The scale bar represents 10 µm. 
Sb. 9194 Sm. 9183 Sk. 9185 
3.9% petites 59.2% petites 
Sc. BY4741 


















4.5. Investigating the target of GdnHCl for the induction of petite mutants 
The observation of GdnHCl treatment inducing petite mutants in several different 
Saccharomyces species led us to further investigate the mechanism of such petite induction by 
this chaotropic agent. As previously mentioned, GdnHCl inhibits the ATPase activity of the 
molecular chaperone Hsp104 to induce the loss of various prions from yeast (Ness et al., 2002). 
This led us to question whether the mechanism of GdnHCl in petite induction is the same as 
leads to prion loss or is Hsp104 independent.  
One scenario is that GdnHCl targets an alternative molecular chaperone to generate petite 
mutants. One strong candidate for such a target is another heat shock protein, namely Hsp78. 
Hsp78 is a disaggregase located in the mitochondrial matrix with similar activity to the cytosolic 
Hsp104. Hsp78 was originally described by Leonhardt et al., (1993), and its chaperone function 
was further verified by Röttgers et al., (2002). Much like its bacterial homologue ClpB, Hsp78 is 
thought to be involved in the reactivation of aggregated proteins, in cooperation with another 
molecular chaperone Hsp70 (Reidy et al., 2012). It has been assumed that Hsp70 is responsible 
for the initial binding and stabilisation of  imported misfolded substrate proteins, releasing them 
to Hsp78 for direct degradation in an ATP-dependent reaction (Röttgers et al., 2002). When 
Hsp70 levels are depleted, Hsp78 also appears to represent a salvage pathway, capable of 
substituting for a mitochondrially-located Hsp70 activity in protein translocation and the initial 
stabilisation of proteins (Schmitt et al., 1995). Consequently, both the role and location of 
Hsp78 in S. cerevisiae made this protein a likely candidate that mediated GdnHCl-induced and 
petite generation.  
4.5.1. A bioinformatic overview of HSP104 and HSP78 genes in Saccharomyces species 
DNA sequences of HSP78 and HSP104 were manually aligned in order to investigate any key 
differences in domains and significant residues, as similarity throughout entire domains is likely 
to be more biologically significant than nearly exact matches (Figure 4.8). As members of the 
AAA+ protein family, both Hsp78 and Hsp104 have ATPase type Nucleotide Binding Domain 1 
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(NBD1) and Nucleotide Binding Domain 2 (NBD2) in common. NBD1 is responsible for the 
ATPase activity of each chaperone, and NBD2 is required for oligomerisation (Abrahão et al., 
2017). In comparison to Hsp104, Hsp78 has a truncated N-terminus making it a shorter protein 
(811 aa) than Hsp104 (908 aa). Interestingly, the N-terminus is responsible for substrate binding 
in Hsp104 and other homologues (Abrahão et al., 2017).  
Sequence similarity scores and sequence identity scores were calculated between HSP104 in 
different Saccharomyces species, and between HSP78 in the same Saccharomyces 
species in order to assess sequence homology. Sequence similarity was calculated in 
BLAST (Koski & Golding, 2001), followed by manual alignment and comparison of percentage 
homology using MUSCLE (EMBL-EBI). Sequences with >60% similarity are inferred as 
showing significant similarity (Koski & Golding, 2001) .  
The comparison of HSP104 sequences revealed a significant level of similarity in all species, bar 
S. kudriavzevii (Figure 4.9). A high degree of amino acid conservation in HSP104 was observed
between S. cerevisiae, S. bayanus and S. mikatae. The scores of HSP104 sequence homology 
could not be calculated for S. kudriavzevii, as this particular gene sequence was only accessible 
as an incomplete shotgun sequence.   
98 aa  344 aa 
 163 aa  411 aa       532 aa    557 aa  870 aa 
Figure 4.8: A schematic of domain organisation of Hsp104 and Hsp78 in S. cerevisiae. Key 
domains nucleotide binding domain 1 (NBD1) and nucleotide binding domain 2 (NBD2) are 
labelled in each protein. The N-terminal domain (NTD) and middle domain (MD) are also 
labelled for comparison. Amino acid residue 184 (D184) was identified as the target of GdnHCl 
by Jung et al (2002), and is also labelled.  
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Figure 4.9: A comparison of HSP104 in all species. Panel A: The number of amino 
acids in HSP104, along with the predicted molecular weight for each Saccharomyces 
species. Panel B: Alignment of HSP104 gene sequences in Saccharomyces species. 
The sequence of S. kudriavzevii was only available as an incomplete shotgun sequence 
and therefore could not be estimated. 
Analysis of the homology of the HSP78 amino acid sequence between the Saccharomyces 
species revealed that conservation of amino acid composition of the protein is maintained 
(Figure 4.10). High percentages of sequence homology are seen between all species, with 
the highest sequence homology seen between S. bayanus and S. kudriavzevii at a 
percentage of 96.01%. The high sequence homology reflects the close evolutionary 
relationship between these species as seen with Hsp104. The HSP78 sequence of S. mikatae 





4.5.2. Analysis of the target residue of GdnHCl in both Hsp104 and Hsp78 
GdnHCl cures yeast prions by inactivating Hsp104 by blocking its critical ATPase activity (Ness 
et al., 2002). An independent screen to identify mutations in S. cerevisiae that affect [PSI+] 
formation characterised amino acid residue 184 as the target of GdnHCl. Mutations in HSP104 
at this site affected both prion propagation and the ability of GdnHCl to eliminate [PSI+] further 
highlighting its importance in both processes (Jung et al., 2002). Residue D184 is conserved 
A) 
B) 
Figure 4.10: A comparison of HSP78 in all species. Panel A: The number of amino acids in 
HSP78, along with the predicted molecular weight for each Saccharomyces species. Panel B: 
Alignment of HSP78 gene sequences in Saccharomyces species. The HSP78 sequence of S. 
mikatae was only available as a 128 amino acid stretch, thus accurate sequence comparisons 
could not be estimated. 
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among Hsp100 proteins and is located at the N-terminal end of NBD1 in Hsp104 (Figure 4.8). 
There is no equivalent residue in NBD2 of Hsp104 (Jung et al., 2002). 
Sequence comparison and alignment of Hsp104 and Hsp78 between each species revealed the 
conservation of residue D184 in both proteins in Saccharomyces species, bar S. mikatae, as 
the HSP78 sequence of was only available as a 128 aa stretch (Figure 4.11). The overall 
conservation of this residue among species a) confirms the ability of GdnHCl to target Hsp104 
in all species of Saccharomyces and b) supports the hypothesis that GdnHCl could target 
Hsp78 and this in turn may be responsible for petite mutant generation.  
Figure 4.11: Alignment of amino acid sequence spanning the D184 residue of ScHsp104. The 
target residue D184 of GdnHCl is highlighted in red in each protein, and gaps for S. mikatae are 
shown as dashes, as HSP78 was only available as a 128 amino acid stretch, thus accurate sequence 
comparisons could not be estimated. 
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4.6. Petite induction by GdnHCl in Δhsp78 and Δhsp104 mutants of S. cerevisiae 
The role of both Hsp104 and Hsp78 in petite generation by GdnHCl was evaluated by deletion of 
the non-essential HSP104 and HSP78 genes. These two strains, constructed in the haploid strain 
of Sc. BY4741 were available from the BY4741 knockout collection (see Materials and Methods, 
section 2.7) 
Prior to their use it was felt to be important to confirm that the strains obtained contained the 
desired gene knockout. Using polymerase chain reaction (PCR) DNA amplification, the gene 
knockouts of HSP104 and HSP78 in BY4741 were confirmed as follows. In each knockout the 
kanMX4 gene had been inserted in the place of each indicated gene. Primers were designed to 
specifically target and therefore confirm (1) the presence or absence of either HSP104 or HSP78 
in both the wildtype and knockout derivative of Sc. BY4741; (2) the presence or absence of 
kanMX4 in the place of each indicated gene in both the wildtype and knockout derivative; and (3) 
the presence or absence of the kanMX4 gene in the correct orientation and correct point of 
insertion (see Figure 4.12). Both Δhsp78 and Δhsp104 S. cerevisiae knockouts were confirmed 










Figure 4.12: PCR DNA amplification of S. cerevisiae gene knockouts of HSP104 and HSP78.
Panel A) The strategy used to confirm the gene knockouts of HSP104 and HSP78 in Sc strain 
BY4741. 1. indicates the region targeted to confirm the presence or absence of either HSP104 and 
HSP78. 2. indicates the region targeted to confirm the presence or absence of kanMX4 in the place 
of each indicated gene. 3. indicates the presence or absence of the kanMX4 gene in the correct 
orientation and point of insertion. Labelled letters indicate the starting point of each primer, and 
numbers in red indicate the predicted size of PCR product required to confirm both Δhsp78 and 
Δhsp104 S. cerevisiae knockouts. Panel B) Agarose gel analysis of PCR products. Visualised 
bands are indicative of PCR products at the expected sizes. 1) confirms the presence of HSP104
or HSP78 in the wildtype control respectively, but not in the Sc. Δhsp104 or Sc. Δhsp78 2) confirms 
the presence of kanMX4 in the place of HSP104 or HSP78 in Sc. Δhsp104 or Sc. Δhsp78
respectively, and 3) confirms the presence of kanMX4 in the correct orientation and point of insertion 
in Sc. Δhsp104 and Sc. Δhsp78 respectively. 
A) B) 
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4.6.1. Growth analysis of Sc. Δhsp78 and Sc. Δhsp104 
Each knockout strain of Sc. BY4741 and the wildtype control were grown in complete medium 
containing glucose as the sole carbon source, and YEPG containing glycerol as the sole carbon 
source to determine the frequency of petite mutants in these strains. Each condition included 
the addition of GdnHCl over a range of 0- 8 mM. The growth of each strain was analysed using 
the multi-well plate reader in two biologically independent experiments, each time in triplicate. 
The data reflect the average of all experiments. 
In both the Δhsp78 and Δhsp104 Sc. knockouts, the doubling time reduced following the addition 
of 8mM GdnHCl in YEPD (Figure 4.13). This was not the case for wildtype Sc. BY4741, 
suggesting that these two mutants show a greater sensitivity to GdnHCl compared to the wild-
type. In YEPG however, the doubling time of each strain increased significantly following the 
addition of GdnHCl (Figure 4.13). As petite mutants are unable to grow using glycerol as a sole 
carbon source, the observed slower doubling time may be consistent with a higher number of 
GdnHCl-induced petite mutants in the growing culture. 
The slowest doubling time was apparent in the Δhsp78 Sc. knockout (Figure 4.13). Such results 
may suggest that the highest number of GdnHCl-induced petite mutants are seen in this strain, 
despite the absence of the HSP78 gene, and that Hsp78 is not required for mitochondrial function 
and/or maintenance. An increase in GdnHCl-induced petite mutants would suggest that the target 
of GdnHCl is still present and functioning in this mutant strain i.e. Hsp78 is not the target for 
GdnHCl in petite generation.   
The observed similar doubling time for Sc. BY4741 and its Δhsp104 derivative in YEPG + 8mM 
GdnHCl (Figure 4.13) would suggest that a similar number of GdnHCl-induced petite mutants 
are generated in each of these strains, in both the presence and absence of the HSP104 gene. 
This would be consistent with there being an alternative target of GdnHCl in petite induction. 
However, it remains unclear whether an increase in doubling time reflects impaired of delayed 
cell growth, or the death of cells within the population studied. Alternatively, it may simply be that 
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the growth of all strains is delayed when using glycerol rather than glucose as a carbon source, 
rather than the generation of petite mutants and therefore a complete lack of growth.  
Figure  4.13: Doubling times of all strains grown in YEPD and YEPG containing 8 
mM GdnHCl. All species show a significant increase in doubling time when grown in YEPG + 8 
mM GdnHCl. The graph represents three biological replicates each containing two 
technical repeats. Error bars denote Standard Deviation. Paired two-tail t-tests were carried 
out on both biological and technical replicates: *p<0.05, **p<0.01.
The results of the growth experiment indicated a slower or impaired level of growth in all strains, 
and a delay in reaching diauxic shift following the additions of varying concentrations of GdnHCl 
when compared to growth in glycerol alone. It is unclear whether this impaired growth is a direct 
result of increasing concentrations of GdnHCl, or reflects an increase in GdnHCl-induced petites 
in each strain.  
In the wildtype Sc. BY4741, growth was impaired with the addition of GdnHCl (Figure 4.14). 
There is an extremely low level of growth observed in YEPG + 8 mM GdnHCl, suggesting 
an increase in the number of petite mutants that are unable to grow in this condition. This  
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would further suggest that in this control strain, the target of GdnHCl for the generation of petite 
mutants is still functional.  
The growth profile of the Sc. Δhsp104 strain showed a reproducible delay in reaching diauxic shift 
in each addition of GdnHCl (Figure 4.14). Some growth was still observed in YEPG with the 
addition of 8mM GdnHCl. Growth of the remaining population in this condition suggest a lower 
level of petite mutants present in this strain suggesting that the target for GdnHCl in petite 
generation is absent. The growth profile of the Sc. Δhsp78 strain revealed impaired growth in 
each addition of GdnHCl, and almost a complete absence of growth in YEPG + 8 mM (Figure 
4.14). This may indicate a higher level of GdnHCl-induced petite mutants in this growth condition, 
highlighting that the target of GdnHCl is still present and the target of GdnHCl in petite generation 
is not Hsp78. The most direct way to test the hypotheses described above is to determine petite 
induction directly. 
Figure 4.14: The growth profiles of Panel A) Sc. BY4741 in glycerol with different 
concentrations of GdnHCl, Panel B) Sc. BY4741 Δhsp104 in glycerol with different 
concentrations of GdnHCl, and Panel C) Sc. BY4741 Δhsp78 in glycerol with different 
concentrations of GdnHCl. Each graph represents three biological replicates containing two 
technical triplicates. 
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4.6.2. The frequency of spontaneous and induced petite mutants in Δhsp78 and 
Δhsp104 of S. cerevisiae 
The frequency of spontaneous, GdnHCl-induced and EtBr-induced petite mutants was 
determined in Δhsp78 and Δhsp104 knockouts of S. cerevisiae, to further investigate the target 
of GdnHCl in petite mutant generation. Following growth on YEPD with concentrations of 
GdnHCl up to 5 mM or 10 μg/ml EtBr, the TTC assay was used as an indicator of respiratory 
proficiency and the percentage of petites after each treatment was calculated.  
In wildtype Sc. BY4741, Sc. Δhsp78 and Sc. Δhsp104, a significant percentage increase was 
observed in GdnHCl-induced petite mutants when compared to the frequency of non-induced 
petites (Figure 4.15). Interestingly, the highest level of GdnHCl-induced petite mutants was seen 
in Sc. Δhsp78. This would suggest that in the absence of HSP78, the target of GdnHCl for petite 
induction remains, further supporting the findings reported in Section 4.6 above implying that 
Hsp78 is not the target.  
A statistically significant increase in GdnHCl-induced petite mutants was also seen in Sc. 
Δhsp104, compared to both the spontaneous frequency of petite mutants in this strain, and the 
frequency of GdnHCl-induced petite mutants in wildtype Sc. BY4741 (Figure 4.15). This 
suggests that in the absence of Hsp104, GdnHCl is targeting an alternative protein for 
petite mutant generation as suggested by the findings reported in Section 4.6. Alternatively, it 
may indicate the presence of a ‘salvage pathway’ for GdnHCl-induced petite generation in cells 
lacking the primary target i.e Hsp104.  The status of all petite mutants as described was 
confirmed by a lack of growth on glycerol.  
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A statistically significant increase in the frequency of EtBr-induced petite mutants was observed 
in wildtype Sc. BY4741, Sc. Δhsp78 and Sc. Δhsp104, compared to the frequency of spontaneous 
petite mutants in each of these strains (Figure 4.16). The percentage of EtBr-induced petite 
mutants were observed at a frequency above 80% in each strain, with little difference observed 
between strains. This would suggest that 10 µg/ml is sufficient in petite generation in each strain 
despite the absence of either Hsp104 or Hsp78. It has previously been reported that EtBr induces 
petite mutants at a comparable frequency to GdnHCl in S. cerevisiae (Nagley & Linnane, 1970). 
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Figure 4.15: The frequency of petite mutants in Sc. BY4741 and Sc. knockouts Δhsp78 
and Δhsp104 following treatment with 5 mM GdnHCl. The percentage of petite mutants 
was calculated by counting the number of respiratory deficient (white) colonies observed in a 
total of ~250 colonies, taken across three biologically independent TTC overlay assays, each 
with two technical replicates. The dataset presents an average of these biological replicates 
and these technical replicates, and error bars denote Standard Deviation. Paired two-tail t-tests 
were carried out on both biological and technical replicates: *p<0.05.
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4.6.3. DNA and mitochondria in Δhsp78 and Δhsp104 knockouts of S. cerevisiae 
To further investigate the target of GdnHCl in petite mutant generation and the increase in 
GdnHCl-induced petite mutants in both knockout derivatives of Sc. BY4741, the impact of 
GdnHCl on mtDNA and nuclear DNA was explored at an ultrastructural level. Hoechst staining of 
DNA showed bright intact nuclear DNA in all strains when visualised using fluorescent 
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Figure 4.16: The frequency of petite mutants in Sc. BY4741 and Sc. knockouts Δhsp78 
and Δhsp104 following treatment with 10 μg/ml EtBr. The percentage of petite mutants 
was calculated by counting the number of respiratory deficient (white) colonies observed in a 
total of ~250 colonies, taken across three biologically independent TTC overlay assays, each 
with two technical replicates. The dataset presents an average of these biological replicates 
and these technical replicates, and error bars denote Standard Deviation. 
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The mitochondria of Sc. BY4741, Sc. Δhsp78 and Sc. Δhsp104 were examined at an 
ultrastructural level using mitochondrial-matrix direct GFP as described in Section 4.6.3 above. 
When observing mitochondrial shape and size, no differences were observed between each of 
the strains (Figure 4.18). As previously found, the mitochondria of the wildtype strain appeared 
to be fragmented as opposed to long, tubular structures. In both Sc. BY4741 and its Δhsp78 
derivative, the mitochondria appeared to be bright and at the periphery of the cell. This was also 
the case for the mitochondria in the majority of Sc. Δhsp104 cells, but overall the fluorescence 
levels were detectably lower. When comparing all cells expressing the mitochondrial matrix-
directed GFP to the same cells visualised using DIC, it is interesting to note that the mitochondria 
are not fluorescing in all cells of each sample. This may be indicative of inefficient DNA 
transformation and a reduced uptake of the plasmid across the population, or loss of the plasmid 
as its maintenance is not being selected for.   
Sc. BY4741 Sc. BY4741 Δhsp104 Sc. BY4741 Δhsp78 
Figure 4.17: Visualisation of DNA in Δhsp104 and Δhsp78 Sc. BY4741 using Hoechst 
dye. Cells of each species were visualised using fluorescent microscopy at a magnification of 
100x, following Hoechst staining and three wash steps with PBS. Each strain was visualised in 
three independent biological experiments, and at least ~200 cells were visualised in each 
condition. The scale bar represents 10 µm.  
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DAPI staining was used to confirm the petite status of all GdnHCl-treated cells of BY4741 and its 
Δhsp78 and Δhsp104 derivatives. Prior to treatment with GdnHCl, both nuclear and cytoplasmic 
DAPI staining was visible in all strains, indicative of the presence of mtDNA (Figure 4.19). 
Following GdnHCl-induced petite generation, only a nuclear signal was observed in all strains, 
highlighting the absence of mtDNA and confirmation of the [rhoo] phenotype (Figure 4.19). Both 
confirmation of petite status using DAPI and the percentage of GdnHCl-induced petite mutants 
in each strain further highlights the ability of GdnHCl to generate petite mutants even in the 
absence of Hsp104 and Hsp78, implying an alternative target of GdnHCl in the generation of 
petite mutants. Alternatively, it may be that in the absence of one protein, the other ‘replaces’ its 
function, and it would therefore be of value to assess the frequency of petite generation and the 
impact of GdnHCl in a double knockout of HSP78 and HSP104.  







Fig ure 4.1 8: Visualisation  of mitochondr ial morpholog y followi ng GdnHCl-induc ed petite 
generation using a mitochondrial matrix-directed GFP. Cells of each species were visualised 
using both DIC and fluorescent microscopy at a magnification of 100x following the expression of 
mitochondrial matrix-directed GFP, and the same cells can be seen in each condition. Each 
strain was visualised in three independent biological experiments, and at least ~200 cells were 









4.7. The impact of GdnHCl on the respiratory functions of mitochondria in wildtype S. 
cerevisiae, Sc. Δhsp78 and Sc. Δhsp104 knockouts 
Although the findings described above clearly indicate that GdnHCl generates petite mutants in 
Sc. BY4741, Sc. Δhsp78 and Sc. Δhsp104 knockouts, the specific target of GdnHCl in such petite 
induction remains unclear. While GdnHCl appeared to have no detrimental impact on the 
ultrastructure of mitochondria in all strains, it was also felt important to assess the activity of the 
mitochondria following GdnHCl treatment. This was achieved using a high-resolution 
respirometer to analyse oxygen consumption by three strains, Sc. BY4741, Sc. Δhsp78 and Sc. 
Δhsp104 knockouts, in the presence and absence of 2.5 mM GdnHCl. A lower concentration of 
Sc. BY4741 Δhsp78 Sc. BY4741 Δhsp104 



















Figure 4.19: Visualisation of DAPI stained cells in Saccharomyces species following 
treatment with GdnHCl. Cells of each species were visualised using fluorescent microscopy at 
a magnification of 100x, following staining with fluorescent dye DAPI. Each strain was visualised 
in three independent biological experiments, and at least ~200 cells were visualised in each 
condition. Percentages indicate the frequency of GdnHCl-induced petite mutants in each strain.  
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GdnHCl was chosen as cells are known to show a higher sensitivity to chemical agents using this 
method. Oxygen consumption was measured as O2 flow per specific unit sample (cell). The drugs 
triethiltyn bromide (TET), carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP), and 
antimycin A (AntA) were used to investigate the function of individual components of the 
mitochondrial respiratory chain (Figure 4.20). 
In each respirometry experiment, the routine state of respiration for each strain was first 
established. Following the addition of GdnHCl to YEPD cultures of each strain, the routine level 
of respiration was found to be significantly reduced indicative of a direct impact of GdnHCl on 
overall respiration in all strains (Figure 4.21). A difference between routine respiration in Sc. 
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Figure 4.20: A typical respirometry profile generated from the Oroboros oxygraphy-2k to 
indicate the changes in routine respiration following drug addition. The red trace is indicative 
of the oxygen flux per unit sample (pmol/s*Mill), and the blue line represents oxygen concentration 
in the sample. Each black arrow indicates the steady state oxygen flux (Routine respiration), the 
induced mitochondrial resting state (Leak), the maximal capacity of the electron transport system 
(ETS) and the non-mitochondrial oxygen flux (nMT). The addition of each drug is represented by 
green arrows, with triethiltyn bromide (TET) inducing leak respiration, Carbonylcyanidep-
trifluoromethoxyphenylhydrazone (FCCP) inhibiting ATP synthase and therefore allowing maximal 
electron transport through the ETS and Antimycin A (AntA) inhibiting the ETS.  
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The ‘leak’ level of respiration was then measured following the addition of the drug TET, which 
inhibits ATP synthase complex V (Pious & Hawley, 1972). ATP synthase produces ATP by 
pumping protons across the mitochondrial inner-membrane space (IMS) into the mitochondrial 
matrix. Inhibition of this pathway leads to the accumulation of protons within the IMS, resulting in 
protons returning to the matrix independent of ATP synthase. The results is an overall inhibition 
of the movement of electrons through the electron transport chain, representing an integral control 
mechanism of ATP synthase. The addition of TET therefore indicates the free movement of 
Figure 4.21: The routine, leak, ETS and NMT oxygen flux values for A) Sc. BY4741, B) 
Δhsp78 and C) Δhsp104 with and without the addition of 2.5 mM GdnHCl. The results shown 
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protons independent of the proton pump and is thus labelled ‘leak’ respiration. The addition of 
GdnHCl caused a significant decrease in leak respiration in all strains (Figure 4.21). Prior to the 
addition of GdnHCl, a higher level of respiration which occurs independently of ATP synthase 
proton pumping activity was observed. A decrease in leak respiration in all strains following the 
addition of GdnHCl may instead imply that a TET-induced drop in respiration did not take place. 
This would indicate that oxygen consumption and electron movement already occur 
independently of ATP synthase under these conditions thus showing that following the addition 
of GdnHCl, ATP is not synthesised i.e. uncoupled respiration. 
The maximal capacity of the electron transport system (ETC) was measured following the addition 
of the uncoupling agent FCCP. FCCP forms pores in the IMM making it permeable, allowing the 
free flow of protons across it. This results in the disruption of the membrane potential provided by 
the proton gradient, allowing the ETC to function at its maximal potential. Therefore, the higher 
the ETS detected, the higher the capacity of the ETC. FCCP thus abolishes the link between the 
respiratory chain and the phosphorylation system usually observed in intact mitochondria. In both 
Sc. BY4741 and Sc. Δhsp78, the ETS was higher than the routine level of respiration following 
the addition of FCCP, indicating functional mitochondria capable of making ATP (Figure 4.21). 
In both Sc. BY4741 with the addition of GdnHCl, and Sc. Δhsp104 knockouts with and without 
GdnHCl, the level of ETS is completely abolished (Figure 4.21). Thus in cells treated with GdnHCl 
and/or lacking a functional Hsp104, the overall capacity of the ETS was reduced and the 
mitochondria non-functional.   
Finally, the level of non-mitochondrial (nMT) respiration was measured following the addition of 
Ant A. AntA inhibits cytochrome C reductase (complex III), preventing the transfer of electrons. 
Complex III is the third phase in the ETC and causes oxidation at the Qi site. Inhibition at this 
specific site therefore prevents re-oxidation by oxygen, and any oxygen consumption detected 
after the addition of AntA is therefore of nMT origin. A high level of nMT was detected in the Sc. 
Δhsp104 strain, mimicking the high level of nMT observed in all three strains under test following 
the addition of GdnHCl. This would suggest that without a functional Hsp104 in Sc. BY4741, the 
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function of mitochondria ceases. Hsp104 therefore appears to be the target of GdnHCl in petite 
generation (Figure 4.21). 
Individual components of the ETC were further analysed to identify whether a specific component 
was affected by the addition of GdnHCl. These components were analysed by comparing the 
oxygen flux ratios between the Routine and ETS (R/E) and the Leak and ETS (L/E). The R/E 
defines how close to the maximal capacity the mitochondria are functioning during routine 
respiration. Moreover, the closer the R/E ratio is to 1, the closer to maximum capacity the ETS is 
working in the strain (Figure 4.22). Sc. BY4741 showed a high R/E, which could not be calculated 
following the addition of GdnHCl due to a complete lack of ETS. A reasonably high R/E was also 
observed in Sc. Δhsp78, which increased following the addition of GdnHCl. This may suggest 
that the mitochondria were not functioning at their maximum capacity prior to GdnHCl treatment. 
In this case, an increase in R/E may suggest more uncoupling of the ETC, an increase in ADP 
driven respiration or a limitation of the ETC components. Finally, no R/E could be calculated for 
Sc. Δhsp104, as the ETS was completely abolished. 
To determine whether a high R/E was due to uncoupled respiration, the L/E was also calculated. 
The closer the L/E to 1, the higher the levels of uncoupled respiration that are occurring 
independently of ATP synthase (Figure 4.22). Uncoupled respiration is not transformed into 
energy by phosphorylation of ADP. In Sc. BY4741, the L/E is relatively low, which suggests a 
relatively low level of uncoupled respiration. As the mitochondria in these wildtype cells are 
functioning close to their maximal capacity, we can conclude that these cells are neither necrotic 
or apoptotic. The impact of GdnHCl on L/E in Sc. BY4741 could not be assessed due to a lack of 
ETS. An increase in the L/E following the addition of GdnHCl in Sc. Δhsp78 implied an increase 
in uncoupled respiration. As with R/E, L/E could not be calculated for Sc. Δhsp104, as the ETS 
was completely abolished. 
139 
In conclusion, it is evident that both a loss of Hsp104 and treatment with GdnHCl completely 
abolishes mitochondrial respiration. GdnHCl stops respiration completely in both Sc. BY4741 and 
in Sc. Δhsp78, but has little to no effect in Sc. Δhsp104 because the mitochondria are already in 
a suppressed state in this strain. Therefore, it was concluded that Hsp78 is not the target of 
GdnHCl in respiratory-deficient petite mutant generation. 
The direct impact of GdnHCl on Hsp104 could be further established by a time point analysis, 
where the activity of mitochondria is measured at specific time points following the addition of 
GdnHCl. This would allow the production of a timeline between the addition of GdnHCl and the 
generation of petite mutants. Furthermore, the frequency of petite mutants in each of the 
respiratory deficient strains should be calculated by taking samples directly from the respirometer 



































Figure 4.22: The oxygen flux ratios between the Routine and ETS (R/E) and the Leak and 
ETS (L/E) are shown for all strains with and without the addition of 2.5 mM  GdnHCl. 
* indicates complete abolishment of the ETS in that condition and therefore no ratio
calculation was possible.  The results shown represent the average of three biological repeats,
each with two technical replicates.  
* * *
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and following the addition of GdnHCl should also be analysed in all species of 
Saccharomyces, to provide a complete story for the role of GdnHCl in petite generation.
4.8. Discussion 
Both a loss of Hsp104 activity and treatment with GdnHCl causes mitochondrial suppression in 
S. cerevisiae. The same reduction in mitochondrial activity in each of these conditions is
consistent with Hsp104 being the target of GdnHCl that leads to the generation of petite mutants. 
Petite mutants can also be generated during the translation of proteins that are relocated into the 
mitochondria, further implying that the target of GdnHCl does not have to be mitochondria-based. 
In turn, it is possible that such mutants restrict the levels of protein available to the mitochondria, 
and Hsp104 may be associated with such a mechanism. It has been suggested that Hsp104 
regulates redox states within the cell. In hsp104Δ cells for example, mitochondria lose both 
membrane integrity and control of the electron transport chain, thus resulting in a higher level of 
intracellular ROS (Ueom et al., 2003). 
An alternative explanation for the role of Hsp104 in petite generation could be the formation of an 
mPOS (Mitochondrial Precursor Over-Accumulation Stress) response. When stressed, 
mitochondria may face inefficient protein import, resulting in reduced cell fitness by disruption of 
the proteostatic network in the cytosol (Coyne & Chen, 2018). mPOS is characterised by the 
accumulation of toxic unimported mitochondrial proteins in the cytosol. When under stress, the 
yeast cell will upregulate suppressor genes which likely alleviate mPOS by reducing protein 
synthesis, thus leading to reduced protein misfolding and increased protein turnover. When a 
cell’s capacity to stabilise the proteome is exceeded, these proteins accumulate in the cytosol, in 
turn generating an mPOS response and decreasing cell viability. Defects in many pathways 
including mutations in mt-protein import machinery, IMM protein misfolding and mt-DNA 
mutations may cause an mPOS response. Therefore, it is likely that mitochondrial damage does 
not directly target the core protein import machinery, but is still sufficient in compromising mt-
protein import and causing cell death (Coyne & Chen, 2018). This may signify that GdnHCl targets 
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Hsp104, which in turn causes an mPOS response resulting in the formation of petite mutants. 
This hypothesis must be tested by confirming the presence of an mPOS response, using 
antibodies that target specific proteins which accumulate in the cytosol, for example Aac2; 
encoding the major isoform of adenine nucleotide translocase involved in ATP/ADP exchange 
across the IMM (Wang et al., 2008) 
The experimental findings reported in this Chapter strongly suggest that Hsp78 is not directly 
impacted in GdnHCl-induced petite generation. Although the link between Hsp78 and GdnHCl-
induced petite generation may not be direct, studies by others suggests that Hsp78 may still play 
a role in thermotolerance and stress protection. For example, under extreme heat stress, hsp78Δ 
cells lose all respiratory function (Röttgers et al., 2002). 
Interestingly, GdnHCl still induces petite mutants in S. cerevisiae in the absence of Hsp104, 
highlighting the possibility of an alternative target of GdnHCl in petite generation. It is therefore 
likely that Hsp104 acts as the primary target of GdnHCl, but that an alternative protein plays a 
role in salvaging the pathway of petite mutant generation in the absence of this protein. Hsp70 
would be a likely candidate for GdnHCl-induced petite induction, in the absence of Hsp104 since 
the integrity of the mitochondrial genome and a sufficient mitochondrial membrane potential 
necessary for efficient protein import requires at least one of Hsp70 and Hsp78 (Moczko et al., 
1995). Moczko et al., also (1995) suggest that Hsp78 only becomes important in situations where 
the activity of mt-Hsp70 is limiting, and Hsp78 may simply provide an additional component of 
the mitochondrial system of chaperone proteins. Petite mutant generation and a strongly reduced 
mitochondrial membrane potential may be indicative of a specific role of Hsp78 in the import of 
preproteins under conditions of impaired mt-Hsp70 function (Moczko et al., 1995). These findings 
imply that a similar interaction may be the case between GdnHCl and Hsp70, which is only 
significant when Hsp104 function is impaired. 
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Chapter 5: The impact of natural genetic 
variation on protein aggregation in 
Saccharomyces species
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5. Chapter 5: The impact of natural genetic variation on protein aggregation in
Saccharomyces species
5.1. Introduction
Haploid strains of S. cerevisiae can facilitate and perpetuate the formation of a range of 
heterologous, amyloid-forming proteins including the Alzheimer’s disease-associated protein 
Aβ42 (Goedert & Spillantini, 2006) and Huntingtin (Htt)-associated exon 1 of the huntingtin protein 
(Htt) with a range of glutamine (Q) expansions e.g. Htt-97Q (Norremolle et al., 1994). The impact 
of disease-associated Htt-97Q on growth and viability of S. cerevisiae had been demonstrated 
previously including the ability of these proteins to cause toxicity and form aggregates indicative 
of amyloids (Masino et al., 2002). No studies of these heterologous proteins expressed in other 
species belonging to Saccharomyces have been reported to date.  
In order to gain an understanding of the impact of expressing either Aβ42 or Htt-97Q in other 
genetically-related species of Saccharomyces, two other species of the Saccharomyces were 
used; namely S. bayanus and S. mikatae. S. kudriavzeveii was eliminated from this study as the 
plasmids used to express the amyloidogenic proteins were based on the GAL1 promoter and 
hence require induction with galactose. The strains of S. kudriavzeveii used in this project have 
a non-functional GAL gene network of pseudogenes (Scannell et al., 2011).  
In addition, one genetically marked wild strains of S. cerevisiae (Cubillos et al., 2009) was used 
in a parallel study representing a diverse ecological niche. As mentioned in Chapter 1, Section 
1.11, the variable nature of accessory genomes between different strains of the same 
species may uncover different impacts of amyloid-forming proteins on host growth and 
behaviour. Alternate laboratory strain of S. cerevisiae, namely 74D-694 and Sc. BY4741 were 
also used throughout this chapter. The full list of yeast species/strains used in this study is 
provided in Materials and Methods. 
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The initial aim of this work was to determine whether each of these species can generate and 
propagate the amyloid forms of Aβ42 and polyQ, and if so, the impact these amyloid-forming 
proteins have on growth and viability of the host. However, this also required an  investigation 
into whether the behaviour of these amyloidogenic proteins was impacted upon by the prion state 
of the host yeast species. For example, in S. cerevisiae, Htt-Q97 is only toxic if the strain 
contains an endogenous [PIN+]-like prion (Meriin et al., 2002). Initially, Meriin et al., (2002) 
showed that deficiencies in molecular chaperons Sis1 and Hsp104 inhibited the seeding of 
polyQ aggregates. Since Hsp104 is required for prion maintenance in yeast, this suggested a 
role for prions in polyQ aggregation and toxicity (Meriin et al., 2002). 
To determine whether cell growth and toxicity of Aβ42 or Htt-97Q in these other strains and 
species was dependent on a [PIN+]-like prion or another endogenous prion, the function of the 
endogenous molecular chaperone Hsp104 was impaired by chemical inhibition. This would block 
the propagation of any Hsp104-dependent prion states although one cannot rule out that Hsp104-
independent prions may also exist in these strains/species. Creating such ‘prion-free’ cells would 
thus allow us to determine whether the impact of expression of Htt-Q97 has the same 
requirements in all species as in S. cerevisiae, whether the other genetically-related species of 
S. cerevisiae have a [PIN+]-like prion and whether Aβ42 also relies on an endogenous prion for
aggregation and/or toxicity. 
5.2. Impact of expression of Htt-97Q in Saccharomyces species 
Laboratory strains of S. cerevisiae, a genetically-marked wild strain of S. cerevisiae and strains 
of S. bayanus and S. mikatae were each transformed with pYES2-based plasmids expressing 
either Htt-25Q (which acts as the control) and Htt-97Q. In each case the transformed cells had 
the target Htt-Q25/97 sequence under the control of the regulatable promoter GAL1. Expression 
of the target gene was induced by transferring cells from a glucose-based medium into a medium 
containing galactose as the sole carbon source.  The growth of each strain was then analysed 
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using the multi-well plate reader in two independent experiments, with each time point in triplicate. 
The data reflect the average of all of these experiments. 
5.2.1. Htt-Q97 aggregation impacts growth of all species of Saccharomyces 
 When induced with galactose, the expression of Htt-97Q resulted in a slight but statistically 
significant increase in doubling time relative to the growth of all strains transformed with the 
plasmid but not induced for expression, in the glucose-based control medium (i.e. SD-ura), 
(Figure 5.1). The doubling time of all strains induced for expression of Htt-97Q was also 
statistically different to the doubling time of all strains expressing Htt-25Q as a control. This 
result suggests that expression of Htt-97Q in all strains and species tested inhibits cell growth 
although it is unclear whether this reflects an impaired rate of cell growth or an increase in cell 
death within the Htt-Q97 expressing population.  
Figure 5.1: Doubling times following the induction of Htt-25Q and Htt-97Q expression. All 
species show an increase in doubling time when induced with galactose to express Htt-97Q. The 
data reflects the average of three biological repeats, each with two technical replicates. Statistics 
were performed on both the biological and technical replicates. Error bars denote standard 
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As previously shown in S. cerevisiae  by Meriin et al. (2002) (Meriin et al., 2002), Htt-97Q has a 
toxic effect on the cell, resulting in an increased doubling time as was observed for the 
two strains of S. cerevisiae and two Saccharomyces species tested here (Figure 5.1). 
Overlaying the growth curves for the different strains growing on SD-Ura+Gal i.e. 
expressing Htt-97Q, revealed a difference in growth profile when compared to the 
typical growth profile of Saccharomyces species (detailed in Chapter 6) (Figure 5.2). 
Diauxic shift refers to the stage of growth where cells undergo dramatic metabolic 
changes, following the exhaustion of a fermentative carbon source. At this stage, cells 
prepare for post-diauxic respiratory growth where they consume the by-product of 
fermentative growth, ethanol (Figure 5.2).  
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Figure  5.2: Growth profile of yeast strains expressing  Htt-97Q. Panel  A) Cell growth was 
monitored following Htt-97Q expression in Saccharomyces species. Panel B) A ‘typical’ growth 
curve for S. cerevisiae indicating the growth stages seen within a typical growth profile 





















The data indicate that expression of Htt-97Q has a detrimental impact on the growth of all strains 
and species tested as evidenced by a reduced growth rate. This is indicative of cell toxicity linked 
directly to the synthesis of Htt-Q97. However, the data do not extend into further stages of growth 
such as post-diauxic growth or stationary phase growth and so it was not possible to comment 
on the impact Htt-97Q has on the entire growth profile of each strain.  
5.3. Aβ42 aggregation impacts optimal growth of all species of Saccharomyces 
Laboratory strains of S. cerevisiae, a genetically-marked wild strain of S. cerevisiae and strains 
of S. bayanus and S. mikatae were each transformed with pBEVY-GU-based plasmids 
expressing either Aβ42 fused in frame to mNeonGreen or mNeonGreen alone as control. 
mNeonGreen is a fluorescent protein that can be used to observe localisation and aggregation in 
the yeast cell (Shaner et al., 2013). The growth of each strain was analysed in two independent 
experiments, each time in triplicate, and the data shown reflects the average of these 
experiments. 
When expressing Aβ42, all strains bar S. mikatae showed a statistically significant increase in 
doubling time compared to the strains expressing mNeonGreen alone as controls (Figure 5.3). 
This suggests that the expression of Aβ42 in all strains causes an impairment or delay in cell 
growth, and a possible reduction in cell population size indicative of cell death.  
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An increase in doubling time in most strains expressing Aβ42 may suggest a negative effect on 
cell growth rate, and a level of toxicity in the cell caused by the Aβ42 moiety. A notable 
difference between the observed growth profiles of Sc. BY4741 and Sb. 9194 were observed 
when compared to their ‘typical’ growth profile (See Chapter 6).  However, when comparing the 
growth curves of all strains expressing Aβ42, it was evident that there was little difference in the 
growth profiles of Sc. 3883 and Sm. 9183 (Figure 5.4).  
Figure 5.3: The doubling times of all strains as a consequence of induction of 
mNeonGreen and Aβ42 expression. The data reflects the average of three biological repeats, 
each with two technical replicates. Statistics were performed on both the biological and 
technical replicates. Error bars denote standard deviation. Paired two tail T-tests were carried 
out: *p<0.05, n.s = not significant.
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The data suggest that the impact of expressing Aβ42 intracellularly on cell growth is inconsistent 
both within and between species of Saccharomyces. As with the expression of Htt-97Q, and 
particularly in the cases of Sc. BY4741 and Sb. 9194, without data extending further into the 
stages of growth it is not possible to comment on whether Aβ42 is detrimental to the cell. Caine 
et al., (2007) showed that Aβ42 fusion proteins are non-toxic to yeast, although Aβ42-GFP 
expression caused a slight decrease in growth rate (Caine et al., 2007) which is inconsistent with 
the observed effect with S. mikatae. In the case of the other three yeast strains/species examined 
where there was a statistically significant change in growth rate, and a small but reproducible 
increase in doubling time of strains expressing Aβ42 suggesting some impairment of growth when 














Sc. BY4741 Aβ42 Sc. 3883 Aβ42 Sb. 9194 Aβ42 Sm. 9183 Aβ42
Figure 5.4: Growth profile of strains as a consequence of Aβ42 expression. This data 
represents an average of two biological repeats, each with three technical replicates. 
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5.4. Disease-associated Htt-97Q has minimal impact on the growth of diploid S. 
cerevisiae BY4743 
All strains of all species previously tested here were haploid yeast strains, but both Aβ42 and Htt-
Q97 are mainly studies in diploid organisms (Caine et al., 2007; Meriin et al., 2002). Consequently 
we next examined the effects of expression of these two amyloid-forming proteins in the diploid 
laboratory strain Sc. BY4743. The strain was therefore transformed with either pYES2-25Q or 
pYES2-97Q and expression induced as described above. The growth of BY4743 was analysed 
in biological triplicate across two independent experiments, and all data shown reflects the 
average of these experiments (Figure 5.5). 
Figure 5.5: The doubling time of diploid strain BY4743 expressing either Htt-25Q or 
Htt-97Q. Sc. BY4743 expressing Htt-25Q and Htt-97Q suggests an increase in doubling time 
from control media to -ura Galactose. The data reflects the average of three biological repeats, 
each with two technical replicates. Statistics were performed on both the biological and technical 
replicates. Error bars denote standard deviation, paired two tailed tests were carried out: 
*p<0.05, n.s. = not significant.
Sc. BY4743 
152 
When transferred to a galactose-based medium, BY4743 expressing Htt-97Q showed a 
significant increase in doubling time compared to growth in control medium SD-ura, when the 
strain was not induced for plasmid expression (Figure 5.5). In contrast with the results seen in 
the haploid version Sc. BY4741 (Figure 5.1), the doubling time of BY4743 expressing Htt-97Q 
reduced when compared to the expression of Htt-25Q, although these results were not 
statistically significant.  
In contrast with the findings displayed in Figure 5.2, the expression of Htt-25Q and Htt-97Q in 
Sc. BY4743 showed no effect on growth profile (Figure 5.6). The results of the growth 
experiment indicate that the expression of Htt-Q97 has no significant impact on growth rate or 















Figure 5.6: Growth profile of Sc. BY4743 cells expressing Htt-Q25 or Htt-97Q. This data 
represents an average of two biological repeats, each with three technical replicates. 
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5.5. Impact of expression of Htt-Q97 on cell viability of various yeast strains and 
species 
The impact Htt-Q97 has on the viability of the various strains and Saccharomyces 
species was next investigated by determining cell viability using two different approaches; 
indirectly by use of a vital stain and directly by measuring the number of cells able to form a 
colony.  
5.5.1. Assessing impact of Htt-Q97 expression indirectly using methylene blue 
staining 
Previous studies have suggested that Htt-Q97 causes both aggregation and toxicity in S. 
cerevisiae (Meriin et al., 2002). To better understand the underlying mechanism of cell toxicity 
caused by Htt-Q97, and to differentiate a cytocidal effect from a cytostatic one, yeast cell viability 
was first measured by determining the percentage of observable cells in a population that take 
up a vital stain such as methylene blue (Matthews, 1914). Consequently, following the expression 
of Htt-Q97 or Htt-Q25 as a control, in the laboratory strains of S.cerevisiae, wild strain of S. 
cerevisiae, strains of S. bayanus and strains of S. mikatae, cells were stained with methylene 
blue and immediately visualised. While living cells have an active dehydrogenase system which 
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reduce methylene blue, dead cells cannot reduce the stain and therefore remain blue (Matthews, 
1914) (Figure 5.7). 
In each strain, a minimum of 200 cells were manually counted across 3 independent experiments 
and labelled as blue (dead) or white (alive) following staining with methylene blue. Data shown 
reflects the average of these experiments. When analysing the percentage of viable cells 
following expression of Htt-Q97 and Htt-Q25, a statistically significant decrease in viable cells 
was seen in all strains and species, with the exception of the diploid strain Sc. BY4743 (Figure 
5.8) suggesting that diploid strains have a higher resistance to Htt-Q97-mediated toxicity, 









Figure 5.7: Methlyene blue staining for detecting dead cells. While living cells have an 
active dehydrog enase s ystem which reduce met hylene blue, dead cells c annot r educe the 
stain and therefore remain blue. In each strain, a minimum of 200 cells were manually 




 In summary, these data demonstrate that expression of Htt-Q97 has a clear impact on cell 
viability across all haploid strains of all Saccharomyces species tested, but not in the single 
diploid strain tested.  
5.5.2. Assessing impact of Htt-Q97 expression on cell viability directly 
Cell toxicity can also be observed using a spotting test assay as shown in Figure 5.9. In each 
case, expression of Htt-Q25 and Htt-Q97 was induced with galactose for 24 hours, and a dilution 
series of each culture was made and plated onto a rich glucose-based growth medium. Toxicity 
is evident in all strains expressing Htt-Q97, albeit at different levels. Sc. BY4741 shows the 
highest level of toxicity, compared to the visible development of colonies remaining in the highest 
dilution in all other strains. As expected, all strains induced to express the control Htt-Q25 grow 
without visible impairment. The observed toxicity of Htt-Q97 in all strains would be consistent with 
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Figure 5.8: Expression of Htt-Q97 causes an increased cell death in different yeast 
strains and species following methlyene blue staining for detecting dead cells, where 
dead cells stain blue. While living cells have an active dehydrogenase system and stain white, 
dead cells cannot reduce the stain and therefore remain blue. In each strain, a minimum of 200 
cells were manually counted across three independent biological experiments with two technical 
repeats, and labelled as blue (dead) or white (live). Statistics were performed on all of these 
replicates. Error bars denote standard deviation. Paired two tailed tests were carried out: 
*p<0.05, n.s. = not significant.
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As with the earlier growth experiments, the spotting assay does not tell us whether the growth 
phenotype of the Htt-Q97 expressing strains is a cytostatic effect, where cells remain viable while 
halting division, or whether cells have died. Although visible growth impairment is apparent in all 
strains expressing Htt-Q97, this only indicates that those cells that remain are able to grow into a 
multicellular colony when plated onto a solid medium, and does not give any insight into cytostatic 




























Figure 5.9: A plate assay to determine the effect of Htt-Q25 and Htt-Q97 expression on 
the growth and formation of colonies of all species on solid medium.  In each case, 
expression of Htt-Q25 and Htt-Q97 was induced with galactose for 24 hours, and a dilution 
series of each culture was made and plated onto a rich glucose-based growth medium. The 
slope denotes serial dilution, with each step indicating a 1/10 dilution.  
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still regrow once released from the effects of the toxic protein. In summary, it is evident that Htt-
Q97 causes toxicity in all strains, but the exact mechanism remains unclear. 
5.6. Visualisation of disease-associated amyloid aggregation in all Saccharomyces 
species using fluorescence microscopy 
As described with the toxicity caused by Htt-Q97, this amyloid-forming protein has also been 
shown to form aggregates in S. cerevisiae cells carrying the [PIN+] prion (Meriin et al., 2002). 
Detecting the formation of the Htt-associated proteins using fusions to a green fluorescent protein 
can be used to  indicate whether a) aggregate formation occurs, and b) whether there are differing 
requirements for aggregation between each strain/species particularly with regard to the 
endogenous prion state. Detection of Aβ42 aggregation is also possible using fusions to 
mNeonGreen (Shaner et al., 2013). 
5.6.1. Htt-Q97 and Aβ42 form aggregates in all strains and species of Saccharomyces 
When Htt-Q97 was expressed, fluorescent foci indicative of amyloid aggregates were evident in 
all strains in stationary phase. Htt-Q25 expression resulted in diffuse fluorescence across all 
strains, as expected for the control. Haploid strains of S. cerevisiae displayed 1-2 foci in most 
cells, much like the diploid strain Sc. BY4743, however aggregate size (based on fluorescent 
intensity) appeared to vary. S. mikatae showed a much higher number of foci per cell, and most 
cells observed displayed 3+ foci per cell. When expressing fluorescent fusion proteins, strains of 
S. bayanus showed an alteration of cell size and shape, with elongated cells being particularly
evident (Figure 5.10). The reason for this effect is unknown but may reflect some form of stress 
response. 
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Aβ42 also formed aggregates in all strains tested as detected by the presence of fluorescent foci 
when compared to the diffuse fluorescence displayed in all strains expressing mNeonGreen 
alone. Aggregate size and number appeared to be consistent across strains and species, with an 
upper limit of 3 foci per cell and the majority of cells observed displaying 2 fluorescent foci per 




















Figure 5.10: Cells expressing Htt-Q97 and Aβ42 form amyloid-associated aggregates in 
all species. Images shown were taken by fluorescent microscopy during stationary phase of 
growth, following 24 hours induction with galactose. Fluorescent signal represents the presence 
of the amyloid-forming proteins within cells, and vectors containing GFP alone to act as a control 
for each protein. Each strain was visualised in three independent experiments at 100x 
magnification, and at least 200 cells were visualised per condition. The scale bar represents 
10 µm.   
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cell. The only exception to this was the diploid strain Sc. BY4743, with the majority of cells 
containing 3 or more fluorescent aggregates per cell.  
5.7. Visualisation of disease-associated amyloid aggregation in all species following 
treatment with GdnHCl 
Following the visualisation of Htt-Q97 and Aβ42 aggregation in all strains, the [PIN+] 
requirements for such aggregation was further by creating [prion-] cells.  As previously shown by 
Meriin et al. (2002), Htt-Q97 aggregation relies on the endogenous [PIN+] prion in S. cerevisiae, 
so creating [prion-] cells and revisiting the aggregation status of both Htt-Q97 and Aβ42 would 
be a means of establishing whether an endogenous [PIN+]-like prion is required for disease-
associated amyloid aggregation in all the Saccharomyces species under test here.  
Guanidine hydrochloride causes reversible inhibition of the chaperone activity of Hsp104 which 
is necessary for endogenous prion propagation (Ness et al., 2002) with exposure to 3-5 mM 
GdnHCl efficiently generating prion-free [including [pin-] cells (Sondheimer & Lindquist, 2000).  
5.7.1. Visualisation of disease-associated amyloid aggregation in [prion-] strains 
All strains were plated onto minimal media lacking uracil, supplemented with millimolar 
concentrations (5 mM) of GdnHCl for three independent rounds. Visualisation of all 
strains showed that fluorescent foci indicative of Htt-Q97 aggregation were no longer present, 
and diffuse fluorescence was seen across all cells in all strains (Figure 5.11). Interestingly, 
aggregates remained in S. mikatae until the concentration of GdnHCl used was increased to 
8mM suggesting either reduced efficiency of uptake of GdnHCl or a reduced sensitivity of 
Hsp104 to GdnHCl (see Chapter 4).  
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In contrast, Aβ42 aggregates remained in all cells of all species following the same treatment with 
GdnHCl on solid medium. These findings suggest that aggregation of Htt-Q97 relies on [PIN+] 
and Hsp104 (albeit indirectly) in all species, or an alternative [PIN+]-like endogenous prion that 
also relies on Hsp104 for propagation. In contrast, the findings suggest that aggregation of Aβ42 
does not rely on Hsp104 or an endogenous prion i.e. [PIN+] in any species tested (Figure 5.11). 


































Figure 5.11: Visualisation of disease-associated amyloid aggregation in [prion-] strains. 
Image s sh own w ere taken by fl uorescent m icrosco py during stationa ry phase of 
growth, follo wing 24 ho urs induct ion with galact ose. E ach str ain was visual ise d at a 
magnifica tion of 100x in three independent biological experiments, and at least 200 cells 
per condition were visualised. The scale bar represents 10 µm.   
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5.7.2. Visualisation of disease-associated amyloid aggregation in all strains 
following GdnHCl curing and continued inhibition of Hsp104 
In the previous experiments (Figure 5.11) the presence or absence of aggregates was evaluated 
after the cells had been released from GdnHCl and hence Hsp104 activity would have been 
restored in these cells. In the next set of experiments, following three rounds of growth on solid 
medium supplemented with 5 mM millimolar concentrations of GdnHCl, strains were 
then transferred to a liquid medium containing 5 mM GdnHCl right up until the point of 
visualisation of aggregates via fluorescence microscopy thereby ensuring cells remained in a 
prion-free state and Hsp104 remained inactivated. 
Visualisation of all strains showed that fluorescent foci indicative of Htt-Q97 aggregation were not 
observed in any strain (Figure 5.12), further supporting the reliance of Htt-Q97 on [PIN+] and 
indirectly Hsp104 for aggregation. Following the prolonged inhibition of Hsp104, Aβ42 
aggregates remained in all cells of all species (Figure 5.12). These findings further suggest that 
Aβ42 aggregation does not require Hsp104 or an endogenous prion i.e. [PIN+] in any of the 
species tested.  
162 





















































Figure 5.12: Visualisation of disease-associated amyloid aggregation in [prion-] strains 
following continued inh ibition  of H sp10 4 by GdnHC l. Ima ges sh own w ere taken by 
fluores cent micros copy du ring station ary p ha se of gro wth, follow in g 24 h ours indu ction with 
galactose supplemented with GdnHCl. Each strain was visualised at a magnification of 100x in 
three independent biological experiments, and at least 200 cells were visualised per condition. 
The scale bar represents 10 µm.   
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5.7.3. Confirming the requirement of Hsp104 for Htt-Q97 aggregation using Sc. 
Δhsp104 
Although millimolar concentrations of GdnHCl are unlikely to affect the ability of either Htt-Q97 or 
Aβ42 to form aggregates, the requirement for Hsp104 for aggregation is best evaluated by 
deletion of the non-essential HSP104 gene. Htt-Q25, Htt-Q97, mNeonGreen and Aβ42 were 
therefore expressed in the Sc. BY4741 Δhsp104 strain. Visualisation of each disease-associated 
amyloid forming protein further supported the evidence that Htt-Q97 aggregation relies on 
Hsp104, whereas aggregation of Aβ42 does not (Figure 5.13).  
5.8. Exploring the impact of Htt-Q46 and Htt-Q72 expression in S. cerevisiae 
We next investigated whether the length of the polyQ expansion had an impact on aggregates 
formed in S. cerevisiae. Sc. BY4741 was transformed with plasmids GAL46Q+ProGFPp416 and 
GAL72Q+ProGFPp416 and induced for gene expression using galactose. Duennwald et al. 
(2006) (Duennwald et al., 2006) have reported that Htt-Q46, Htt-Q72 and Htt-Q97 all form 
aggregates in S. cerevisiae compared to the Htt-Q25 control, and an increase in length of the 
polyQ region also increases toxicity in the cell. Thus, the expression of these proteins in S. 














Figure 5.13: Confirming the requirement of Hsp10 4 for Htt-Q97 aggregation using Sc. 
Δhsp104. Images shown were taken by fluorescent microscopy during stationary phase of 
growth. Each strain was visualised at 100x magnification in three independent biological 
experiments, and at least 200 cells were visualised per condition. The scale bar represents 
10 µm.   
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cerevisiae provides a model for the length-dependant aggregation and toxicity of polyQ 
expansions.  
As discussed in Section 5.2.1, Htt-Q25 expression resulted in diffuse fluorescence in Sc. BY4741, 
as expected for the control. Sc. BY4741 expressing Htt-Q97 displayed 1-2 foci indicative of Htt-
Q97 aggregation. [PIN+] cells expressing Htt-Q46 and Htt-Q72 also formed fluorescent 
aggregates. With an increase in polyQ expansion, there was no observed difference in aggregate 
size or number per cell (Figure 5.14). Further analysis must be carried out in other species of 
Saccharomyces to comment on the aggregation status of Htt-Q46 and Htt-72 in these other 
closely related species. Expression of Htt-Q46 and Htt-Q72 following curing with GdnHCl 
must also be investigated across all species, in order to comment on the role of [PIN+] and 
Hsp104 in the aggregation of these proteins, and any alternative requirements for maintenance.  
5.9. Further analysis of Aβ42 aggregation in S. cerevisiae cells lacking a functional 
Hsp104 
Observations suggest that Aβ42 aggregate number increased following treatment with GdnHCl 
in Sc. BY4741. Following Aβ42 expression, cells were put through three independent rounds of 









Htt-Q25 Htt-Q46 Htt-Q72 Htt-Q97 
Figure 5.14: Analysis of Htt-Q46 and Htt-Q72 aggregation in Sc. BY4741. Images shown 
were taken by fluorescent microscopy during stationary phase of growth, following 24 hours 
induction with galactose. Each condition was visualised at a 100x magnification in three 
independent biological experiments, and at least 200 cells per condition were visualised. The 
scale bar represents 10µm.   
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GdnHCl. Preliminary data involving manual counting of foci suggests that after both conditions, 
foci per cell increased. Cells with zero foci appeared to remain consistent across conditions, and 
cells containing either 2 foci or 3+ foci indicative of Aβ42 aggregates increased (Figure 5.15). 
These findings have only been made in one strain of S. cerevisiae, so it is not possible to 
comment on the impact GdnHCl has on Aβ42-associated aggregate number amongst other 
strains and species. 
5.10. Exploring the requirement of Hsp90 for Aβ42 aggregation 
Although the results presented above suggest that the aggregation of Aβ42 does not require 
Hsp104 in any species tested, the possibility remains that Aβ42 may require an alternative 
chaperone for aggregation and this was further investigated focusing on Hsp90. Hsp90 is an 
ATPase that associates directly with Hsp104. Hsp90 in S. cerevisiae exists as two near identical 
Hsp90 isoforms, Hsc82 and Hsp82, and only one must be maintained for viability (Newnam et 
al., 1999). The N-terminal domain of Hsp90 harbours an ATP/ADP binding site that specifically 
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Figure 5.15: Analysis of Aβ42 aggregate number in S. cerevisiae cells lacking a functional 
Hsp104. In each condition, the foci in 200 cells were manually counted and an average was 
taken across three independent biological experiments, each with two technical replicates. 
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et al., 1998). We therefore use radicicol as a chemical inhibitor of Hsp90 function in S. cerevisiae 
to investigate the requirement of Hsp90 for Aβ42 aggregation in this species. 
At increasing concentrations of radicicol (0-10 µg/ml) foci indicative of Aβ42 aggregates 
remained in Sc. BY4741 (Figure 5.16). The concentration of radicicol was increased to 15 µg/ml 
until cell growth stalled, observed by a lack of overnight growth in liquid culture. These results 





























0 µg/ml radicicol 1 µg/ml radicicol 5 µg/ml radicicol 10 µg/ml radicicol
Figure 5.16: Exploring the requirement of Hsp90 for aggregation of Aβ42 by treatment with 
0-10 µg/ml radicicol. Images shown were taken by fluorescent microscopy during stationary
phase of growth, following 24 hours induction with galactose, then grown in radicicol. Each strain
was visualised in three independent biological experiments at a magnification of 100x, and at
least 200 cells per condition were visualised. The scale bar represents 10 µm.
Although relatively low concentrations of radicicol are unlikely to affect the ability of Aβ42 to form 
aggregates, the requirement of Hsp90 for aggregation was further evaluated by deletion of the 
HSP82 gene. Control mNeonGreen and Aβ42 were each expressed in the Sc. BY4741 Δhsp82 
mutant. Continued appearance of these amyloid-forming proteins further support the evidence 
that Hsp90 is not required for aggregation of Aβ42 in S. cerevisiae, although it must be noted that 
Hsc82 is still present in the strain under test (Figure 5.17).  
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5.11. Analysing the role of the UPF1/2/3 genes in disease-associated amyloid 
aggregation 
The Upf1/2/3 proteins form the nonsense-mediated decay (NMD) complex that recognises 
premature stop codons in mRNA transcripts at the ribosome, and Upf1p is responsible for 
shuttling mRNA transcripts containing premature stop codons to P-bodies for degradation 
(Mendell & Dietz, 2008). Both eRF1 (Sup45) and eRF3 (Sup35) interact with Upf proteins in yeast, 
and UPF gene deletions promote nonsense suppression (Wang et al., 2001). 
Sc. BY4741 strains carrying either the upf1Δ, upf2Δ or upf3Δ gene deletions were transformed 
to express all Htt and Aβ associated amyloid-forming proteins. It was of interest to determine 
whether these proteins would suppress disease-associated amyloid aggregation, and whether 
any suppression of aggregation was due to the absence of Upf1p, or due to the function of the 
NMD complex as a whole.  
Preliminary data by Gemma Staniforth in our laboratory showed that deletion of the UPF1 gene 















Figure 5.17: Exploring the requirement for Hsp90  in aggregation of Aβ42 using Sc. BY4741 
Δhsp82 expressing mNeonGreen and Aβ42. In each condition, at least 200 cells were 
visualised at 100x magnification in three independent biological experiments. The scale bar 
represents 10 µm. 
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Further work by Selena Li in our laboratory showed that deletion of the UPF3 gene did not 
suppress the overexpression of Rnq1 and polyQ-mediated toxicity, suggesting that the 
suppression is not due to the function of the UPF genes as a complex, as Upf3 is involved in the 
core machinery.  
5.11.1. Aggregation of Htt-Q97 relies on UPF1p, but aggregation of Aβ42 does 
not 
In contrast to the results observed in Sc. BY4741 Δupf1, aggregation of Htt-Q97 was not 
suppressed by Δupf2 and Δupf3 (Figure 5.18) These results indicate that Upf1p, but not Upf2p 
or Upf3p, is essential for the aggregation of Htt-Q97 in S. cerevisiae. This would also suggest 
that it is not the activity of each component of the NMD complex that plays a role in Htt-Q97 
aggregation, but Upf1p specifically. It is known that proteins rich in glutamine and asparagine 
are required for P-body (processing body) assembly, so it could be that P-bodies act as ‘seeding 
factors’ for Htt-Q97 aggregation. These results may indicate that a reduction in P-body formation 
slows the rate of Htt-Q97 aggregate formation, so that the cell is able to maintain Htt-Q97 in a 
non-toxic state. Alternatively, it may simply be that Htt-Q97 expression levels are reduced in the 
upf1Δ strain. In contrast, Figure 5.18 shows that Upf1p, Upf2p and Upf3p are not required for 
Aβ42 aggregation. This further highlights the differing requirements for maintenance of this 
disease-associated amyloid forming protein compared to Htt-Q97. 
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5.12. Discussion 
In summary, both chemical inhibition of Hsp104 and the deletion of the gene show that Htt-Q97 
aggregates are unable to form in all species, suggesting a requirement for a [PIN+]-like prion and 
Hsp104 in Htt-Q97 aggregation. One explanation for this may be the need for an endogenous 
prion to act as a ‘seeding factor’ for polyglutamine expansion proteins, facilitating the formation 
of toxic amyloid. This is consistent with the idea that cross-seeding may be an important factor in 
the establishment of protein misfolding in yeast (Von Der Haar et al., 2007). By contrast, the same 
experiments showed that aggregation of Aβ42 does not require an endogenous prion or Hsp104 



















Htt-Q25 Htt-Q97 mNeon-Green Aβ42 
Figure 5.1 8: Exploring the requirement for UPF1p in disease-associated amyloid aggregation. 
Images shown were taken by fluorescent microscopy during stationary phase of growth, following 24 
hours indu ction with galacto se. Each cond ition was visu al ised a t a 100x mag ni fication in three 
independent biological experiments, and at least 200 cells were visualised in each condition. The 
scale bar represents 10 µm. 
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gene further suggested that Aβ42 does not require Hsp90 for aggregation in S. cerevisiae. Our 
findings suggest that although requirements for disease-associated amyloid aggregation differ 
between proteins, the requirements of each protein appear to be consistent across strains and 
species.   
Similarly, our results indicate that Upf1p, but not Upf2p or Upf3p, is essential for the aggregation 
of Htt-Q97 in S. cerevisiae, but not for the aggregation of Aβ42. This further highlights the differing 
requirements for maintenance of this disease-associated amyloid forming protein compared to 
Htt-Q97. One possible reason is that the Upf1 protein may interact with Htt-Q97 directly, thus 
facilitating the aggregation of Htt-Q97, generating toxic aggregates in a [PIN+] background. 
However, deletion of upf1 may affect the protein-protein interaction and thus Htt-Q97 may form 
non-toxic inclusion bodies. Alternatively, such protein-protein interaction may be sequence-
specific to UPF1, thus highlighting a role for this protein in the formation of toxic oligomers. This 
sequence may be incapable of interacting with Aβ42, thus explaining the differing requirements 
for maintenance of the proteins. Table 5.1 summarises the differing behaviours of the two 
proteins in Saccharomyces species under test. 
Table 5.1: A summary of the differing behaviours of the two proteins; Htt-Q97 and Aβ42 in 
Saccharomyces species. 
Htt-Q97 Aβ42 
[PIN+]-dependent Yes No 
Hsp104-dependent Yes No 
Upf1-dependent Yes No 
Growth defect Yes – in initial growth phases Yes – in initial growth phases 
of Sc. BY4741 and Sb. 9194 
Fluorescent foci Multiple dot Multiple dot 
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Chapter 6: Prion mediated phenotypic 
heterogeneity in Saccharomyces 
species
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6. Chapter 6: Prion-mediated phenotypic heterogeneity in Saccharomyces species
6.1. Introduction
The phenotype of an organism is not only defined by its genotype; a significant contribution can 
also be made by several epigenetic factors. Such epigenetic factors are largely based on inherited 
changes in protein modification and/or structure as typified by the prion. Naturally-occurring 
prions in yeast promote heritable changes in protein conformation and function that can lead to 
the evolution of diverse new traits and survival in fluctuating environments (Chakrabortee, Byers, 
et al., 2016; Halfmann et al., 2012). Although we have learnt much about prions in 
Saccharomyces cerevisiae, we know almost nothing about the existence and/or function of prions 
in other evolutionarily-related yeast species (Nakayashiki et al., 2005). This chapter presents 
results exploring whether prions might act as novel epigenetic regulators of phenotype in 
species of Saccharomyces. 
Near complete genome sequences and a collection of genetically marked haploid strains of S. 
bayanus, S. mikatae and S. kudriavzevii were made available for comparison to the S. cerevisiae 
reference genome (Scannell et al., 2011). Among these lineages, the divergence time relative to 
the origin of the genus, which coincides with the divergence of S. bayanus, was estimated using 
106 genes spanning the yeast genome. For each species, relative divergence was expressed as 
a percentage. Respectively, the divergence of S. kudriavzevii and S. mikatae was 78% and 53% 
as old as the lineage, and the divergence of S. cerevisiae was 33% as old as the lineage (Scannell 
et al., 2011) (Figure 6.1). Thus, the discovery of well-established S. cerevisiae prions or novel 
prion-like proteins in these species would support the notion that prions are not simply ‘laboratory 
artifacts’ that arise through cultivation of fungal cells under conditions far removed from the 
environment, and instead exist in fungal lineages which diverged many years ago.  
The ability to detect gene orthologues in the Saccharomyces lineages has allowed the 
identification of species-specific gains and losses at the genetic level, thus providing a 
means to review how 
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genetic networks have developed during the evolution of the genome. The conservation of S. 
cerevisiae genes that are essential for prion-forming proteins within these species would indicate 
the evolutionarily conservation of prion-like conformational switches and may imply the 
significance of such switches in a variety of common biological processes. Genetic losses were 
categorised into a) lineage-restricted losses i.e. lost in one or two species; b) widespread losses 
i.e. absent from more than two species; and c) duplicate gene losses i.e. losses of one paralogue
of a duplicate gene pair descended from the whole-genome duplication. Genetic gains are 
categorised as genes that are present in one or more of the Saccharomyces species, but not in 
the Saccharomyces ancestor (Scannell et al., 2011). Such clear genetic diversity between these 
species may be an indication of naturally-occurring epigenetic diversity. 
This chapter also describes a preliminary study on prion-related phenotypes using non-
domesticated wild strains of S. cerevisiae that have been isolated from remote parts of the 
planet (Wang et al., 2012). The origin of such strains ranged from fruit, fruit trees and orchard 
soil in secondary forests to rotten wood and tree bark in primeval forests in Northern and 
Figure  6.1: The phylogenetic tree of Saccharomyces species. The species divergence in
percentage points relative to the origin of the genus, which coincides with the divergence of S. 
bayanus (taken from Scannell et al., 2011). 
Species divergence in % points relative to the origin of the genus 
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Southern China. Duan et al., (2018) showed that the genetic diversity of S. cerevisiae is 
contributed by the highly structured wild population under study, with greatly 
diverged lineages in China. Interestingly, neither the geographic nor ecological factors can 
explain the structure of the wild population. For example, wild isolates from the same 
locations may belong to greatly diverged lineages, or a single lineage has been shown to 
contain isolates from geographically separate regions (Duan et al., 2018). Further studies 
should focus on both genetic and proteomic profiling of these non-domesticated wild 
strains, with a particular focus on well-established prion-forming proteins.  
Analysis in such non-domesticated wild strains of the same species allows us to account for the 
pan-genome; the concept of ‘accessory’ non-conserved genes across strains of the same species 
which contribute to intra-specific variability (McCarthy & Fitzpatrick, 2019). Accessory genes 
which differ between strains have been shown to make up approximately 15% of the pan-genome 
in S. cerevisiae. This chapter outlines the analysis of prion-mediated phenotypic heterogeneity in 
wild strains of yeast, as well as investigation into well-established yeast prions such as [PIN+] and 
[GAR+] in these strains, which reveals distinct individual differences between strains.  
6.2. The generation of [prion-] derivatives of Saccharomyces species 
Guanidine hydrochloride (GdnHCl) is a chaotropic inhibitor of the chaperone activity of Hsp104, 
through a direct target of amino acid residue 184, inhibiting the ATPase activity of Hsp104 (Jung 
et al., 2002). This ATPase activity is necessary for the propagation of endogenous prion 
aggregates as Hsp104 actively fragments Sup35 prion fibrils, creating new propagons, thus 
increasing the availability of ‘recruiting’ ends (Chernoff et al., 1995; Glover et al., 1997). Exposure 
to millimolar concentrations of GdnHCl therefore generates prion-free [prion-] cells (Tuite, Mundy 
and Cox, 1981; Ferreira et al., 2001).  
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Exposure to GdnHCl by addition to yeast growth media is a commonly used method for prion 
“curing” in S. cerevisiae, converting a [PRION+] cell to a [prion-] state (Ness et al., 2002). Cells 
are grown on solid medium supplemented with 3 – 5 mM GdnHCl for three independent rounds, 
to ensure continued inhibition of Hsp104, and to limit the possibility of GdnHCl-induced petite 
mutations which could impact the level of phenotypic heterogeneity. Naturally-occurring prions 
are not established in all species of Saccharomyces, so the conversion from [PRION+] to [prion-] 
is assumed in all strains. Additionally, any naturally-occurring prions in these strains may not be 
dependent on Hsp104 for propagation and therefore may not be eliminated by GdnHCl. Cured 
strains i.e. those that have undergone treatment with GdnHCl, and their non-cured derivatives 
are indicated throughout this chapter by a ‘-‘ or ‘+’ respectively e.g. Sk. 9185- and Sk. 9185+. 
As described in Chapter 1, Section 1.6.1, conformational conversion of the well-established prion 
protein Sup35p reduces the functional pool of Sup35p available for translation termination, 
resulting in the nonsense suppressor phenotype associated with the presence of [PSI+] (Wickner, 
1994). In the prion form, such proteins catalyse the conversion of homologous proteins in the 
[prion-] state to the [PRION+] state, allowing the protein conversion event to become 
conformationally dominant within the strain. In the S. cerevisiae strain 74D-694 (detailed in 
Materials and Methods) the ADE1 gene required for adenine synthesis is represented by the 
ade1-14 nonsense allele. Thus, [psi-] cells are Ade- due to termination of Ade1 synthesis at a 
premature UGA stop codon, causing an accumulation of a red intermediate of the adenine 
synthesis pathway, represented by red colony growth on solid medium (Patino et al., 1996). In 
[PSI+] cells, the premature stop codon of ade1-14 is suppressed, forming Ade+, white-coloured 
colonies. In all rounds of GdnHCl-mediated curing described below, Sc. 74D-694 was used as a 
control strain, as a white to red colour change was indicative of the successful conversion of a 
[PRION+] state to [prion-], and confirmed the likelihood of the same event in all species of 
Saccharomyces (Figure 6.2).  
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To establish the optimal concentration of GdnHCl required for prion curing in all species of 
Saccharomyces, all strains were grown on glucose-rich media supplemented with varying 
concentrations of GdnHCl up to 10 mM for three independent rounds. S. mikatae showed a 
reduced sensitivity to GdnHCl, visualised by successful growth with several dilution series on 
media supplemented with 10 mM GdnHCl (Figure 6.2). This indicates GdnHCl-
resistance relative to other species. In contrast, S. kudriavzevii was particularly sensitive 
to GdnHCl, with limited growth at 2.5 mM GdnHCl (Figure 6.2). This particular species is 
cryotolerant with an optimal growth temperature of ~24 oC and was thus incubated at a 
lower temperature than the other Saccharomyces species. The increased sensitivity of S. 
kudriavzevii to GdnHCl may be indicative of a more efficient uptake of this chemical, 
relative to S. mikatae. Furthermore, it is not clear whether visible growth impairment is 









Figure 6.2: The effect of different concentrations of guanidine hydrochloride of the 
growth of Saccharomyces species. To establish the optimal concentration of GdnHCl 
required for prion curing in Saccharomyces species, all strains were grown on glucose-
rich media supplemented with varying concentrations of GdnHCl for 3 days, for three 
independent rounds. Data shown represents one round of GdnHCl curing. Sc 74D-694 was 
used as a control. Each step indicates a 1/10 dilution within the dilution series. 
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The growth rate of all strains was analysed following three independent rounds of GdnHCl-
mediated curing on solid medium, followed by continued growth in GdnHCl supplemented liquid 
medium. The growth profiles of [PRION+] and [prion-] derivatives of each species were overlaid 
to investigate the direct impact of GdnHCl on growth. The results indicated that the growth profiles 
of S. bayanus and S. mikatae are not directly impacted by GdnHCl, and a final OD600 after 28 
hours above 2.5 confirmed the reduced sensitivity of S. mikatae to GdnHCl (Figure 6.3). By 
contrast, both the results of the growth experiment (Figure 6.3), and growth on solid medium 
(Figure 6.2) showed the detrimental impact of GdnHCl on the growth of S. kudriavzevii  (Figure 
6.3). Growth analysis was carried out at 24 oC to eliminate any growth defects caused 
by temperature, but in the [prion-] state the growth of S. kudriavzevii was still impaired. This 


















Figure 6.3: Growth profiles of [PRION+] and [prion-] derivates of each Saccharomyces 
species. Panel A. The growth profile of S. bayanus. Panel B. The growth profile of S. 
mikatae. Panel C. The growth profile of S. kudriavzevii. The growth profiles of S.  bayanus 
and S. mikatae reveal no difference in growth profile when compared to the GdnHCl-
cured derivative. The data reflects the average of three biological replicates, each with 





6.3. The impact of GdnHCl on prion-mediated phenotypic heterogeneity 
To identify the level of phenotypic heterogeneity between [prion-] and [PRION+] strains of 
Saccharomyces species, the impact of osmotic stress on growth and the level of sensitivity to 
antifungal agent fluconazole were analysed. Observed growth defects in such fluctuating 
environments may be indicative of the presence of endogenous prions in these species. 
Prior to carrying out these phenotypic-based experiments, all species were grown on media 
containing glycerol as the sole carbon source, in order to eliminate petite mutants generated by 
GdnHCl and allow the selection of respiratory-efficient grande cells (see Chapter 4). It must also 
be noted that GdnHCl-induced petite mutants may still arise during these experimental 
procedures, thus impacting the growth of these strains. 
6.3.1. Endogenous prions may provide a growth advantage to Saccharomyces
species in conditions of hyper-osmolarity
In order to identify species of Saccharomyces with the ability to grow under conditions of high 
osmotic stress, both [PRION+] and [prion-] derivatives were grown on complete medium 
supplemented with varying concentrations of sodium chloride (NaCl) (0.4 - 0.8 M). Under 
conditions of hyper-osmolarity, yeast cells activate a stress pathway in which Msn2 and 
Msn4 bind to the stress-response elements (STREs) of stress-response genes, in turn 
activating their transcription (Li & Kowal, 2012). Deletion of MSN2 leads to an increase in 
the frequency of [PSI+] formation, indicating the involvement of stress-response proteins in 
prion formation (Li & Kowal, 2012). Although the exact role of endogenous prions in osmotic 
stress responses remains unclear, it may be that the endogenous [PRION+] state is 
advantageous to cell survival during levels of high osmolarity.  
Some [PSI+]-associated phenotypes may be generated as a result of inactivating stop codon 
mutation (ISCMs) readthrough. Approximately 26,000 single nucleotide polymorphisms (SNPs) 
were identified in S. cerevisiae strain 74D-694 compared to reference strain S288C, some of 
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which cause potential ICSMs. These ICSMs were identified in genes with involvement in a variety 
of cellular processes, including oxidative stress response. Specifically, the presence of an ISCM 
in the MSN4 gene could have major implications for 74D-694’s ability to deal with high levels of 
NaCl, and may help to explain previously identified complex phenotypes associated with the 
presence of [PSI+] (An et al., 2016). 
In the presence of increasing concentrations of NaCl (0.4 - 0.8 M), a decrease in growth of S. 
kudriavzevii in a [prion-] state was observed, compared to its wild type derivative (Figure 6.4). 
This may indicate the presence of an endogenous prion in this species, which is advantageous 













































































Figure 6.4: Growth profiles of Sk. 9185+ and Sk. 9185- in YEPD + 0.4 M NaCl, following 
three rounds of GdnHCl-mediated curing on solid  medium. Panel A) The growth profile 
of S. kudriavzevii in a [PRION+] and [prion-] state in glucose-containing medium. Panel B) The 
growth profile of S. kudriavzevii in a [PRION+] and [prion-] state in YEPD + 0.4 M NaCl. The data 
reflects the average of three biological repeats, each with two technical replicates.
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6.3.2. Endogenous prions impact the survival of Saccharomyces species in the  
presence of fluconazole
Both [PRION+] and [prion-] derivatives of species were grown on complete medium 
supplemented with varying concentrations (1 – 5µg) of the ergosterol synthesis inhibitor 
fluconazole. Interestingly, prions have been shown to encode a natural resistance to fluconazole 
in laboratory strains of S. cerevisiae. [MOD+] yeast contain a higher level of ergosterol than [mod-
] yeast, and an increased resistance to fluconazole (Suzuki & Tanaka, 2013). Fluconazole also 
caused selective pressure on [mod-] yeast, which in turn increased the de novo appearance of 
[MOD+]. This indicates the fitness advantage gained during Mod5p prion conversion, providing 
an increased chance of cell survival when faced with environmental stress (Suzuki & Tanaka, 
2013). In addition, removal of fluconazole showed the loss of [MOD+] over time, suggesting such 
prion conversion plays a critical role in fast cellular adaption to less advantageous environments 
(Suzuki & Tanaka, 2013). Bioinformatic studies should focus on identifying (a) the presence of 
MOD5 in other Saccharomyces species and (b) the % identity and % similarity if this gene is 
present. Endogenous prions in non-laboratory strains of S. cerevisiae also provided cells with 
increased survival in the presence of fluconazole. One confirmed [PSI+] wine strain was 
resistant to this antifungal agent (Byers & Jarosz, 2014), as was strain Sc. UCD#824 isolated 
from white wine (Halfmann et al., 2012). All observed phenotypes were prion dependant 
and eliminated by GdnHCl-mediated prion curing (Byers and Jarosz, 2014; Halfmann et 
al., 2012). In contrast to laboratory strains of S. cerevisiae, most of the observed prion- 
mediated phenotypes of wild strains were adaptive as opposed to neutral or detrimental to the 
cell (McGlinchey et al., 2011). 
In contrast to the findings with S. cerevisiae,  the non-cured [PRION+] strain of S. bayanus 
showed a clear growth disadvantage in the presence of fluconazole, when compared to the 
cured [prion] derivative (Figure 6.5). A difference in growth profile may be indicative of the 
presence of an endogenous prion within this species that is detrimental to the cell in the 
presence of fluconazole, however further analyses into (a) the confirmed presence of an 
endogenous prion within this species, and (b) the impact of such a prion on the host must be 
carried out.  
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6.4. Preliminary studies with non-domesticated wild strains of Saccharomyces 
cerevisiae 
As previously mentioned in Section 6, preliminary studies with wild strains of S. cerevisiae 



































Figure 6.5: Growth profiles of S. bayanus in YEPD + fluconazole following three rounds of 
GdnHCl-mediated curing on solid medium. Panel A)  The growth profile of S. bayanus in a [PRION+] 
and [prion-] state in glucose-containing medium. Panel B) The growth profile of S. bayanus in a 
[PRION+] and [prion-] state in YEPD + 1 µg fluconazole. The data reflects the average of three 
biological analyses, each with two technical replicates.
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mediated phenotypic heterogeneity in these strains. As with all species of Saccharomyces, 
exposure to GdnHCl by addition to yeast growth media was used to convert all wild strains of S. 
cerevisiae from a [PRION+] cell to a [prion-] state. Prior to the following experimental 
procedures, GdnHCl-induced petite mutants were not eliminated by growth on glycerol and 
therefore may be present in the analyses. Such mutants may impact the growth profiles of 
these strains, and further analyses into the frequency of both spontaneous and GdnHCl-
induced petite mutants are required.  Strains were grown on a solid rich (YEPD) 
medium supplemented with 5 mM GdnHCl for three consecutive rounds of sub-culturing. As with 
species of Saccharomyces, naturally-occurring prions have not yet been described in 
these non-domesticated wild strains of S. cerevisiae. 
In an attempt to establish whether phenotypic heterogeneity between [prion-] and [PRION+] 
strains of wild yeast occurs; the levels of osmotic stress, antibiotic sensitivity, and the ability of 
the yeast to grow on alternative carbon sources were analysed. Observed differences in survival 
between strains during conditions of hyperosmolarity, exposure to antifungal agents, and a 
natural ability to utilise alternative sources of carbon may be indicative of the presence of 
endogenous prions in these strains. 
6.4.1. Endogenous prions may be detrimental to wild strains of S. cerevisiae in 
conditions of hyper-osmolarity 
In order to identify wild S. cerevisiae strains with the ability to grow under conditions of high 
osmotic stress, both [PRION+] and [prion-] derivatives were also grown on complete medium 
supplemented with varying concentrations of NaCl (0.4 - 0.8 M). In contrast with the findings by 
Li and Kowal (2012), Newnam, Birchmore and Chernoff (2011) suggested that prolonged 
incubation in the presence of NaCl for at least 24 hours caused an increase in [PSI+] loss, which 
could be caused by an increased induction of Hsp104 (Newnam et al., 2011).  
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An increase in cell survival in a [prion-] state was observed in the non-domesticated wild strain of 
S. cerevisiae HN11, isolated from a primeval forest in China (Wang et al., 2012). In this
particular strain, increased cell growth on solid medium and a statistically significant improved 
growth profile was apparent in increasing concentrations of NaCl, following rounds of GdnHCl-
mediated prion curing (Figure 6.6). This would suggest the presence of an endogenous prion in 
this strain, which is detrimental to the cell in conditions of hyper-osmolarity. Eleven other non-
domesticated wild strains were tested for their levels of growth in conditions of hyper-osmolarity, 















Sc. HN11+ 0.4M NaCl Sc. HN11- 0.4M NaCl
Figure 6.6: Growth profiles of Sc. HN11+ and Sc. HN11- in YEPD + 0 .4M NaCl, following three 
rounds of GdnHCl-mediated curing on solid medium. Panel A)  The growth profile of HN11 
derivatives in glucose-containing medium. Panel B)  The growth profile of Sc. HN11- reveals a 
statistically significant increase in growth, when compared to the growth rate of its non-cured 




















6.4.2. Naturally-occurring prions affect the ability of wild strains of S. cerevisiae to 
utilise alternate carbon sources to glucose 
Following GdnHCl-mediated prion curing, twelve strains of wild yeast were grown on galactose, 
fructose and maltose in order to distinguish any differences between [PRION+] and [prion-] states 
in their ability to utilise alternative fermentable carbon sources. Differences in the growth of [PSI+] 
and [psi-] S. cerevisiae cells originating from 7 different genetic backgrounds were observed, in 
the presence of dextrose, galactose and lactate (True & Lindquist, 2000). In each genetic 
background, fresh stable [psi-] cells were generated using GdnHCl, to ensure that the observed 
phenotypic differences were due to the direct effects of the prion, rather than secondary genetic 
changes that may have occurred during long-term culture. In the presence of such fermentable 
carbon sources, [PSI+] cells in several S. cerevisiae strains displayed a positive difference in 
growth when compared to their GdnHCl-cured derivative (True & Lindquist, 2000). 
In support of these findings, non-domesticated wild strain S. cerevisiae SX2 isolated from a 
primeval forest in China showed impaired growth across several dilutions on solid fructose-
containing medium following GdnHCl-mediated prion curing. This was also the case for S. 
cerevisiae HN15, also isolated from the Chinese primeval forest, which showed impaired growth 
on galactose when in the [prion-] state. These findings are indicative of an endogenous prion in 
these two strains, which provides the cell with a mechanism of increased likelihood of cell survival 
in fluctuating environments. However, all conditions tested were only carried out on solid medium 
and scored for visual growth defects, and further analyses detailing the growth profile of each 
strain over time are required.  
In contrast, S. cerevisiae strain BJ14 displayed an increase in the level of growth in galactose, 
fructose and maltose when in the cured [prion-] state. This was also the case for S. cerevisiae 
Sc. HN11- in the presence of galactose. The increased level of growth in these strains 
following GdnHCl-mediated prion curing may be due to an endogenous prion, which acts as a 
burden to cells and exhibits a measurable demand on cell function and survival. Interestingly, 
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the yeast [SWI+] prion manifests as reduced growth on carbon sources other than glucose 
(Crow & Li, 2011). Specifically, poor growth of [SWI+] S. cerevisiae is observed in 
medium containing raffinose, galactose, and glycerol, and mild growth defects were observed in 
medium containing sucrose (Du et al., 2008). Interestingly, growth of [SWI+] cells improved 
on alternative carbon sources following 5 mM GdnHCl curing (Du et al., 2008). The 
phenotype of [SWI+] cells displayed in such experiments may suggest the presence of [SWI+] in 
these non-domesticated wild strains. 
6.4.3. Endogenous prions may impact the survival of wild strains of S. cerevisiae 
in the presence of various antifungal agents 
In order to identify strains of wild yeast where the ability to grow in the presence of various 
antifungal agents may be prion dependent, both [PRION+] and [prion-] derivatives were grown on 
complete medium supplemented with varying concentrations of protein synthesis inhibitors 
sordarin and cycloheximide, and fluconazole; an inhibitor of ergosterol biosynthesis. In certain 
conditions, the presence of an endogenous prion may be harmful to a cell’s survival, as 
demonstrated by Radchenko et al., (2011). Their study suggests that when compared to the 
[ISP+] strain of S. cerevisiae, its [isp-] derivative displayed a higher level of resistance to the 
actions of cycloheximide (Radchenko et al., 2011).  
Our investigations produced results in support of the findings by Radchenko et al., (2011) with 
Sc. wild strain SX6 maintaining a higher level of cycloheximide resistance following GdnHCl-
mediated prion curing, compared to its non-cured derivative. On solid medium, the zones of 
killing surrounding cycloheximide-infiltrated discs were significantly larger for Sc. SX6+ 
compared with the cured strain.  This level of cycloheximide sensitivity was confirmed in liquid 
culture, indicating the detrimental effects of an endogenous prion in this strain for survival 






























Sc. SX6+ Glucose Sc. SX6- Glucose
A) 
B)
Figure 6.7: Growth profiles of Sc. SX6+ and Sc. SX6- in YEPD + 0.25 µg/ml cycloheximide, 
following three rounds of GdnHCl-mediated curing on solid medium. Panel A) The growth 
profile of Sc. SX6 derivatives in glucose. Panel B) The growth profile of Sc. SX6- reveals a 
statistically significant increase in growth, when compared to the growth rate of its non-cured 
derivate. The data reflects the average of three biological repeats, each with two technical 
replicates. 
Interestingly, further investigations of the effects of cycloheximide specifically on [PSI+] strains of 
S. cerevisiae revealed no significant loss of the prion, but instead an increase in bright, sharp foci
indicative of Sup35-GFP seeds (Bailleul-Winslett et al., 2000). One explanation is that the
inhibition of protein synthesis by cycloheximide prevents accumulation of both newly synthesised
Sup35p and Sup35-GFP, thus leading to concentration of most of the Sup35-GFP in the






























Sc. BJ14+ Glucose Sc. BJ14- Glucose
A) 
B)
Figure 6.8: Growth profiles of Sc.  BJ14+ and Sc. BJ14- in YEPD + 25 µg/ml 
fluconazole, following three rounds of GdnHCl-mediated curing on solid 
medium. Panel A) The growth profile of both Sc. BJ14 derivates in glucose. Panel 
B) The growth profile of Sc. BJ14- reveals a statistically significant decrease in
growth, when compared to the growth rate of its non-cured derivative. The data
reflects the average of three biological replicates, each with two technical repeats.
In support of previous literature, our findings showed that the Sc. strain BJ14 was 
slightly more resistant to fluconazole in the wild type [PRION+] state (Figure 6.8). It 
could be inferred that this particular strain has an increased chance of survival in the 
presence of fluconazole, which may be a trait encoded by a naturally-occurring prion.   
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Interestingly, Sc. BJ6 only showed resistance to sordarin at certain concentrations of the drug 
when in the [PRION+] state. At concentrations of less than 0.5 µg/ml sordarin, the GdnHCl-cured 
version of Sc. BJ6 displayed a higher level of resistance, compared to its non-cured derivative. 
At 0.5 µg/ml to 1 µg/ml sordarin, Sc. BJ6 showed a reproducible higher growth and survival rate 
when in the [PRION+] state (Figure 6.9). These results are indicative of a change in the level of 
resistance when a certain threshold is reached. It can be inferred that at increasingly harmful 
levels of sordarin, the de novo appearance of an endogenous prion is upregulated, thus 















Sc. BJ6+ 0.5 µg/ml Sordarin Sc. BJ6- 0.5 µg/ml Sordarin
Figure 6.9: Growth profiles of Sc. BJ6+ and Sc. BJ6- in YEPD + 0.5 µg/ml sordarin, 
following three rounds of GdnHCl-mediated curing on solid medium. Panel A) The growth 
of both BJ6 derivatives in glucose. Panel B) The growth profile of Sc.  BJ6- reveals a 
statistically significant decrease in growth, when compared to the growth rate of its non-cured 
derivative, in contrast with results at lower concentrations of sordarin. The data reflects 



















6.5. All non-domesticated wild strains of S. cerevisiae are [pin-] 
The presence of an endogenous [PIN+] state in wild strains of S. cerevisiae may indicate the 
biological relevance of prions occurring in non-laboratory strains and further highlight the 
requirement of advantageous prion-mediated phenotypes being maintained across generations. 
To evaluate this, in twelve wild strains of S. cerevisiae, the joining of a GFP-tagged Rnq1 
fragment to endogenous prion aggregates made of the homologous Rnq1 protein was visualised 
by the formation of fluorescent foci, indicative of endogenous [PIN+]. pAG426-RNQ1-GFP was 
expressed in all strains under the control of the GAL1 promoter. In [PIN+] S. cerevisiae, 
endogenous Rnq1p induces the exogenous ScRnq1-GFP to convert to the prion form, thus 
forming bright fluorescent foci, while the ScRnq1-GFP remains soluble and dispersed across the 
cell in a [pin-] state (Derkatch et al., 2001).  
In laboratory strains of S. cerevisiae, the presence of prions formed by Rnq1 was sufficient in 
making cells [PIN+] (Derkatch et al., 2001). Deletion of the RNQ1 gene in Sc. BY4741 caused 
the loss of the [PIN+]-mediated phenotype, and [PIN+] could not be transmitted to the Δrnq1 
strain via cytoduction. Furthermore, in vivo ScRnq1-GFP aggregation analyses revealed Rnq1 
in an aggregated state in [PIN+] Sc. BY4741 (Derkatch et al., 2001). In support of these findings, 
ScRnq1-GFP was detected as bright fluorescent foci in the [PIN+] control strain Sc. 
BY4741 (Figure 6.10)  
In contrast, ScRnq1-GFP was expressed in twelve wild strains of S. cerevisiae using a plasmid 
conferring hygromycin B resistance to these strains. Yeast cells containing this plasmid were 
directly selected following transformation by growth on hygromycin B. All wild strains under 
test displayed ScRnq1-GFP as a soluble protein with fluorescence diffusely dispersed across all 
cells, confirming the [pin-] state of all non-domesticated wild strains of S. cerevisiae (Figure 6.10). 
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The [pin-] state revealed in all wild strains of S. cerevisiae in this study may contribute to the 
debate that prions in yeast are laboratory cultivated. However, in 70 alternative wild strains of S. 
cerevisiae originating from various geographical locations such as Belgium and West Africa, 11 
were found to be strong [PIN+] candidates, with clear formation of ScRnq1-GFP foci that was 
cured by growth on GdnHCl (Nakayashiki et al., 2005). This highlights the presence of [PIN+] in 
individual wild strains of S. cerevisiae.  
6.6. Characterisation of the [GAR+] prion in Saccharomyces and non-domesticated 
wild strains of S. cerevisiae
As described in Chapter 1, Section 1.6.6 the [GAR+] trait results in an override in the preference 
of carbon source in yeast, in contrast with [gar-] cells which act as metabolic specialists primarily 
metabolising glucose. [GAR+] cells are also resistant to glucosamine, a monosaccharide which 





Figure 6.10: Expression of ScRnq1-GFP in both laboratory and wild strains of S. 
cerevisiae. Panel A) ScRnq1-GFP forms bright fluorescent foci in [PIN+] control Sc. BY4741 
highlighted by red circles. Panel B) ScRnq1-GFP forms diffuse dispersed fluorescence in Sc. 
HN11, representative of all wild strains of S. cerevisiae. All non-domesticated wild strains 
displayed diffuse fluorescence, confirming their [pin-] state. Images shown were taken by 
fluores cent microsc opy du ring both log and statio nary phase s of growth, follow in g 24 hours 
induction with galactose. Each strain was visualised in three independent biological 
experiments, and at least 200 cells per condition were visualised. 
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2014). The [GAR+] state creates a bacteria-friendly environment by reducing the ethanol output 
by >50%, and it has been suggested that such promotion of survival in less favourable 
environments comes from the secretion of chemical messengers from bacteria in close proximity 
to the yeast (Jarosz, Brown, et al., 2014). More recently, this chemical messenger was identified 
as lactic acid, which caused yeast cells to heritably bypass glucose repression on exposure 
(Garcia et al., 2016). Lactic acid also induced [GAR+]-associated phenotypes in fungi with ~200 
million years of evolutionary distance from S. cerevisiae, indicating the independent evolution of 
glucose repression and highlighting the significance of a bacterial metabolite with the ability to 
induce a yeast prion (Garcia et al., 2016) 
6.6.1. S. bayanus is naturally [GAR+], indicated by successful growth on GGM 
To explore whether or not all species of Saccharomyces had the [GAR+] phenotype, all species 
of Saccharomyces were grown on medium containing 2% glycerol and 0.05% glucosamine 
(GGM), to select for [GAR+] strains with resistance to glucosamine and the ability to utilise 
glycerol as a carbon source. Previous studies have identified the laboratory strains Sc. 
BY4741 and Sc. 74D-694 as [GAR+], as well as the genetically marked wild strains Sc. 3903, 
Sc. 3913 and Sc. 3923 (M.F.Tuite, unpublished data) taking these as suitable control strains 
for growth on GGM. Two strains of S. bayanus displayed a strong level of growth on GGM, 
indicative of a strong [GAR+] phenotype in this species (Figure 6.11). However, further analyses 
are required to confirm the presence of the [GAR+] prion as this prion is not Hsp104 
dependent and hence would not be eliminated by GdnHCl-mediated curing (Brown & 
Lindquist, 2009).  
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6.6.2. [GAR+] is identified in non-domesticated wild strains of S. cerevisiae 
As with strains of Saccharomyces, all wild strains of S. cerevisiae were grown on medium 
containing 2 % glycerol and 0.05 % glucosamine (GGM). All [prion-] derivatives were 
also grown on GGM following GdnHCl-mediated prion curing, to confirm that [GAR+] 
behaves the same in wild strains of S. cerevisiae i.e. does not rely on Hsp104 for propagation.   
Seven wild strains of S. cerevisiae were found to be [GAR+] by their ability to grow on GGM 
medium (Figure 6.12). Interestingly, in comparison with Sc. HN14 in its natural [PRION+] state, 
the GdnHCl-cured [prion-] derivative did not grow. This difference in growth between cured and 
non-cured derivatives of the same strain may suggest a differentiation in the level of the [GAR+] 








Figure 6.11: S. bayanus is [GAR+], indicated by successful growth on GGM. Control strains 
of [GAR+] S. cerevisiae are also shown, displaying a range of strong and weak [GAR+] phenotypes 
by varying degrees of growth on GGM. The data shown are representative of three biologically 
independent experiments for each strain.   
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phenotypes are shown by small and large colonies respectively, and weak [GAR+] strains have 
been shown to convert to strong levels of [GAR+]-associated growth, indicating a favourable 
selection of the strong phenotype (Brown & Lindquist, 2009). The ‘strength’ of this phenotype 
may be altered during GdnHCl-curing in certain strains, leading to varying levels of growth on 
GGM (Figure 6.12). This may imply either (a) a role for Hsp104 or an alternative target of GdnHCl 
in [GAR+] yeast, or (b) a relationship between GdnHCl-induced petite mutants and the [GAR+] 
trait. Furthermore, the presence of papillae observed in some strains in Figure 6.12 may indicate 
‘stronger’ [GAR+] strains emerging in the cell population.  
6.7. Discussion 
The findings reported in this chapter suggest the possible presence of endogenous prions in 
Saccharomyces species and non-domesticated wild strains of S. cerevisiae which may control 
phenotypic traits that impact on a cell’s chance of survival in unfavourable and fluctuating 
environments. A summary of the experimental findings of this chapter can be found in Table 
6.1, outlining both prions and prion-related phenotypes detected in the strains and species 
under test. Prion-related phenotypes may either be detrimental or advantageous to the strain in 
question, refer to relevant sections for details.  
Figure 6.12: Identification of [GAR+] strains of wild S. cerevisiae by successful growth on 
GGM, following three rounds of curing with GdnHCl. Seven wild strains of S. cerevisiae grow 
on GGM, indicative of the presence of the [GAR+] prion in these strains. The data shown are 
representative of three biologically independent experiments for each strain.   
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Table 6.1: Endogenous prion states and prion-related phenotypes detected in the strains 
and species under test. Ticks indicate both the prion state and prion-related phenotypes 
confirmed in each strain. Prion-related phenotypes may either be detrimental or advantageous to 

































[pin-] ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
[GAR+] ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
[gar-] ✓ ✓ ✓ ✓ ✓
 Notably, searching for prion-mediated phenotypic traits that are sensitive to GdnHCl-mediated 
curing only allows uncovering those yeast prions which rely on Hsp104 for their propagation. 
There has been no evidence that GdnHCl can inhibit any other molecular chaperones although 
some e.g. Hsp70 do have associated ATPase activity and are involved in prion propagation albeit 
indirectly (Newnam et al., 1999).  While Hsp104 is the core chaperone involved in prion regulation 
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and propagation, its role is carried out in association with co-chaperones, such as members of 
the Hsp70 family (Kryndushkin & Wickner, 2007).  
The presence of well-established S. cerevisiae prions such as [PIN+] and [GAR+] reveals distinct 
individual differences between strains and species. A number of proteins such as Pma1, Std1 
and Hxt3 were identified as playing key roles in the [GAR+]-associated phenotype in S. cerevisiae, 
and have different degrees of sequence conservation in other yeast species such as S. bayanus 
(Jarosz, Lancaster, et al., 2014). Further analyses into the % identities and % similarities of 
these proteins in other Saccharomyces species is required. Prion-based strategies as 
responses to metabolic stresses are therefore likely to extend across various Saccharomyces 
species and possibly wider afield.  
[GAR+] is an example of a yeast prion which is able to transmit its epigenetic state without 
Hsp104, and instead relies on Hsp70 (Jarosz, Lancaster, et al., 2014). This is also the case for 
the novel non-amyloid prion [SMAUG+] which is responsible for delaying meiosis in response to 
starvation and formed by the RNA-binding protein Vts1 (Parfenova & Barral, 2020). Using a 
fluorescent reporter repressed by Vts1, [SMAUG+] was found in several natural yeast isolates, 
enabling these yeasts to optimise sporulation efficiency depending on nutrient availability in their 
environment. The self-templating properties of this prion have denoted it as a ‘transgenerational 
memory element’, as [SMAUG+] cells are able to ‘predict’ the duration of their next starvation 
period based on the history of the strain (Parfenova & Barral, 2020).  
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7. Chapter 7: Final Discussion
Prions are protein-based epigenetic determinants that undergo self-perpetuating, heritable 
changes in their structure, resulting in an alternative conformational form of a protein that typically 
assembles in cells into amyloid-based aggregates. To date, fungal prions have been almost 
exclusively studied in laboratory-bred strains of S. cerevisiae, and in this thesis I have broadened 
their study to wild strains i.e. non-laboratory strains of S. cerevisiae and three related 
Saccharomyces species: S. bayanus, S. mikatae and S. kudriavzevii. 
7.1. The impact of guanidine hydrochloride on genetic and epigenetic determinants in 
Saccharomyces species 
In order to identify prion-associated traits in each Saccharomyces species under examination, 
cells were exposed to low mM levels of GdnHCl in rich growth media. This is a commonly used 
method for prion “curing” in S. cerevisiae, converting a [PRION+] cell to a [prion-] state (Edskes 
et al., 1999; Tuite et al., 1981). Both treatment with GdnHCl and the concomitant loss of Hsp104 
activity also leads a loss of mitochondrial function in S. cerevisiae (Juliani et al., 1973) raising the 
question of whether it is the loss of Hsp104 activity or some other facet of GdnHCl exposure that 
leads to the generation of petite mutants. Remarkably, GdnHCl still induced petite mutants in S. 
cerevisiae in the absence of Hsp104 (see Chapter 4), implicating the possibility of an alternative 
target of GdnHCl in petite generation. Hsp104 may therefore be a primary target of GdnHCl, but 
an alternative protein or proteins may play a role in petite mutant generation in the absence of 
this protein.  
An alternate candidate for the target of GdnHCl in petite generation was hypothesised to be 
Hsp78; a disaggregase located in the mitochondrial matrix with similar activity to the cytosolic 
Hsp104. Hsp78 plays a key role in the translocation and initial stabilisation of proteins in the 
absence of Hsp70; a co-chaperone of Hsp104 (Schmitt et al., 1996). Thus, both the role 
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and location of Hsp70 in S. cerevisiae made this protein a likely candidate that mediated GdnHCl-
induced petite generation. 
However, the experimental findings reported in Chapter 4 suggest that the mitochondrially-
located molecular chaperone Hsp78 is not directly impacted in GdnHCl-induced petite 
generation. An alternative protein target of GdnHCl may instead be one (or more) members of 
the Hsp70 chaperone protein family. This hypothesis is developed from the notion that both the 
integrity of the mitochondrial genome, and a sufficient mitochondrial membrane potential 
necessary for efficient protein import, requires at least one of Hsp70 and Hsp78, in the absence 
of Hsp104 (Moczko et al., 1995).  
In the same manner in which GdnHCl may target Hsp70; an ATPase, this chemical agent was 
also shown to reactivate a dormant septin assembly pathway in S. cerevisiae, that was 
suppressed in this species during fungal evolution (Johnson et al., 2020). Septin proteins evolved 
from an ancestral GTPase, and co-assemble into hetero-oligomers, but subsequently lost the 
ability to hydrolyse GTP (Leipe et al., 2002). Johnson et al., (2020) showed that GdnHCl 
occupies the site of an evolutionarily ‘missing’ arginine in S. cerevisiae, thus steering the protein 
towards the shape required to make the six-unit complex, reactivating the septin assembly 
pathway (Johnson et al., 2020). Moreover, Shu et al., (2019) showed that GdnHCl inhibits 
the ATP hydrolysis and RNA helicase activities of Ebola virus (EBOV) VP35; an RNA 
polymerase cofactor which forms part of the EBOV ribonucleoprotein (RNP) complex (Shu et al., 
2019). Such findings emphasise the additional targets of GdnHCl, and findings by Shu et al., 
(2019) highlight the potential of this chemical to target helicases in S. cerevisiae. More 
specifically, one could hypothesise that Hmi1; a mitochondrially-localised helicase 
required for mitochondrial maintenance and function (Sedman et al., 2000), is a potential 
target of GdnHCl in petite generation. 
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7.2. Can prion-associated traits in other Saccharomyces species by identified by 
GdnHCl-mediated curing? 
Using GdnHCl-mediated prion curing, prion-associated traits were identified in other 
Saccharomyces species. The experimental findings reported in Chapter 6 highlight the possible 
existence of phenotypes linked to one or more endogenous prions in Saccharomyces species 
other than S. cerevisiae as well as in genetically undefined wild strains of S. cerevisiae. 
These prions may control phenotypic traits that impact on a cell’s chance of survival in 
unfavourable and fluctuating environments which these organisms are exposed to in their 
‘natural habitats’, such as conditions of high osmolarity. However, searching for prion-mediated 
phenotypic traits that are sensitive to GdnHCl-mediated curing only allows us to reveal a class 
of prions which rely on Hsp104 for their propagation.  
To date, there is no evidence that GdnHCl inhibits molecular chaperones other than Hsp104, 
although certain co-chaperones e.g. Hsp70, associate with Hsp104 ATPase activity and are 
indirectly involved in prion propagation (Newnam et al., 1999). Hsp70 is also thought to be 
responsible for the initial binding and stabilisation of mitochondria-imported misfolded substrate 
proteins, releasing them to Hsp78 for direct degradation in an ATP-dependent manner (Röttgers 
et al., 2002). Changes in the level of proteins by inhibition or overexpression can also remove 
prion traits, seen by inhibition and overproduction of Hsp104 (Ness et al., 2002; Ness et al., 2017), 
and overproduction of the chaperone Sse1, which eliminates the [URE3] yeast prion 
(Kryndushkin & Wickner, 2007). Sse1 together with a second co-chaperone Fes1 are nucleotide 
exchange factors which promote the release of ADP by Hsp70, thus allowing ATP to bind and 
thereby affecting the abilities of Hsp70 to bind, release and refold substrate proteins. Deletion of 
either the SSE1 or FES1  genes completely blocks [URE3] propagation (Kryndushkin & Wickner, 
2007). Future studies should therefore employ the use of inhibitors of other chaperone proteins 
and relevant gene knockouts, such as SSE1 or FES1, in order to uncover Hsp104-independent 
prion proteins in other Saccharomyces species.  
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7.3. Alternative mechanisms of protein inheritance in Saccharomyces species 
In addition to the studies of Hsp104-independent prion proteins in other Saccharomyces 
species, future work should also broaden the search for prions in Saccharomyces and strains of 
S. cerevisiae to encompass prion-like elements that do not fulfil all the classic properties of a
yeast prion e.g. mnemons (Caudron & Barral, 2013). An example of protein that can switch 
conformation to a mnemon form is Whi3 which encodes the ‘memory’ of a mating pheromone 
refractory state (Caudron & Barral, 2013). After prolonged exposure to a mating pheromone in 
the absence of a successful mating partner, budding yeast cells escape pheromone-induced 
cell cycle arrest through coalescence of the G1 cell cycle inhibitor Whi3 into a dominant, 
inactive super assembly, and resume their cell cycle (Caudron & Barral, 2013). Furthermore, 
these cells bud for the remainder of their life span even in the presence of mating pheromone, 
highlighting a memory state (Caudron et al., 2020). This pheromone refractory state remains 
stable over many cell cycles but is not passed on to daughter cells during mating. Mnemons 
share structural features with prions, yet the maintenance and asymmetric inheritance of 
Whi3mnem  is unknown, and remains to be characterised in both S. cerevisiae and 
Saccharomyces species (Caudron et al., 2020). Preliminary studies into the sequence 
similarity of WHI3 between Saccharomyces species reveals a relatively high degree of 
amino acid conservation between S. cerevisiae and S. bayanus and S. mikatae, at 
81% and 85% respectively. The scores of WHI3 sequence similarity could not be calculated 
for S. kudriavzevii as this particular gene sequence was only accessible as an incomplete 
shotgun sequence. Future work should focus on (a) the exact alignment of Whi3 between 
Saccharomyces species (b) key sequence features relative to the conformational switch to a 
mnemon, and (c) the possible production of mating pheromones in these species.  
The molecular chaperone Hsp70 prevents the formation of Whi3 super-assemblies, while 
Hsp104 promotes their formation, thus highlighting a complex role for molecular chaperones in 
prion-like elements that also remains to be established in alternative Saccharomyces species 
(Caudron & Barral, 2013).  
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An alternative strategy with potential for uncovering protein-based epigenetic determinants in 
Saccharomyces species is the transient overexpression of proteins, used by Chakrabortee et 
al., (2016) to uncover traits that remained heritable long after their relative protein 
expression returned to normal (Chakrabortee et al., 2016). Such protein overexpression 
uncovered a common type of protein-based inheritance in S. cerevisiae, through which 
intrinsically disordered proteins drive the emergence of novel phenotypes (Chakrabortee et al., 
2016). Similarly, Sideri et al., (2017) used a proteome-wide screen to identify the Ctr4 copper 
transporter subunit as a potential prion-forming candidate in S. pombe, with a predicted 
prion-like domain (Sideri et al., 2017). Overexpression of the CTR4 gene resulted in large 
protein aggregates that were heritable in a non-Mendelian fashion, corresponding with other 
fungal prions (Sideri et al., 2017). This strategy uncovered the first transmissible protein-based 
determinant of trait in fission yeast, but naturally-occurring prion-like proteins in species of 
Saccharomyces are yet to be addressed using this method. 
Moreover, Simpson-Lavy et al., (2017) uncovered a controlled, non-pathological role of protein 
aggregation in the regulation of glucose response mechanisms. SNF1; responsible for the 
switch from respiration to fermentation in S. cerevisiae, is reduced by a reversible non-
amyloid aggregation of Std1 (Simpson-Lavy et al., 2017). Std1 aggregation may function as 
short-term memory of prior nutrient status, thus regulating Snf1 function, leading to a change in 
phenotype in S. cerevisiae (Simpson-Lavy et al., 2017). The potential for this mechanism in 
species of Saccharomyces remains to be established. 
7.4. The impact of natural genetic variation on protein aggregation in Saccharomyces 
species
In addition to searching for prion-related phenotypes in species of Saccharomyces, the ability of 
these genetically-related species to facilitate and perpetuate the formation of other amyloid-
forming but heterologous proteins; in particular the Alzheimer’s-related protein Aβ42 and 
Huntington’s disease-associated Htt-polyQ, was examined. The results indicate that each of the 
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Saccharomyces species under test can propagate the aggregated forms of Aβ42 and polyQ, but 
these amyloid states were differentially impacted upon by the endogenous prion state of the host 
yeast species. Chemical inhibition of Hsp104 demonstrated that Htt-Q97 aggregates are unable 
to form in Saccharomyces species, namely S. bayanus and S. mikatae. Deletion of the HSP104 
gene in S. cerevisiae supported these findings, and the use of HSP104 gene knockouts in other 
Saccharomyces species would further complement the strategy used here i.e. chemical 
inhibition of Hsp104 using GdnHCl. The inability of Htt-Q97 to aggregate in Saccharomyces 
species following Hsp104 inhibition suggests a requirement for a [PIN+]-like prion and indirectly 
Hsp104 in Htt-Q97 aggregation, since Hsp104 is required for prion maintenance in yeast (Meriin 
et al., 2002). By contrast, the same experiments showed that aggregation of Aβ42 does not 
require an endogenous prion or Hsp104 in any species tested, as Aβ42 aggregates remained in 
all Saccharomyces species following GdnHCl-induced inhibition of Hsp104. Similarly, the results 
outlined in this thesis indicate that Upf1, but not Upf2 or Upf3, is essential for the aggregation of 
Htt-Q97 in S. cerevisiae, but not for the aggregation of Aβ42 and further highlights the differing 
requirements for maintenance of these amyloid-forming proteins. 
The Upf1/2/3 proteins form the nonsense-mediated decay (NMD) complex that recognises 
premature stop codons in mRNA transcripts at the ribosome, and Upf1p is responsible for 
shuttling mRNA transcripts containing premature stop codons to P-bodies for degradation 
(Mendell & Dietz, 2008). Unlike in S. cerevisiae, an animal with a UPF1 knockout is not viable, 
indicating the possibility of a further requirement of this protein separate to its role in NMD 
(Mendell & Dietz, 2008). Interestingly, mammals also have two Upf3 genes; UPF3a and UPF3b, 
highlighting subtle differences between the NMD complexes in mammals and S. cerevisiae 
(Mendell & Dietz, 2008). Despite these differences, our experimental findings highlight the role of 
UPF1 in Htt-Q97 aggregation in S. cerevisiae, which may indicate a role of Upf1 in mammalian 
disease-associated amyloid aggregation and a potential as an anti-aggregation target.  
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Son and Wickner (2018) showed that Upf1 and Upf3 were frequently detected as anti-prion genes 
in a genetic screen (Son & Wickner, 2018). Interestingly, almost all [PSI+] variants that arose in 
the absence of these proteins were eliminated by restoring the Upf1 and Upf3 protein levels back 
to normal (Son & Wickner, 2018). Upf1 and Upf3 may therefore act as anti-aggregation targets, 
by either (a) blocking the addition of new monomers to the Sup35 amyloid or (b) blocking the 
propagation of new [PSI+] prion variants. Interestingly, Urakov et al., (2018) showed that Upf1 
only acted as an anti-[PSI+] protein in the presence of Pub1; an RNA-binding protein (Urakov et 
al., 2018). The interplay between Upf1, Pub1, and [PIN+] in S. cerevisiae is yet to be 
established, but [PIN+]-associated aggregation may decrease in the absence of Upf1, thus 
inhibiting the aggregation of Htt-Q97.  
Using Htt-72Q expressed in S. cerevisiae, Aktar et al., (2019) also showed that Htt-GFP depends 
on Hsp104 for aggregation; with an inability to form inclusion bodies in a Δhsp104 strain (Aktar 
et al., 2019). Moreover, rnq1Δ strains expressing Htt-72Q were also unable to form inclusion 
bodies, small particles, aggregates or liquid assemblies, indicative of the requirement of Rnq1 
for Htt-GFP aggregation (Aktar et al., 2019; Meriin et al., 2002; Peskett et al., 2018). Aktar et 
al., (2019) also showed that Htt-GFP inclusions concentrate together with Hsp104, 
which is expressed significantly above cytoplasmic levels in the inclusion body. This may 
suggest a specific role for Hsp104 in catalysing Htt fibres in the cytoplasm, before unwinding 
them in the inclusion body (Aktar et al., 2019). 
These findings, along with the experimental outcomes reported in this thesis indicate the 
possibility of either (a) a direct role for Hsp104 in Htt-polyQ aggregation or (b) an indirect role 
for Hsp104 in Htt-polyQ aggregation via an effect on an Hsp104 substrate that is in turn 
required for aggregation. However, the precise involvement in aggregation interaction 
remains to be established. It seems most likely that Htt-polyQ directly relies on a [PIN+]-
like factor for aggregation, much like the [PSI+] prion. Htt-polyQ may use [PIN+] as a 
template for initial seed formation, and co-localisation studies with Htt-polyQ, [PIN+] and 
Hsp104 may help to uncover a more specific role of these proteins in Htt-polyQ 
aggregation. Following seed formation, it is possible that [PIN+] may act as a 'distraction' 
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mechanism to Hsp104, reducing the clearance of Htt-Q97 by directly competing for Hsp104 
binding, thus titrating its activity. The findings reported in this thesis extend the initial 
observations of the requirement of Hsp104 for Htt-polyQ aggregation into other species of 
Saccharomyces, as chemical inhibition of Hsp104 in these species demonstrated that Htt-
Q97 aggregates are unable to form.   Remarkably, some other less evolutionary-related 
fungi have apparently evolved powerful mechanisms to overcome the toxicity 
associated with aggregating and potentially toxic amyloid protein. This is demonstrated by the 
fungal pathogen Candida albicans, in which the expression of polyQ stretches up to 230Q 
have no effect on C. albicans growth and hence can withstand proteotoxic stress, despite 
having a glutamine-rich proteome similar to S. cerevisiae (Leach et al., 2017). This 
highlights the possibility that alternate fungal species have the ability to overcome the 
toxicity associated with Htt-polyQ aggregation, thus providing novel models for the 
investigation of disease-associated amyloid proteins. 
7.5. The cross-species prion transmission barrier 
The experimental findings presented in Chapter 3 highlight an inability of other Saccharomyces 
species to form fluorescent GFP foci following the expression of either ScSup35-GFP and 
ScRnq1-GFP. This finding is consistent with the existence of a cross-species prion transmission 
barrier rather than an intrinsic inability to form these prions (Chen et al., 2007). The cross-
species barrier has been particularly well studied with the [PSI+] prion in Saccharomyces 
species, where studies have revealed a high level of sequence divergence of the Sup35-PFD 
between these species resulting in asymmetric prion transmission (Bruce and Chernoff, 2011, 
see also Chapter 1, Section 1.4.3). [PSI+] can be transferred between members of 
Saccharomyces, but this depends on the combination of Sup35-PFD sequences used, 
and the [PSI+] conformational variant in the S. cerevisiae ‘donor’ strain (Afanasieva et al., 
2011; Chen et al., 2007, 2010). It may be that the two related prion proteins are simply 
unable to interact; oligomers formed by one misfolded protein may be unable to 
promote the polymerisation of another, and are therefore responsible for the observed prion 
species barrier. However, the ability of non-cerevisiae Sup35 proteins to transform into 
a stable [PSI+] conformation in their native cellular context remains to be   
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established. Remarkably, Nakayashiki et al., (2001) showed the potential of certain [PSI+] 
prions to overcome this cross-species barrier, with inter-species [PSI+] transmissibility and 
propagation between Kluyveromyces lactis and S. cerevisiae (Nakayashiki et al., 2001). Grizel, 
et al., (2016) summarised that the prion strain, amino acid sequence, cell environment, and 
conditions of the aggregation reaction all play a role in the cross-species prion transmission 
barrier (Grizel et al., 2016). Studies by Sharma et al., (2015) further highlighted that the 
major characteristics of the prion species barrier between members of Saccharomyces are 
determined by protein sequence, rather than intracellular environment, shown by 
transfection of cellular extract from one species to another (Sharma et al., 2015). Protein 
aggregation of both S. bayanus and S. paradoxus are also influenced by the type of anion 
present during the formation of the initial prion seed (Sharma et al., 2015). More specifically, 
salts present during seed formation determine the seed conformation, which in turn 
influences the efficiency of conformational adaptation of the added monomer to the preformed 
nuclei provided by the seed (Sharma et al., 2015). Salt present during amyloid formation can 
therefore alter the parameters of the species barrier, and a more pronounced barrier was 
apparent in the more divergent S. bayanus (Sharma et al., 2015).  Future experimental work 
should therefore focus on overcoming the issue of the Saccharomyces-associated species 
barrier, by cloning SUP35 and RNQ1 genes from all Saccharomyces species, to create GFP 
fusions that can be expressed in each of the species. The corresponding expression of Sup35-
GFP and Rnq1-GFP fusions in each of the Saccharomyces species may uncover more 
distinct barriers associated with certain species combinations. 
7.6. Yeast models of neurodegenerative diseases 
S. cerevisiae has served as a primary model for a variety of key cellular processes, including but 
not limited to the impact of oxidative stress on mitochondrial morphology (Rogov et al., 2018) and 
autophagy (Reggiori & Klionsky, 2013). The Saccharomyces Genome Database 
(https://www.yeastgenome.org/) is a readily available toolkit providing comprehensive biological 
information for Saccharomyces cerevisiae, making relevant material available to establish 
techniques for the genetic manipulation and modification of this species. S. cerevisiae-based 
models have therefore been used to unravel several human disease mechanisms including the 
molecular mechanisms underlying cancer (Ferreira et al., 2019). It has also provided an 
important 
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resource for characterising the ~17% of yeast genes which exist as members of orthologous 
gene families associated with human diseases (Foury, 1997). Using high-throughput screening 
methods, the expression of human proteins in yeast cells has also been significant for the 
discovery of chemical or protein inhibitors of their activity (Heinicke et al., 2007).  
S. cerevisiae has also been exploited as a suitable model for neurodegenerative disorders, due 
to the presence of a number of endogenous amyloid-forming proteins, including prions. To date, 
~12 different prions have been identified in yeast, which are linked to either a loss of normal 
protein function, or a gain by that protein of a novel function (Wickner et al., 2018). S. cerevisiae 
has also provided a model for the discovery of alternative mechanisms of protein inheritance 
(Caudron & Barral, 2013; Chakrabortee et al., 2016) S. cerevisiae has therefore given us insight 
into amyloid protein-associated disease mechanisms, specific aspects of the pathobiology of 
neurodegenerative disorders, the role of cellular factors in protein-associated toxicity, and novel 
mechanisms of molecular memory.  
Studies with S. cerevisiae has also contributed to the development of potential therapeutic 
strategies, by identifying molecular chaperones that disaggregate potentially toxic forms of 
disease-related proteins. Hsp104 has been identified as essential for the maintenance of several 
endogenous prions, as well as the aggregation of Huntington’s disease-associated Htt-Q97 (see 
Chapter 5). Although there is no mammalian orthologue of Hsp104, this yeast chaperone can 
disaggregate and reduce levels of toxicity associated with several protein aggregates involved in 
neurodegenerative disorders (March et al., 2019).  
There are however limitations in using S. cerevisiae as a disease model that must not be 
overlooked. Firstly, yeast cell-based neurodegenerative disease models typically involve 
expression of the target protein, and the evaluation of cell toxicity or protein aggregation. 
However, in their typical disease state, such proteins often interact with other proteins within the 
neuron for which there is no yeast orthologue, giving rise to the disease pathology. One example 
of this can be found with the AD-associated Tau protein, which is not toxic when expressed in 
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yeast, yet displays levels of toxicity when co-expressed with αsynuclein (Zabrocki et al., 2005). 
Further studies should therefore seek to replicate neuron-specific pathways in yeast; involving the 
correct expression and localisation of multiple heterologous proteins simultaneously. Secondly, in 
the majority of yeast cell-based disease models, the expression of the target protein is often 
regulated to be on or off. This limits studies into disease-associated proteins with an aggregation 
propensity that is concentration dependent. 
On the other hand, throughout this thesis, species of Saccharomyces have been used 
to explore extrachromosomal regulators of phenotypic heterogeneity, and the ability of these 
species to facilitate and perpetuate the formation of other amyloid-forming proteins. 
However, using alternate species of yeast as model organism may provide unique challenges 
and limitations. Despite being included in the first genomic comparisons of the Saccharomyces 
group, there is only one strain of S. mikatae for which genomic data are available; limiting the 
levels of inter-strain variation to be uncovered in this species (Borneman & Pretorius, 2014). 
Moreover, the largest collection of S. mikatae strains all originate from environments in one 
country i.e. Japan, further limiting the potential levels of inter-strain variation. In contrast, 
studies using S. kudriavzevii have isolated strains from both Japan and Europe, representing 
a range of ecological niches. Furthermore, strains of S. bayanus are predominantly highly 
recombined, interspecific hybrids that comprise almost equal genomic contributions from 
S. eubayanus and S. uvarum, with minor input (70-80 kb) from S. cerevisiae (Libkind et al., 
2011).  
Despite the limitations faced by the use of Saccharomyces species, even a single representative 
strain of a species provides an additional point of comparison to other 
Saccharomyces species. Overall, yeast cell-based models remain as first-step models of 
neurodegenerative disorders (Tuite, 2019), and expanding studies into other species of 
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